coriell cell line repository identifier: GM06985
coriell cell line repository identifier: GM06993
coriell cell line repository identifier: GM06994
coriell cell line repository identifier: GM07000
coriell cell line repository identifier: GM07022
coriell cell line repository identifier: GM07034
coriell cell line repository identifier: GM07055
coriell cell line repository identifier: GM07056
coriell cell line repository identifier: GM07345
coriell cell line repository identifier: GM11829
coriell cell line repository identifier: GM11830
coriell cell line repository identifier: GM11831
coriell cell line repository identifier: GM11832
coriell cell line repository identifier: GM11839
coriell cell line repository identifier: GM11881
coriell cell line repository identifier: GM11882
coriell cell line repository identifier: GM11992
coriell cell line repository identifier: GM11993
coriell cell line repository identifier: GM11994
coriell cell line repository identifier: GM12003
coriell cell line repository identifier: GM12004
coriell cell line repository identifier: GM12005
coriell cell line repository identifier: GM12006
coriell cell line repository identifier: GM12043
coriell cell line repository identifier: GM12044
coriell cell line repository identifier: GM12056
coriell cell line repository identifier: GM12057
coriell cell line repository identifier: GM12144
coriell cell line repository identifier: GM12145
coriell cell line repository identifier: GM12155
coriell cell line repository identifier: GM12264
coriell cell line repository identifier: GM12716
coriell cell line repository identifier: GM12717
coriell cell line repository identifier: GM12750
coriell cell line repository identifier: GM12762
coriell cell line repository identifier: GM12813
coriell cell line repository identifier: GM12814
coriell cell line repository identifier: GM12815
coriell cell line repository identifier: GM12872
coriell cell line repository identifier: GM12874
coriell cell line repository identifier: GM12891
clip antibody: monoclonal anti-PTB antibody (BB7)
library source: monomeric PTB-RNA complex
developmental stage: Embryonic stem cells
cell type: Peripheral blood mononuclear cells (PBMC)
cell type: Chronic Myelogenous Leukemia cell line
cell type: Acute Promyelogenous Leukemia cell line
rna type: chromatin-associated RNA (CAR)
clinical characteristics: Distal normal liver tissue of liver hemangioma
clinical characteristics: Distal liver tissue of liver hemangioma in HBV infected liver
clinical characteristics: Distal liver tissue of liver hemangioma in severe chronic hepatitis B liver
tumor stage: HBV-related HCC Distal Tissue
clinical characteristics: Distal liver tissue of primary HBV-related HCC
tumor stage: HBV-related HCC Adjacent Tissue
clinical characteristics: Adjacent liver tissue of primary HBV-related HCC
tumor stage: HBV-related HCC Side Tissue
clinical characteristics: Side liver tissue of primary HBV-related HCC
clinical characteristics: Primary HBV-related HCC
tumor stage: HCV-related HCC Adjacent Tissue
clinical characteristics: Adjacent liver tissue of primary HCV-related HCC
clinical characteristics: Primary HCV-related HCC
tumor stage: HBV(-) HCV(-) Adjacent Tissue
clinical characteristics: Adjacent liver tissue of primary HBV(-) HCV(-) HCC
clinical characteristics: Primary HBV(-) HCV(-) HCC
cell type: C3H10T1/2 / MIA PaCa-2 coculture
crosslinker and crosslinking wavelength: 4-SU / 365 nm
crosslinker and crosslinking wavelength: 6-SG/ 365 nm
weight of protein recovered: ca. 200 kDa
sequencing protocol: paired-end, 36-mer sequencing
cell type: human epithelial cervical cancer cells
cell type: nasopharyngeal carcinoma cell line
supplier: Dr. Steve Ethier, University of Michigan
isolation: fluorescence activated cell sorting
cell type: H1 human embryonic stem cells
sample type: Lin28 immunoprecipitated fractioni
cell type: Differentiated fused HEF19 and FL24 cells
cell line: human embryonic stem cell (hESC) H9
datatype description: Sequencing analysis of RNA expression
rnaextract description: Rna shorter than 200 nt that has not been seperated based on Poly Adenalyation
readtype description: Single 36 nt reads
localization description: The fluid between the cells outer membrane and the nucleus
protocol description: This kind of library was made from RNA < 200 nucleotides that were pre-treated with Tobacco Acid Pyrophosphatase to remove any 5' caps that would preclude cloning. Hence, both capped and 5' monophosphate RNAs will be cloned.
localization description: Large membrane bound part of cell containing chromosomes and the bulk of the cell's DNA
cell description: skin fibroblast, "The line was established from skin taken from normal foreskin." - ATCC. (PMID: 9916803)
readtype description: Single 101 nt reads
protocol description: This kind of library was made from RNA < 200 nucleotides that was pre-treated sequentially with Calf Intestinal Alkaline Phosphatase followed by Tobacco Acid Pyrophosphatase. Hence, it will be enriched for capped RNAs.
protocol description: No special treatment or protocol applies
localization description: The part of the nucleus where ribosomal RNA is actively transcribed
localization description: Nuclear DNA and associated proteins
disease state: acute lymphoblastic leukemia (ALL)
vector: LS*mock, expressing recombinant, HA-tagged wild-type RPB1 (amanitin resistant)
vector: LS*mock, expressing recombinant, HA-tagged R1810->A RPB1 (amanitin resistant)
cell type: human embryonic stem cells (HESCs)
cell type: HS181-derived embryoid bodies
genotype/variation: HP1 gamma knock down
data processing (alignment) algorithm: Bowtie
enzymatic digestion: complete T1 digestion
enzymatic digestion: mild MNase digestion
cell type: Neural crest cells (hNCC) derived from H9 ESC
tissue: breast invasive ductal carcinoma
tissue: head and neck squamous cell carcinoma
cell type: large airway epithelial cells
cell type: primary human mammary epithelial cells
disease status: stage III colorectal cancer patients
tissue type: Bowel adenocarcinoma tissue
cell type: kidney proximal tubule epithelial cell line
sample composition: 10 human cell lines of various origins (B lymphocyte, brain, breast, cervix, liposarcoma, liver, macrophage, skin, testis, and T lymphocyte)
sample composition: Several brain regions from 23 adult donors
sample type: universal human reference (MAQC)
tissue source: Commercial / AMS biotechnology
tissue source: Netherland Brain Bank, Netherlands
tissue source: National Disease Research Interchange, USA (NDRI)
description: lymphoblastoid cell-line derived from NA12878
cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus
rnaextract description: Poly(A)+ RNA longer than 200 nt
readtype description: Paired 76 nt directed reads
rnaextract description: Poly(A)- RNA longer than 200 nt
readtype description: Paired 76 n.t. directed reads
cell description: mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis
rnaextract description: Total RNA extract (longer than 200 nt)
localization description: That part of the nuclear content other than the chromosomes or the nucleolus
cell description: skeletal muscle myoblasts
cell description: neuroblastoma cell line, treatment: differentiated with retinoic acid, (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)
cell description: mammary epithelial cells
cell description: epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis
readtype description: Paired 101 nt directed reads
tissue: brain region BA22 (temporal cortex)
tissue: brain region BA41 (temporal cortex)
tissue: brain region BA09 (frontal cortex)
cell type: Cultured primary human lung fibroblast
cell type: Cultured primary human foreskin fibroblast
knockdown: ELAVL1/HuR  siRNA1 (see Lebedeva et. Al 2011)
knockdown: ELAVL1/HuR siRNA1 (see Lebedeva et. Al 2011)
cell type: hTERT-immortalized retinal pigment epithelial
disease state: castration resistant prostate cancer
cell line: Cell line derived from Burkitt's lymphoma
treatment: Sendai virus (MOI = 10, 16 hours)
cell type: bead purified CD10+ myoepithelial cells
cell type: bead purified CD24+ epithelial cells
cell type: bead purified CD44+ progenitor cells
cell type: cd44+ cells from BRCA2 mutation carrier
cell type: cd44+ cells from BRCA1 mutation carrier
developmental stage: 31 year adult female
disease/cell type: transformed with adenovirus 5 DNA
developmental stage: Healthy women (30 +/-0.9 years old, primiparity) when the infant were aged at 60 days
cell line: IMR90 human primary lung embryo fibroblasts
cell type: Melanocytes over-expressing red fluorescent protein (RFP) - control sample
cell type: Melanocytes over-expressing BRAFv600e
cell type: human foreskin fibroblasts (HFF)
clinical form: Localized cutaneous leishmaniasis
datatype description: RNA Paired-End Tags
readtype description: Paired 36 nt reads
localization description: Strand of mRNA with ribosomes attached
lab description: Ruan - Genome Institute of Singapore
datatype description: RNA Paired-End Tag
cell description: lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus
sample type: human colon carcinoma cell line established from the primary colon carcinoma of an adult man
binding/selection: Fragmentented & 2x Poly(A) selected ds-cDNA
cell type: MCF10A breast epithelial cells
cell type: Basal Cell Carcinoma, nodular
cell type: Basal Cell Carcinoma, infiltrative
phenotype (sq=squamous lung cancer, ad=adenocarcinoma lung cancer): Sq
phenotype (sq=squamous lung cancer, ad=adenocarcinoma lung cancer): benign
phenotype (sq=squamous lung cancer, ad=adenocarcinoma lung cancer): Ad
phenotype (sq=squamous lung cancer, ad=adenocarcinoma lung cancer): AdSq
cell type: human GBM-derived "stem-like" cells
transfected with: AFF2 SMARTpool siRNA duplex
transfected with: AFF3 SMARTpool siRNA duplex
transfected with: AFF4 SMARTpool siRNA duplex
shRNA expression: expressing shRNA targeting EGR1
shRNA expression: expressing shRNA targeting ATF3
cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC
cell type: immortalised chronic myelogenous leukemia (CML)
cell line: Cell line derived from Merkel Cell Carcinoma
antibody manufacturer: Aviva Systems Biology
genotype/variation: Control knockdown (Control siRNA)
genotype/variation: AR knockdown (AR siRNA)
treatment: siRNA transfection with 5nM siCTL
treatment: siRNA transfection with 5nM siGPS2
cell type: Peripheral blood mononuclear cells
treatment: Flagelline at 0.25 ug/ml for 4 hours
treatment: Flagelline at 0.25 ug/ml for 4 hours and 20 ug/ml of IDR-1018
cell type: human hepatocellular liver carcinoma cells
molecule type: Ribosomal RNA-depleted total RNA
cell type: RNA extracted from B Lymphoblastoid cell lines established by Epstein-Barr Virus, with equimolar concentrations of ERCC spike-in standards at 5 % of total RNA
cell type: isogenic hTERT-immortalized normal human mammary epithelial cell lines with lentiviral vector transducing the LacZ gene
cell type: isogenic hTERT-immortalized normal human mammary epithelial cell lines with lentiviral construct expressing an ATM shRNA
treatment: transfected with pCBASce plasmid and collected at 12 h post-transfection.
treatment: transfected with pCBASce plasmid and collected at 16 h post-transfection.
treatment: transfected with pCBASce plasmid and collected at 20 h post-transfection.
treatment: transfected with pCBASce plasmid and collected at 24 h post-transfection.
treatment: transfected with a plasmid having the same vector backbone but missing I-SceI and collected at 20 h post-transfection as control.
tissue: metastatic melanoma to lymph node
tissue: acrolentiginous melanoma (3.0 mm, level IV)
tissue: metastatic melanoma to the lymph node
tissue: primary cutaneous melanoma (11.5 mm, level V)
tissue: primary cutaneous melanoma (4.0 mm, level IV)
tissue: primary cutaneous melanoma (2.8 mm, level IV)
tissue: primary cutaneous melanoma (2.5 mm, level IV)
tissue: primary cutaneous melanoma (2.0 mm, level IV)
cell type: human preimplantation blastomere (Oocyte)
cell type: human preimplantation blastomere (zygote)
cell type: human preimplantation blastomere (2-cell)
developmental stage: peri-implantation stem cells
cell type: human preimplantation blastomere
cell type: lung adenocarcinoma cell line
origen of cultured cells: RPE isolated from 16 weeks gestation human fetus
transepithelial electrical resistance: 600 ± 30 ohm*cm^2
transepithelial electrical resistance: 740 ± 55 ohm*cm^2
origen of cultured cells: hESC H1 line - derived RPE
transepithelial electrical resistance: 150 ± 20 ohm*cm^2
transepithelial electrical resistance: 155 ± 20 ohm*cm^2
transepithelial electrical resistance: 220 ± 35 ohm*cm^2
origen of cultured cells: hESC H9 line - derived RPE
transepithelial electrical resistance: 160 ± 10 ohm*cm^2
transepithelial electrical resistance: 115 ± 10 ohm*cm^2
transepithelial electrical resistance: 730 ± 10 ohm*cm^2
peak transepitheilal electrical resistance (ksr only): N/A
transepithelial electrical resistance: 41±1 ohm*cm^2
peak transepitheilal electrical resistance (ksr only): 150±10 ohm*cm^2
transepithelial electrical resistance: 37± 4 ohm*cm^2
peak transepitheilal electrical resistance (ksr only): 110±10 ohm*cm^2
transepithelial electrical resistance: 49± 4 ohm*cm^2
peak transepitheilal electrical resistance (ksr only): 55±4 ohm*cm^2
genotype/variation: lentiviral-mediated knockdown of GFP (control)
genotype/variation: lentiviral-mediated knockdown of RBFOX1
disease state: Tetralogy of Fallot (TOF)
disease status: ductal carcinoma in situ
cell type: M1 macrophages (classically activated)
cell type: M2 macrophages (alternatively activated)
sirna: 5'-NNCCUGAAUG GGCGCGAAUUC-3' dsRNA oligo from Dharmacon
sirna: 5'-NNGACCGAGA UUACAUGGAUA-3' dsRNA oligo from Dharmacon
treatment: 30 minutes incubation at 43ºC (heat shock)
cell type: Primary Human Aortic Endothelial Cells
treated with: 500 nM Trichostatin A (TSA) for 12hr
lab description: Snyder - Yale University
treatment description: 30 m of Interferon alpha (Snyder)
rnaextract description: Isolated Poly(A) RNA
treatment description: Interferon alpha treatment - 6 hours (Snyder)
treatment description: Interferon gamma treatment - 30 minutes (Snyder)
treatment description: Interferon gamma treatment - 6 hours (Snyder)
disease state: clear cell renal cell carcinoma  recurrence
disease state: clear cell renal cell carcinoma  stage IV
disease state: clear cell renal cell carcinoma  without recurrence
treatment description: 1 h with 100 pM Dexamethasone (Myers)
treatment description: No special treatment or protocol applies
treatment description: 1 h with 100 nM Dexamethasone (Myers)
treatment description: 1 h with 0.02% Ethanol (Myers)
treatment description: 4 h with 100 nM Genistein (Myers)
treatment description: 1 h with 500 pM Dexamethasone (Myers)
treatment description: 1 h with 1 nM Dexamethasone (Myers)
treatment description: 1 h with 5 nM Dexamethasone (Myers)
cell type: peripheral blood mononuclear cells
cell type: benign prostate epithelial cells
overexpressing: empty vector containing GFP
cell type: epithelial breast cancer cells
cell type: mesenchymal-like breast cancer cells
stably transfected with: miR-23b with specific sponge vector
cell line stably expressing: HIS/FLAG/HA-tagged ALKBH5
cell line stably expressing: HIS/FLAG/HA-tagged C17orf85
cell line stably expressing: HIS/FLAG/HA-tagged C22orf28
cell line stably expressing: HIS/FLAG/HA-tagged CAPRIN1
cell line stably expressing: HIS/FLAG/HA-tagged ZC3H7B
cell type: Human embryonic stem cell line
treatment: siRNA knockdown of ADAR1, 24 hour time point
treatment: siRNA knockdown of ADAR1, 48 hour time point
treatment: siRNA knockdown of ADAR1, 72 hour time point
treatment: siRNA knockdown of ADAR1, 96 hour time point
treatment: non-targeting control siRNA, 96 hour time point
treatment: 4SU+6SG labeling and biotin-purified
sirna: ON-TARGETplus Non-Targeting siRNA Control (Dharmacon, D-001810-01)
sirna: ON-TARGETplus Non-Targeting siRNA against GATA3
sirna: ON-TARGETplus Non-Targeting siRNA against TCF7L2
germinal zone: inner subventricular zone (ISVZ)
germinal zone: outer subventricular zone (OSVZ)
cell type: HEK293T human embryonic kidney cell line
organ-tropism: higher metastasis ability specific to lung
organ-tropism: dual metastasis ability to lung and celiac lymph node
treatment protocol: G28.5 treatment (1 ug, 24 hour)
antibody/capture: poly(A) selection (Oligotex mRNA Mini Kit, QIAGEN)
rna associated: overexpressed (T7) DGCR8
thyroid tissue type: follicular thyroid adenoma
thyroid tissue type: follicular thyroid carcinoma
transfected with: lentivirus harboring shRNA of control (Arab1)
transfected with: lentivirus harboring shRNA of both GATA6 and HOPX
ip antibody: Anti-FLAG (Sigma, Catalog# A2220, Lot# SLBB7030)
cell line specificity: HEK293-T-Rex inducible cell line expressing ZNF143
treatment: 0h Induction with 1µg/mL ofdoxycycline
treatment: 24h Induction with 1µg/mL ofdoxycycline
cell type: Head and Neck Squamous Cell Carcinoma cells
readtype description: Paired 75 nt reads
insertlength description: insert length of 200nt
readtype description: Single 75 nt directed reads
insertlength description: No special treatment or protocol applies
insertlength description: insert length of 400nt
treatment description: Myocytes differentiated from myoblasts for 7 days. See specific cell protocol for treatment details. (Wold)
cell type: leukocyte from blood of healthy individual
cell type: NG2-sorted cell from blood of melanoma patient
sample type: universal human reference RNA
developmental stage: 18-22 weeks of gestation
sample source: Semen from a normally fertile donor
sample source: From commercial libraries
cell type: in vivo differentiated B cell
cell line: FlpIn T-Rex Human embryonic kidney 293 stable cell line
photoactivatable ribonucleoside and crosslinking wavelength: 4-SU / 365 nm
antibody: anti-FLAG M2 [Sigma-Aldrich, cat# F1804, lot#101M6216]
immunoprecipitated protein: wt FLAG-HA FMR1 iso1
immunoprecipitated protein: wt FLAG-HA FMR1 iso7
immunoprecipitated protein: I304N FLAG-HA FMR1 iso1
immunoprecipitated protein: I304N FLAG-HA FMR1 iso7
immunoprecipitated protein: wt FLAG-HA FXR1
immunoprecipitated protein: wt FLAG-HA FXR2
antibody used for sorting: Anti-human KDR-PE (R&D Systems, cat#FAB357P); Anti-human CD31-FITC (BD Biosciences; cat#555445) CD144-FITC (BD bioscience; cat#560411)
cell type: Hematovascular Mesodermal Precursors/Direct Precursors of Hemogenic Endothelium
cell type: Mesodermal subset without hematopoietic potential
antibody used for sorting: CD31 (BD Biosciences 555445), CD43 (BD Biosciences 555475), CD41a (BD Biosciences 555467), CD73(BD Biosciences 550257), CD144(BD Biosciences 560411), CD235a (BD Biosciences 555570)
cell type: Hematopoietic cells enriched in erythro-megakaryocytic progenitors
cell type: Angiogenic hematopoietic progeniotrs
cell type: Endothelial intermediates formed during development of hemangioblast colonies in semisolid medium
antibody used for sorting: CD43 (BD Biosciences 555475), CD45(BD Biosciences 555485), CD41a (BD Biosciences 555467), CD235a (BD Biosciences 555570)
cell type: lin-CD34+CD43+CD45-CD38- multipotent hematopoietic progeniotrs
cell type: lin-CD34+CD43+CD45+CD38- multipotent hematopoietic progeniotrs
cell type: Human umbelical vein endothelial cells
antibody used for sorting: Anti-human APJ-APC (R&D Systems; cat#FAB856A)
cell type: Hemogenic endothelial progenitors
cell type: Angiogenic hematopoietic progenitors
cell type: Non-hemogenic endothelial progenitors
tissue: placenta from full-term pregnancy
treatment: LIN28 shRNA (TRCN0000102579; Open Biosystems)
patient condition: chronic rhinosinusitis with nasal polyps
genotype/variation: control [empty retroviral vector]
treatment protocol: Doxycycline +/ Shield -
treatment protocol: Doxycycline -/ Shield -
treatment protocol: Doxycycline -/ Shield +
treatment: transfected with 42nM of siLuciferase
treatment: transfected with 14nM of each siTUT7
dilutions of the malignant b-cell line: Normal
dilutions of the malignant b-cell line: 0.5% malignant
dilutions of the malignant b-cell line: 1% malignant
dilutions of the malignant b-cell line: 5% malignant
dilutions of the malignant b-cell line: 10% malignant
dilutions of the malignant b-cell line: 20% malignant
dilutions of the malignant b-cell line: 30% malignant
dilutions of the malignant b-cell line: 100% malignant
cell type: primary CD34+ stem/progenitor cells
treatment: incubated for 1h with TNF-alpha (10 ng/mL)
treatment: incubated for 1h with GM-CSF (5 ng/mL)
molecule subtype: total RNA - ribosome depleted
treatment: total RNA was sequenced in a Hela cell clone upon EGF stimulation and depletion of INTS11
source: HeLa Tet-inducible INTS11 shRNA cell clone
treatment: total RNA was sequenced in cycling wt Hela Cells
antibody 2: catalog #: clone 4H11 sc-47711
cell line: breast cancer cell line MCF-7/S0.5
cell line: breast cancer cell line MCF-7/TAMR-1
cell line: breast cancer cell line MCF-7/TAMR-4
cell line: breast cancer cell line MCF-7/TAMR-7
cell line: breast cancer cell line MCF-7/TAMR-8
rna state: formalin-fixed, paraffin-embedded (FFPE)
cell type: ES-derived embryoid body cells
cell type: Primary Human Umbilical Vein Endothelial Cells
cell type: human umbilical vein endothelial cells
cell type: primary cell culture  from gastric cancer tissue
cell type: EBV B95-8-infected lymphoblastoid cells
cell type: primary neonatal human foreskin fibroblasts
cell type: normal human bronchial epithelial (HBE) cells
cell type: non-small cell lung carcinoma
cell type: human breast cancer cell line
sequencing library: paired-end, 1st 4 bases of Read 1 used for multiplexing
condition: Quiescence induced by serum depletion
condition: pre-senescence; 5 dys after RASG12V induction
protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 5 days
condition: Senescence; 14 dys after RASG12V induction
protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 14 days
condition: Transformed cells (induced by RASG12V in the background of stable p53 and p16INK4A kds)
protocol: BJ cells expressing hTERT, p16INK4A-KD, p53-KD and SV40 small T were retrovirally transduced with pBabe-puro-RASG12V
clip antibody: Anti-AGO2 mAb, clone 2E12-1C9(Abnova)
treatment: treated with control shRNA and further treated with actinomycin D (2 ug/ml) for 4 hours
treatment: treated with PTB shRNA and further treated with actinomycin D (2 ug/ml) for 4 hours
treatment: shRNA scramble (pLKO backbone, sigma)
treatment: shRNA RAB7 (pLKO backbone, sigma, GATTGACCTCGAAA)
treatment: cycloheximide (5µg/mL) pretreat 30min
treatment: TNF-α (10ng/mL) 1hr; cycloheximide (5µg/mL) pretreat 30min
cell type: human nasopharyngeal carcinoma cells
antibodies: TAF15 (Bethyl Lab, A300-308A)
treatment: CXCL12 (0ng/mL) + IGF1 (0ng/mL)
treatment: CXCL12 (30ng/mL) + IGF1 (10ng/mL)
treatment: CXCL12 (300ng/mL) + IGF1 (100ng/mL)
protocol: supplemented with 1:1 ratio of MSC
tissue: brain (dorsolateral prefrontal cortex)
treatment: severe heat shock (44C 2 hours)
library-type (for tophat and cufflinks): fr-secondstrand
extract_protocol: Illumina GAII, non strand-specific
library-type (for tophat and cufflinks): fr-unstranded
extract_protocol: Illumina HiSeq 2000,  strand-specific
library-type (for tophat and cufflinks): fr-firststrand
sample type: Mouse ES X Human Fib Heterokaryons
cell line(s): mouse ES cells and human fibroblast
sample type: Human Fib X Human Fib Homokaryons
sample type: Co-cultured Mouse ES and Human Fib
country/location: Chinese in eastern China
tissue: adjacent normal tissue of colorectal cancer
tissue: tumor tissue of colorectal cancer
therapy: Transcatheter Arterial Infusion chemotherapy one week before surgical resection
purification method: Somatic Cell Lysis Buffer
genotype: SF3B1 somatic heterozygote, H666Q
genotype: SF3B1 somatic heterozygote, K700E
antibody: Nop58; goat polyclonal IgG; sc-23705
antibody vendor: Santa Cruz Biotechnology
antibody: ANTI-FLAG M2; mouse monoclonal
antibody: Fibrillarin; mouse monoclonal;  AFB01
antibody: Dyskerin; rabbit polyclonal IgG (C-15); sc-26982
antibody vendor: From Gunter Meister; PMID:18430891
cell type: human pancreatic stellate cells
condition/treatment: primary PSCs from cancer patient
condition/treatment: primary PSCs from control patient
cell type: human pancreatic adenocarcinoma cell line
condition/treatment: conditioned media from untreated cells
condition/treatment: conditioned media from calcipotriol-treated cells
treatment: treated for 10 minutes with E2
treatment: treated for 40 minutes with E2
cell type: Human umbilical vein endothelial cell
cell type: Liver sinusoidal endothelial cells
cell type: Prostate cancer cell line overexpressing ERa
cell line: human erythroleukemia cell line, HEL
transfected with: myc-tagged NSUN2 C271A construct
cell type: human fetal lung fibroblast Cell
cell type: in vitro cultured primary coronary artery smooth muscle cells
transfected with: scrambled control sequence
cancer subtype: A172-GBM, A431-epidermoid carcinoma, D538MG-anaplastic astrocytoma
cancer subtype: SUPT7-TALL, ONS76-GBM, SH-4-melanoma
cancer subtype: CHL-1-melanoma, DKMG-GBM, JURKAT-TALL
cell type: human embryonic kidney (HEK) 293 T-REx Flp-In cell lines
stable cell line: stable cell lines inducibly expressing FLAG/HA-tagged  RBM10
cell type: lymphoblastoid cell lines (LCLs) derived from healthy control
cell type: lymphoblastoid cell lines (LCLs) derived from patient
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.352532716
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.635899375
plasma free fatty acids under the curve ogtt (mmol/l * min): 23.7
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.491853096
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 132
log10 homair (insulin resistance index based on homa): 0.499381564
log10 homais (insulin secretion index based on homa): 2.316269962
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.60162548
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.470116353
log10 matsuda insulin sensitivity index: 0.608904289
lg10 serum c-reactive protein (mg/l): 0.074450719
lg10 plasma adiponectin (mg/l): 0.799340549
ogtt fasting plasma free fatty acid (mmol/l): 0.39
ogtt 30 min plasma free fatty acid (mmol/l): 0.26
ogtt 120 min plasma free fatty acid (mmol/l): 0.05
ogtt fasting plasma glucose (mmol/l): 4.9
ogtt 30 min plasma glucose (mmol/l): 7.1
ogtt 120 min plasma glucose (mmol/l): 4.9
log10 il1 receptor antagonist (pg/ml): 2.186730376
log10 ogtt fasting plasma insulin (mu/l): 1.161368002
ogtt 30 min plasma insulin (mu/l): 1.721810615
ogtt 120 min plasma insulin (mu/l): 1.862727528
log10 ogtt fasting plasma proinsulin (pm/l): 1.187520721
ogtt 30 min plasma proinsulin (pm/l): 1.383815366
ogtt 120 min plasma proinsulin (pm/l): 1.804139432
log10 serum alanine aminotransfrase (u/l): 1.447158031
log10 total cholesterol (mmol/l): 0.733197265
log10 ldl cholesterol (mmol/l): 0.5774918
log10 hdl cholesterol (mmol/l): 0.029383778
log10 urinary albumin excretion rate (ug/min): 0.726998728
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.527231569
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.552601458
plasma free fatty acids under the curve ogtt (mmol/l * min): 25.95
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.518653156
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 109.5
log10 homair (insulin resistance index based on homa): 0.06279083
log10 homais (insulin secretion index based on homa): 1.769551079
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.278319089
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.186984572
log10 matsuda insulin sensitivity index: 1.01207028
lg10 serum c-reactive protein (mg/l): -0.308918508
lg10 plasma adiponectin (mg/l): 1.068185862
ogtt fasting plasma free fatty acid (mmol/l): 0.38
ogtt 30 min plasma free fatty acid (mmol/l): 0.3
ogtt fasting plasma glucose (mmol/l): 5.2
ogtt 120 min plasma glucose (mmol/l): 3.9
log10 il1 receptor antagonist (pg/ml): 1.87517706
log10 ogtt fasting plasma insulin (mu/l): 0.698970004
ogtt 30 min plasma insulin (mu/l): 1.639486489
ogtt 120 min plasma insulin (mu/l): 1.021189299
log10 ogtt fasting plasma proinsulin (pm/l): 1.056904851
ogtt 30 min plasma proinsulin (pm/l): 1.442479769
ogtt 120 min plasma proinsulin (pm/l): 1.494154594
log10 serum alanine aminotransfrase (u/l): 1.230448921
log10 total cholesterol (mmol/l): 0.759667845
log10 ldl cholesterol (mmol/l): 0.591064607
log10 hdl cholesterol (mmol/l): 0.204119983
log10 total triglycerides (mmol/l): 0.250420002
log10 urinary albumin excretion rate (ug/min): 0.602059991
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.623318869
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.887438141
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.75
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.63481105
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 135
log10 homair (insulin resistance index based on homa): 0.361308025
log10 homais (insulin secretion index based on homa): 1.973127854
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.70981249
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.648320972
log10 matsuda insulin sensitivity index: 0.62415725
lg10 serum c-reactive protein (mg/l): -0.122628654
lg10 plasma adiponectin (mg/l): 1.1430148
ogtt fasting plasma free fatty acid (mmol/l): 0.25
ogtt 30 min plasma free fatty acid (mmol/l): 0.17
ogtt 120 min plasma free fatty acid (mmol/l): 0.04
ogtt fasting plasma glucose (mmol/l): 5.5
ogtt 30 min plasma glucose (mmol/l): 7.9
ogtt 120 min plasma glucose (mmol/l): 5.3
log10 il1 receptor antagonist (pg/ml): 2.276714495
log10 ogtt fasting plasma insulin (mu/l): 0.973127854
ogtt 30 min plasma insulin (mu/l): 2.007747778
ogtt 120 min plasma insulin (mu/l): 1.707570176
log10 ogtt fasting plasma proinsulin (pm/l): 1.113943352
ogtt 30 min plasma proinsulin (pm/l): 1.436162647
ogtt 120 min plasma proinsulin (pm/l): 1.525044807
log10 serum alanine aminotransfrase (u/l): 1.62324929
log10 total cholesterol (mmol/l): 0.804820679
log10 ldl cholesterol (mmol/l): 0.667452953
log10 hdl cholesterol (mmol/l): 0.164352856
log10 total triglycerides (mmol/l): 0.269512944
log10 urinary albumin excretion rate (ug/min): 0.810417027
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.376566407
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.749816692
plasma free fatty acids under the curve ogtt (mmol/l * min): 20.4
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.610102063
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 145.5
log10 homair (insulin resistance index based on homa): 0.104487111
log10 homais (insulin secretion index based on homa): 1.77815125
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.587508921
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.541504359
log10 matsuda insulin sensitivity index: 0.834858425
lg10 serum c-reactive protein (mg/l): -0.097997109
lg10 plasma adiponectin (mg/l): 0.954242509
ogtt fasting plasma free fatty acid (mmol/l): 0.44
ogtt 30 min plasma free fatty acid (mmol/l): 0.2
ogtt fasting plasma glucose (mmol/l): 5.3
ogtt 120 min plasma glucose (mmol/l): 3.6
log10 il1 receptor antagonist (pg/ml): 2.234162819
log10 ogtt fasting plasma insulin (mu/l): 0.73239376
ogtt 30 min plasma insulin (mu/l): 1.966610987
ogtt 120 min plasma insulin (mu/l): 1.255272505
log10 ogtt fasting plasma proinsulin (pm/l): 1.167317335
ogtt 30 min plasma proinsulin (pm/l): 1.494154594
ogtt 120 min plasma proinsulin (pm/l): 1.588831726
log10 serum alanine aminotransfrase (u/l): 1.505149978
log10 total cholesterol (mmol/l): 0.69019608
log10 ldl cholesterol (mmol/l): 0.530199698
log10 hdl cholesterol (mmol/l): 0.220108088
log10 total triglycerides (mmol/l): 0.045322979
log10 urinary albumin excretion rate (ug/min): 0.949661017
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.365129111
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.730864987
plasma free fatty acids under the curve ogtt (mmol/l * min): 16.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.485829309
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 105
log10 homair (insulin resistance index based on homa): 0.045583738
log10 homais (insulin secretion index based on homa): 1.787106093
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.142326883
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.01494035
log10 matsuda insulin sensitivity index: 1.069394356
lg10 serum c-reactive protein (mg/l): 0.173477643
lg10 plasma adiponectin (mg/l): 0.857332496
ogtt fasting plasma free fatty acid (mmol/l): 0.3
ogtt 30 min plasma free fatty acid (mmol/l): 0.18
ogtt 120 min plasma free fatty acid (mmol/l): 0.03
ogtt fasting plasma glucose (mmol/l): 5.1
log10 il1 receptor antagonist (pg/ml): 2.129077324
log10 ogtt fasting plasma insulin (mu/l): 0.69019608
ogtt 30 min plasma insulin (mu/l): 1.33243846
ogtt 120 min plasma insulin (mu/l): 1.324282455
log10 ogtt fasting plasma proinsulin (pm/l): 1.053078443
ogtt 30 min plasma proinsulin (pm/l): 1.26245109
ogtt 120 min plasma proinsulin (pm/l): 1.428134794
log10 serum alanine aminotransfrase (u/l): 1.176091259
log10 total cholesterol (mmol/l): 0.767155866
log10 ldl cholesterol (mmol/l): 0.604226053
log10 hdl cholesterol (mmol/l): 0.176091259
log10 total triglycerides (mmol/l): -0.065501549
log10 urinary albumin excretion rate (ug/min): 0.687029885
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.373093233
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.455462055
plasma free fatty acids under the curve ogtt (mmol/l * min): 40.2
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.16616308
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 453
log10 homair (insulin resistance index based on homa): -0.032452024
log10 homais (insulin secretion index based on homa): 1.49560466
log10 insulin area under the curve (ogtt) (pmol/l * min): 3.807332039
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.582631439
log10 matsuda insulin sensitivity index: 1.190338397
lg10 serum c-reactive protein (mg/l): -0.559090918
lg10 plasma adiponectin (mg/l): 1.053078443
ogtt fasting plasma free fatty acid (mmol/l): 0.67
ogtt 30 min plasma free fatty acid (mmol/l): 0.39
ogtt 120 min plasma free fatty acid (mmol/l): 0.15
ogtt fasting plasma glucose (mmol/l): 5.8
ogtt 120 min plasma glucose (mmol/l): 7.6
log10 il1 receptor antagonist (pg/ml): 2.099231615
log10 ogtt fasting plasma insulin (mu/l): 0.556302501
ogtt 30 min plasma insulin (mu/l): 1.117271296
ogtt 120 min plasma insulin (mu/l): 0.707570176
log10 ogtt fasting plasma proinsulin (pm/l): 0.86923172
ogtt 30 min plasma proinsulin (pm/l): 1.176091259
ogtt 120 min plasma proinsulin (pm/l): 1.385606274
log10 serum alanine aminotransfrase (u/l): 1.255272505
log10 total cholesterol (mmol/l): 0.774516966
log10 ldl cholesterol (mmol/l): 0.572871602
log10 hdl cholesterol (mmol/l): 0.359835482
log10 total triglycerides (mmol/l): -0.148741651
log10 urinary albumin excretion rate (ug/min): 0.646581935
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.230109829
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.46745006
plasma free fatty acids under the curve ogtt (mmol/l * min): 18.15
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.080817528
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -22.5
log10 homair (insulin resistance index based on homa): -0.217686662
log10 homais (insulin secretion index based on homa): 1.684246748
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.372875197
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.33264041
log10 matsuda insulin sensitivity index: 1.164045038
lg10 serum c-reactive protein (mg/l): 0.140508043
lg10 plasma adiponectin (mg/l): 0.826074803
ogtt fasting plasma free fatty acid (mmol/l): 0.28
ogtt 30 min plasma free fatty acid (mmol/l): 0.21
ogtt fasting plasma glucose (mmol/l): 4.7
ogtt 30 min plasma glucose (mmol/l): 4.7
ogtt 120 min plasma glucose (mmol/l): 4.2
log10 il1 receptor antagonist (pg/ml): 2.099646117
log10 ogtt fasting plasma insulin (mu/l): 0.462397998
ogtt 30 min plasma insulin (mu/l): 1.754348336
ogtt 120 min plasma insulin (mu/l): 1.029383778
log10 ogtt fasting plasma proinsulin (pm/l): 1.033423755
ogtt 30 min plasma proinsulin (pm/l): 1.437750563
ogtt 120 min plasma proinsulin (pm/l): 1.46834733
log10 serum alanine aminotransfrase (u/l): 1.531478917
log10 total cholesterol (mmol/l): 0.795880017
log10 ldl cholesterol (mmol/l): 0.646403726
log10 hdl cholesterol (mmol/l): 0.212187604
log10 total triglycerides (mmol/l): 0.10720997
log10 urinary albumin excretion rate (ug/min): 0.572096768
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.202747826
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.508748397
plasma free fatty acids under the curve ogtt (mmol/l * min): 20.1
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.769837844
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 201
log10 homair (insulin resistance index based on homa): 0.215549444
log10 homais (insulin secretion index based on homa): 1.798354636
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.341632336
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.235730397
log10 matsuda insulin sensitivity index: 0.850912144
lg10 serum c-reactive protein (mg/l): 0.213783299
lg10 plasma adiponectin (mg/l): 0.568201724
ogtt fasting plasma free fatty acid (mmol/l): 0.31
ogtt 30 min plasma free fatty acid (mmol/l): 0.22
ogtt fasting plasma glucose (mmol/l): 5.6
ogtt 30 min plasma glucose (mmol/l): 8.2
ogtt 120 min plasma glucose (mmol/l): 6.6
log10 il1 receptor antagonist (pg/ml): 1.935104021
log10 ogtt fasting plasma insulin (mu/l): 0.819543936
ogtt 30 min plasma insulin (mu/l): 1.575187845
ogtt 120 min plasma insulin (mu/l): 1.462397998
log10 ogtt fasting plasma proinsulin (pm/l): 0.991226076
ogtt 30 min plasma proinsulin (pm/l): 1.243038049
ogtt 120 min plasma proinsulin (pm/l): 1.495544338
log10 serum alanine aminotransfrase (u/l): 1.342422681
log10 total cholesterol (mmol/l): 0.680335513
log10 ldl cholesterol (mmol/l): 0.509202522
log10 hdl cholesterol (mmol/l): 0.012837225
log10 total triglycerides (mmol/l): 0.240549248
log10 urinary albumin excretion rate (ug/min): 1.245070488
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.639220552
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.842943832
plasma free fatty acids under the curve ogtt (mmol/l * min): 24.75
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.701306462
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 196.5
log10 homair (insulin resistance index based on homa): 0.142945363
log10 homais (insulin secretion index based on homa): 1.816609502
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.196037941
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.059070913
log10 matsuda insulin sensitivity index: 0.990185811
lg10 serum c-reactive protein (mg/l): 0.308777774
lg10 plasma adiponectin (mg/l): 1.133538908
ogtt 120 min plasma free fatty acid (mmol/l): 0.13
ogtt 120 min plasma glucose (mmol/l): 3.4
log10 il1 receptor antagonist (pg/ml): 2.073351702
log10 ogtt fasting plasma insulin (mu/l): 0.770852012
ogtt 30 min plasma insulin (mu/l): 1.57054294
ogtt 120 min plasma insulin (mu/l): 0.819543936
log10 ogtt fasting plasma proinsulin (pm/l): 0.792391689
ogtt 30 min plasma proinsulin (pm/l): 1.204119983
ogtt 120 min plasma proinsulin (pm/l): 1.152288344
log10 serum alanine aminotransfrase (u/l): 1.397940009
log10 total cholesterol (mmol/l): 0.693726949
log10 ldl cholesterol (mmol/l): 0.477121255
log10 hdl cholesterol (mmol/l): 0.238046103
log10 total triglycerides (mmol/l): -0.080921908
log10 urinary albumin excretion rate (ug/min): 1.044812344
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.475855676
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.886433506
plasma free fatty acids under the curve ogtt (mmol/l * min): 31.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.981567282
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 303
log10 homair (insulin resistance index based on homa): 0.49785074
log10 homais (insulin secretion index based on homa): 2
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.714966482
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.635845508
log10 matsuda insulin sensitivity index: 0.50747184
lg10 serum c-reactive protein (mg/l): 0.29841638
ogtt fasting plasma free fatty acid (mmol/l): 0.65
ogtt 30 min plasma free fatty acid (mmol/l): 0.29
ogtt 120 min plasma free fatty acid (mmol/l): 0.1
ogtt fasting plasma glucose (mmol/l): 5.9
ogtt 30 min plasma glucose (mmol/l): 9.9
ogtt 120 min plasma glucose (mmol/l): 7.3
log10 il1 receptor antagonist (pg/ml): 2.045714059
log10 ogtt fasting plasma insulin (mu/l): 1.079181246
ogtt 30 min plasma insulin (mu/l): 2.033825694
ogtt 120 min plasma insulin (mu/l): 1.643452676
log10 ogtt fasting plasma proinsulin (pm/l): 1.340444115
ogtt 30 min plasma proinsulin (pm/l): 1.870988814
ogtt 120 min plasma proinsulin (pm/l): 1.968482949
log10 serum alanine aminotransfrase (u/l): 1.612783857
log10 total cholesterol (mmol/l): 0.792391689
log10 ldl cholesterol (mmol/l): 0.369215857
log10 hdl cholesterol (mmol/l): 0.033423755
log10 total triglycerides (mmol/l): 0.883093359
log10 urinary albumin excretion rate (ug/min): 0.87185875
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.069738097
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.600171425
plasma free fatty acids under the curve ogtt (mmol/l * min): 27.75
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.904634622
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 238.5
log10 homair (insulin resistance index based on homa): 0.543240028
log10 homais (insulin secretion index based on homa): 2.020361283
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.629287245
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.520562131
log10 matsuda insulin sensitivity index: 0.524273321
lg10 serum c-reactive protein (mg/l): -0.152427341
lg10 plasma adiponectin (mg/l): 0.672097858
ogtt fasting plasma free fatty acid (mmol/l): 0.58
ogtt 30 min plasma free fatty acid (mmol/l): 0.25
ogtt 120 min plasma free fatty acid (mmol/l): 0.09
ogtt 30 min plasma glucose (mmol/l): 9.6
ogtt 120 min plasma glucose (mmol/l): 6.5
log10 il1 receptor antagonist (pg/ml): 2.261619677
log10 ogtt fasting plasma insulin (mu/l): 1.117271296
ogtt 30 min plasma insulin (mu/l): 1.847572659
ogtt 120 min plasma insulin (mu/l): 1.774516966
log10 ogtt fasting plasma proinsulin (pm/l): 0.903089987
ogtt 30 min plasma proinsulin (pm/l): 1.305351369
ogtt 120 min plasma proinsulin (pm/l): 1.692846919
log10 total cholesterol (mmol/l): 0.648360011
log10 ldl cholesterol (mmol/l): 0.456366033
log10 hdl cholesterol (mmol/l): 0.089905111
log10 total triglycerides (mmol/l): 0.152288344
log10 urinary albumin excretion rate (ug/min): 1.134546163
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.584945002
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.437725264
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.439830884
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 46.5
log10 homair (insulin resistance index based on homa): -0.101274818
log10 homais (insulin secretion index based on homa): 1.540790335
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.057704132
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.956408571
log10 matsuda insulin sensitivity index: 1.170063428
lg10 serum c-reactive protein (mg/l): -0.583359493
lg10 plasma adiponectin (mg/l): 0.770852012
ogtt fasting plasma free fatty acid (mmol/l): 0.46
ogtt 30 min plasma free fatty acid (mmol/l): 0.28
ogtt fasting plasma glucose (mmol/l): 5.4
ogtt 30 min plasma glucose (mmol/l): 6.1
ogtt 120 min plasma glucose (mmol/l): 5.5
log10 il1 receptor antagonist (pg/ml): 2.045362103
log10 ogtt fasting plasma insulin (mu/l): 0.51851394
ogtt 30 min plasma insulin (mu/l): 0.892094603
ogtt 120 min plasma insulin (mu/l): 1.488550717
log10 ogtt fasting plasma proinsulin (pm/l): 0.995635195
ogtt 30 min plasma proinsulin (pm/l): 1.017033339
ogtt 120 min plasma proinsulin (pm/l): 1.390935107
log10 serum alanine aminotransfrase (u/l): 0.903089987
log10 total cholesterol (mmol/l): 0.750508395
log10 ldl cholesterol (mmol/l): 0.53529412
log10 hdl cholesterol (mmol/l): 0.307496038
log10 total triglycerides (mmol/l): -0.091514981
log10 urinary albumin excretion rate (ug/min): 0.508676069
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.611832412
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.11805107
plasma free fatty acids under the curve ogtt (mmol/l * min): 14.7
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.515699838
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 84
log10 homair (insulin resistance index based on homa): 0.261024834
log10 homais (insulin secretion index based on homa): 1.903089987
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.4954472
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.411973058
log10 matsuda insulin sensitivity index: 0.783578563
lg10 serum c-reactive protein (mg/l): 0.241795431
lg10 plasma adiponectin (mg/l): 0.612783857
ogtt 30 min plasma free fatty acid (mmol/l): 0.16
ogtt 30 min plasma glucose (mmol/l): 6.5
ogtt 120 min plasma glucose (mmol/l): 5.8
log10 il1 receptor antagonist (pg/ml): 2.337738717
log10 ogtt fasting plasma insulin (mu/l): 0.880813592
ogtt 30 min plasma insulin (mu/l): 1.716837723
ogtt 120 min plasma insulin (mu/l): 1.64246452
log10 ogtt fasting plasma proinsulin (pm/l): 1.245512668
ogtt 30 min plasma proinsulin (pm/l): 1.666517981
ogtt 120 min plasma proinsulin (pm/l): 1.909556029
log10 serum alanine aminotransfrase (u/l): 1.556302501
log10 ldl cholesterol (mmol/l): 0.50242712
log10 hdl cholesterol (mmol/l): 0.056904851
log10 total triglycerides (mmol/l): 0.318063335
log10 urinary albumin excretion rate (ug/min): 0.922510263
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.485385281
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.705854221
plasma free fatty acids under the curve ogtt (mmol/l * min): 29.7
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.04028972
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 333
log10 homair (insulin resistance index based on homa): 0.610660163
log10 homais (insulin secretion index based on homa): 2.087781418
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.808730734
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.72722396
log10 matsuda insulin sensitivity index: 0.385433076
lg10 serum c-reactive protein (mg/l): -0.53313238
lg10 plasma adiponectin (mg/l): 0.414973348
ogtt fasting plasma free fatty acid (mmol/l): 0.34
ogtt 30 min plasma free fatty acid (mmol/l): 0.35
ogtt 120 min plasma free fatty acid (mmol/l): 0.08
ogtt 120 min plasma glucose (mmol/l): 8.2
log10 il1 receptor antagonist (pg/ml): 2.269466243
log10 ogtt fasting plasma insulin (mu/l): 1.184691431
ogtt 30 min plasma insulin (mu/l): 2.031408464
ogtt 120 min plasma insulin (mu/l): 1.954242509
log10 ogtt fasting plasma proinsulin (pm/l): 1.298853076
ogtt 30 min plasma proinsulin (pm/l): 1.688419822
ogtt 120 min plasma proinsulin (pm/l): 1.849419414
log10 serum alanine aminotransfrase (u/l): 1.568201724
log10 total cholesterol (mmol/l): 0.580924976
log10 ldl cholesterol (mmol/l): 0.267171728
log10 hdl cholesterol (mmol/l): 0.068185862
log10 total triglycerides (mmol/l): 0.475671188
log10 urinary albumin excretion rate (ug/min): 1.007061855
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.450543015
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.820917525
plasma free fatty acids under the curve ogtt (mmol/l * min): 18
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.587777516
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 97.5
log10 homair (insulin resistance index based on homa): 0.068103367
log10 homais (insulin secretion index based on homa): 1.650908559
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.321411998
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.244944753
log10 matsuda insulin sensitivity index: 0.964545375
lg10 serum c-reactive protein (mg/l): 0.574841195
lg10 plasma adiponectin (mg/l): 0.880813592
ogtt 30 min plasma free fatty acid (mmol/l): 0.19
ogtt 120 min plasma free fatty acid (mmol/l): 0.02
ogtt 30 min plasma glucose (mmol/l): 7.6
ogtt 120 min plasma glucose (mmol/l): 5.1
log10 il1 receptor antagonist (pg/ml): 2.070665753
log10 ogtt fasting plasma insulin (mu/l): 0.672097858
ogtt 30 min plasma insulin (mu/l): 1.586587305
ogtt 120 min plasma insulin (mu/l): 1.390935107
ogtt 30 min plasma proinsulin (pm/l): 1.338456494
ogtt 120 min plasma proinsulin (pm/l): 1.633468456
log10 serum alanine aminotransfrase (u/l): 1.361727836
log10 total cholesterol (mmol/l): 0.71432976
log10 ldl cholesterol (mmol/l): 0.494154594
log10 hdl cholesterol (mmol/l): 0.217483944
log10 total triglycerides (mmol/l): 0.053078443
log10 urinary albumin excretion rate (ug/min): 0.647287531
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.20051725
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.26100052
plasma free fatty acids under the curve ogtt (mmol/l * min): 22.95
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.714245518
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 264
log10 homair (insulin resistance index based on homa): -0.068881289
log10 homais (insulin secretion index based on homa): 1.789146635
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.568717876
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.533568713
log10 matsuda insulin sensitivity index: 0.898372406
lg10 serum c-reactive protein (mg/l): 0.707825568
lg10 plasma adiponectin (mg/l): 1.045322979
ogtt fasting plasma glucose (mmol/l): 4.8
ogtt 30 min plasma glucose (mmol/l): 7.7
ogtt 120 min plasma glucose (mmol/l): 6.8
log10 il1 receptor antagonist (pg/ml): 2.219767845
log10 ogtt fasting plasma insulin (mu/l): 0.602059991
ogtt 30 min plasma insulin (mu/l): 1.781755375
ogtt 120 min plasma insulin (mu/l): 1.741939078
log10 ogtt fasting plasma proinsulin (pm/l): 1
ogtt 30 min plasma proinsulin (pm/l): 1.423245874
ogtt 120 min plasma proinsulin (pm/l): 1.776701184
log10 serum alanine aminotransfrase (u/l): 1.544068044
log10 total cholesterol (mmol/l): 0.877946952
log10 ldl cholesterol (mmol/l): 0.730782276
log10 hdl cholesterol (mmol/l): 0.240549248
log10 urinary albumin excretion rate (ug/min): 0.575642049
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.389519992
plasma free fatty acids under the curve ogtt (mmol/l * min): 17.4
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 180
log10 homair (insulin resistance index based on homa): -0.120458135
log10 homais (insulin secretion index based on homa): 1.491361694
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.198024426
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.131779009
log10 matsuda insulin sensitivity index: 1.106043024
lg10 serum c-reactive protein (mg/l): -0.573488739
lg10 plasma adiponectin (mg/l): 1.243038049
ogtt fasting plasma free fatty acid (mmol/l): 0.22
ogtt 30 min plasma glucose (mmol/l): 9.1
ogtt 120 min plasma glucose (mmol/l): 4.7
log10 il1 receptor antagonist (pg/ml): 2.19002338
log10 ogtt fasting plasma insulin (mu/l): 0.491361694
ogtt 30 min plasma insulin (mu/l): 1.416640507
ogtt 120 min plasma insulin (mu/l): 1.354108439
ogtt 30 min plasma proinsulin (pm/l): 1.357934847
ogtt 120 min plasma proinsulin (pm/l): 1.672097858
log10 serum alanine aminotransfrase (u/l): 1.322219295
log10 total cholesterol (mmol/l): 0.797959644
log10 ldl cholesterol (mmol/l): 0.550228353
log10 hdl cholesterol (mmol/l): 0.419955748
log10 total triglycerides (mmol/l): -0.075720714
log10 urinary albumin excretion rate (ug/min): 1.078012216
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.084411853
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.302689358
plasma free fatty acids under the curve ogtt (mmol/l * min): 12.45
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 192
log10 homair (insulin resistance index based on homa): 0.504062883
log10 homais (insulin secretion index based on homa): 2.146128036
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.808609287
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.738645811
log10 matsuda insulin sensitivity index: 0.474421526
lg10 serum c-reactive protein (mg/l): -0.067019178
lg10 plasma adiponectin (mg/l): 0.832508913
ogtt fasting plasma free fatty acid (mmol/l): 0.17
ogtt 30 min plasma free fatty acid (mmol/l): 0.15
ogtt 120 min plasma glucose (mmol/l): 6.2
log10 il1 receptor antagonist (pg/ml): 2.857784651
log10 ogtt fasting plasma insulin (mu/l): 1.123851641
ogtt 30 min plasma insulin (mu/l): 1.87909588
ogtt 120 min plasma insulin (mu/l): 2.123851641
log10 ogtt fasting plasma proinsulin (pm/l): 1.127104798
ogtt 120 min plasma proinsulin (pm/l): 1.81756537
log10 serum alanine aminotransfrase (u/l): 1.770852012
log10 total cholesterol (mmol/l): 0.706717782
log10 ldl cholesterol (mmol/l): 0.5132176
log10 hdl cholesterol (mmol/l): 0.133538908
log10 urinary albumin excretion rate (ug/min): 0.794995807
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.511090418
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.6875184
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.8
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.900112063
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 319.5
log10 homair (insulin resistance index based on homa): 0.258584077
log10 homais (insulin secretion index based on homa): 1.932248216
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.586902223
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.519618012
log10 matsuda insulin sensitivity index: 0.701131284
lg10 serum c-reactive protein (mg/l): -0.044793462
lg10 plasma adiponectin (mg/l): 0.968482949
ogtt fasting plasma free fatty acid (mmol/l): 0.4
ogtt 30 min plasma glucose (mmol/l): 9.5
log10 il1 receptor antagonist (pg/ml): 1.772321707
log10 ogtt fasting plasma insulin (mu/l): 0.886490725
ogtt 30 min plasma insulin (mu/l): 1.846337112
ogtt 120 min plasma insulin (mu/l): 1.671172843
log10 ogtt fasting plasma proinsulin (pm/l): 1.029383778
ogtt 30 min plasma proinsulin (pm/l): 1.534026106
ogtt 120 min plasma proinsulin (pm/l): 1.689308859
log10 serum alanine aminotransfrase (u/l): 1.491361694
log10 total cholesterol (mmol/l): 0.761927838
log10 ldl cholesterol (mmol/l): 0.559906625
log10 hdl cholesterol (mmol/l): 0.209515015
log10 total triglycerides (mmol/l): 0.278753601
log10 urinary albumin excretion rate (ug/min): 0.681241237
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.723610629
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.694080445
plasma free fatty acids under the curve ogtt (mmol/l * min): 8.4
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.482807957
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 67.5
log10 homair (insulin resistance index based on homa): -0.172630727
log10 homais (insulin secretion index based on homa): 1.469434426
log10 insulin area under the curve (ogtt) (pmol/l * min): 3.982813762
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.880584956
log10 matsuda insulin sensitivity index: 1.274560314
lg10 serum c-reactive protein (mg/l): -0.404503778
lg10 plasma adiponectin (mg/l): 0.892094603
ogtt fasting plasma free fatty acid (mmol/l): 0.1
ogtt 30 min plasma free fatty acid (mmol/l): 0.1
ogtt 30 min plasma glucose (mmol/l): 7.8
ogtt 120 min plasma glucose (mmol/l): 3.7
log10 il1 receptor antagonist (pg/ml): 1.736635498
log10 ogtt fasting plasma insulin (mu/l): 0.447158031
ogtt 30 min plasma insulin (mu/l): 1.307496038
ogtt 120 min plasma insulin (mu/l): 0.880813592
log10 ogtt fasting plasma proinsulin (pm/l): 0.954242509
ogtt 30 min plasma proinsulin (pm/l): 1.336459734
ogtt 120 min plasma proinsulin (pm/l): 1.413299764
log10 serum alanine aminotransfrase (u/l): 1.301029996
log10 total cholesterol (mmol/l): 0.827369273
log10 ldl cholesterol (mmol/l): 0.648360011
log10 hdl cholesterol (mmol/l): 0.298853076
log10 total triglycerides (mmol/l): 0.041392685
log10 urinary albumin excretion rate (ug/min): 0.739313246
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.58477133
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.879855404
plasma free fatty acids under the curve ogtt (mmol/l * min): 47.85
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.794415866
log10 homair (insulin resistance index based on homa): -0.131029196
log10 homais (insulin secretion index based on homa): 1.575731053
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.154545692
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.07809415
log10 matsuda insulin sensitivity index: 1.123009983
lg10 serum c-reactive protein (mg/l): 0.823082797
lg10 plasma adiponectin (mg/l): 0.763427994
ogtt fasting plasma free fatty acid (mmol/l): 0.82
ogtt 30 min plasma free fatty acid (mmol/l): 0.51
ogtt 120 min plasma free fatty acid (mmol/l): 0.11
log10 il1 receptor antagonist (pg/ml): 2.219348717
log10 ogtt fasting plasma insulin (mu/l): 0.505149978
ogtt 30 min plasma insulin (mu/l): 1.385606274
ogtt 120 min plasma insulin (mu/l): 1.28780173
log10 ogtt fasting plasma proinsulin (pm/l): 0.934498451
ogtt 30 min plasma proinsulin (pm/l): 1.247973266
ogtt 120 min plasma proinsulin (pm/l): 1.505149978
log10 total cholesterol (mmol/l): 0.809559715
log10 ldl cholesterol (mmol/l): 0.617000341
log10 hdl cholesterol (mmol/l): 0.198657087
log10 total triglycerides (mmol/l): -0.346787486
log10 urinary albumin excretion rate (ug/min): 1.06694679
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.542620469
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.74798165
plasma free fatty acids under the curve ogtt (mmol/l * min): 13.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.651051691
log10 homair (insulin resistance index based on homa): 0.369133362
log10 homais (insulin secretion index based on homa): 1.951938555
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.585990584
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.502140227
log10 matsuda insulin sensitivity index: 0.671973688
lg10 serum c-reactive protein (mg/l): 0.421932813
lg10 plasma adiponectin (mg/l): 0.707570176
ogtt 30 min plasma free fatty acid (mmol/l): 0.14
ogtt 120 min plasma glucose (mmol/l): 5.6
log10 il1 receptor antagonist (pg/ml): 2.044735697
ogtt 30 min plasma insulin (mu/l): 1.843232778
ogtt 120 min plasma insulin (mu/l): 1.669316881
log10 ogtt fasting plasma proinsulin (pm/l): 1.025305865
ogtt 30 min plasma proinsulin (pm/l): 1.584331224
ogtt 120 min plasma proinsulin (pm/l): 1.796574333
log10 total cholesterol (mmol/l): 0.725911632
log10 ldl cholesterol (mmol/l): 0.519827994
log10 hdl cholesterol (mmol/l): 0.130333768
log10 total triglycerides (mmol/l): 0.004321374
log10 urinary albumin excretion rate (ug/min): 1.245923737
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.480201657
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.671088803
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.45
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.45224124
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 64.5
log10 homair (insulin resistance index based on homa): -0.180748617
log10 homais (insulin secretion index based on homa): 1.492915522
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.419922721
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.385284455
log10 matsuda insulin sensitivity index: 1.075030415
lg10 serum c-reactive protein (mg/l): 0.244771761
lg10 plasma adiponectin (mg/l): 0.531478917
ogtt fasting plasma free fatty acid (mmol/l): 0.45
ogtt 30 min plasma free fatty acid (mmol/l): 0.13
ogtt 30 min plasma glucose (mmol/l): 6.6
log10 il1 receptor antagonist (pg/ml): 2.06669855
ogtt 30 min plasma insulin (mu/l): 1.796574333
ogtt 120 min plasma insulin (mu/l): 1.113943352
log10 ogtt fasting plasma proinsulin (pm/l): 0.72427587
ogtt 30 min plasma proinsulin (pm/l): 1.495544338
ogtt 120 min plasma proinsulin (pm/l): 1.534026106
log10 total cholesterol (mmol/l): 0.568201724
log10 ldl cholesterol (mmol/l): 0.365487985
log10 hdl cholesterol (mmol/l): -0.013228266
log10 total triglycerides (mmol/l): -0.102372909
log10 urinary albumin excretion rate (ug/min): 0.599768195
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.496036167
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.622149964
plasma free fatty acids under the curve ogtt (mmol/l * min): 26.4
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.13378441
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 415.5
log10 homair (insulin resistance index based on homa): 0.293730757
log10 homais (insulin secretion index based on homa): 1.795880017
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.612062965
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.550619653
log10 matsuda insulin sensitivity index: 0.619624223
lg10 serum c-reactive protein (mg/l): -0.510041521
ogtt fasting plasma free fatty acid (mmol/l): 0.55
ogtt 120 min plasma glucose (mmol/l): 10.2
log10 il1 receptor antagonist (pg/ml): 1.777716739
log10 ogtt fasting plasma insulin (mu/l): 0.875061263
ogtt 30 min plasma insulin (mu/l): 1.675778342
ogtt 120 min plasma insulin (mu/l): 1.933993164
log10 ogtt fasting plasma proinsulin (pm/l): 1.075546961
ogtt 30 min plasma proinsulin (pm/l): 1.654176542
ogtt 120 min plasma proinsulin (pm/l): 1.879669206
log10 total cholesterol (mmol/l): 0.571708832
log10 ldl cholesterol (mmol/l): 0.298853076
log10 hdl cholesterol (mmol/l): 0.117271296
log10 total triglycerides (mmol/l): 0.245512668
log10 urinary albumin excretion rate (ug/min): 0.713910354
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.673759129
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.856303676
plasma free fatty acids under the curve ogtt (mmol/l * min): 34.2
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.03617361
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 222
log10 homair (insulin resistance index based on homa): 0.468937806
log10 homais (insulin secretion index based on homa): 1.751822312
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.525951341
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.425827564
log10 matsuda insulin sensitivity index: 0.57716663
lg10 serum c-reactive protein (mg/l): 0.27392678
lg10 plasma adiponectin (mg/l): 0.380211242
ogtt 30 min plasma free fatty acid (mmol/l): 0.37
ogtt fasting plasma glucose (mmol/l): 6.9
ogtt 30 min plasma glucose (mmol/l): 9.7
ogtt 120 min plasma glucose (mmol/l): 8.1
log10 il1 receptor antagonist (pg/ml): 2.348285388
log10 ogtt fasting plasma insulin (mu/l): 0.982271233
ogtt 30 min plasma insulin (mu/l): 1.546542663
ogtt 120 min plasma insulin (mu/l): 1.870403905
log10 ogtt fasting plasma proinsulin (pm/l): 1.149219113
ogtt 30 min plasma proinsulin (pm/l): 1.447158031
ogtt 120 min plasma proinsulin (pm/l): 1.84260924
log10 serum alanine aminotransfrase (u/l): 1.591064607
log10 total cholesterol (mmol/l): 0.791690649
log10 ldl cholesterol (mmol/l): 0.57634135
log10 hdl cholesterol (mmol/l): 0.250420002
log10 total triglycerides (mmol/l): 0.123851641
log10 urinary albumin excretion rate (ug/min): 0.700546393
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.367816206
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.251302989
plasma free fatty acids under the curve ogtt (mmol/l * min): 20.25
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.653740779
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 217.5
log10 homair (insulin resistance index based on homa): -0.281775196
log10 homais (insulin secretion index based on homa): 1.535113202
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.264510876
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.221648928
log10 matsuda insulin sensitivity index: 1.171841611
lg10 serum c-reactive protein (mg/l): -0.853871964
ogtt fasting plasma free fatty acid (mmol/l): 0.33
ogtt 30 min plasma free fatty acid (mmol/l): 0.24
ogtt 30 min plasma glucose (mmol/l): 8.6
ogtt 120 min plasma glucose (mmol/l): 4.8
log10 il1 receptor antagonist (pg/ml): 2.226728757
log10 ogtt fasting plasma insulin (mu/l): 0.380211242
ogtt 30 min plasma insulin (mu/l): 1.526339277
ogtt 120 min plasma insulin (mu/l): 1.352182518
log10 ogtt fasting plasma proinsulin (pm/l): 0.819543936
ogtt 30 min plasma proinsulin (pm/l): 1.1430148
ogtt 120 min plasma proinsulin (pm/l): 1.600972896
log10 serum alanine aminotransfrase (u/l): 0.954242509
log10 total cholesterol (mmol/l): 0.691965103
log10 ldl cholesterol (mmol/l): 0.498310554
log10 hdl cholesterol (mmol/l): 0.222716471
log10 total triglycerides (mmol/l): -0.124938737
log10 urinary albumin excretion rate (ug/min): 0.49785074
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.977929407
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.289010918
plasma free fatty acids under the curve ogtt (mmol/l * min): 31.05
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 405
log10 homair (insulin resistance index based on homa): 0.602927713
log10 homais (insulin secretion index based on homa): 2.244992866
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.83943405
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.756400263
log10 matsuda insulin sensitivity index: 0.360849371
lg10 plasma adiponectin (mg/l): 0.740362689
ogtt fasting plasma free fatty acid (mmol/l): 0.56
ogtt 30 min plasma free fatty acid (mmol/l): 0.34
ogtt 120 min plasma glucose (mmol/l): 9.6
log10 il1 receptor antagonist (pg/ml): 2.578536067
log10 ogtt fasting plasma insulin (mu/l): 1.222716471
ogtt 30 min plasma insulin (mu/l): 1.846955325
ogtt 120 min plasma insulin (mu/l): 2.194791758
log10 ogtt fasting plasma proinsulin (pm/l): 1.103803721
ogtt 30 min plasma proinsulin (pm/l): 1.307496038
ogtt 120 min plasma proinsulin (pm/l): 1.750508395
log10 serum alanine aminotransfrase (u/l): 1.431363764
log10 ldl cholesterol (mmol/l): 0.549003262
log10 hdl cholesterol (mmol/l): 0.093421685
log10 total triglycerides (mmol/l): 0.204119983
log10 urinary albumin excretion rate (ug/min): 0.768391413
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.898000295
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.710734607
plasma free fatty acids under the curve ogtt (mmol/l * min): 13.5
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.533329732
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 129
log10 homair (insulin resistance index based on homa): -0.076410618
log10 homais (insulin secretion index based on homa): 1.665111737
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.101918834
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.999174056
log10 matsuda insulin sensitivity index: 1.146953948
lg10 serum c-reactive protein (mg/l): -0.003050752
ogtt fasting plasma free fatty acid (mmol/l): 0.24
ogtt 30 min plasma glucose (mmol/l): 7.4
log10 il1 receptor antagonist (pg/ml): 2.157758886
log10 ogtt fasting plasma insulin (mu/l): 0.568201724
ogtt 30 min plasma insulin (mu/l): 1.276461804
ogtt 120 min plasma insulin (mu/l): 1.309630167
ogtt 30 min plasma proinsulin (pm/l): 1.11058971
ogtt 120 min plasma proinsulin (pm/l): 1.348304863
log10 total cholesterol (mmol/l): 0.704150517
log10 ldl cholesterol (mmol/l): 0.511883361
log10 hdl cholesterol (mmol/l): 0.181843588
log10 total triglycerides (mmol/l): -0.180456064
log10 urinary albumin excretion rate (ug/min): 0.783903579
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.149075129
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.507046139
plasma free fatty acids under the curve ogtt (mmol/l * min): 21.15
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.946906274
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 267
log10 homair (insulin resistance index based on homa): 0.174156759
log10 homais (insulin secretion index based on homa): 1.651278014
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.386730765
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.30815874
log10 matsuda insulin sensitivity index: 0.818178344
lg10 serum c-reactive protein (mg/l): -0.232844134
lg10 plasma adiponectin (mg/l): 0.755874856
ogtt fasting plasma free fatty acid (mmol/l): 0.36
ogtt 120 min plasma glucose (mmol/l): 7.8
log10 il1 receptor antagonist (pg/ml): 2.398356731
log10 ogtt fasting plasma insulin (mu/l): 0.748188027
ogtt 30 min plasma insulin (mu/l): 1.501059262
ogtt 120 min plasma insulin (mu/l): 1.663700925
log10 ogtt fasting plasma proinsulin (pm/l): 1.123851641
ogtt 30 min plasma proinsulin (pm/l): 1.367355921
ogtt 120 min plasma proinsulin (pm/l): 1.674861141
log10 serum alanine aminotransfrase (u/l): 1.204119983
log10 total cholesterol (mmol/l): 0.592176757
log10 ldl cholesterol (mmol/l): 0.357934847
log10 hdl cholesterol (mmol/l): 0.037426498
log10 urinary albumin excretion rate (ug/min): 0.90045523
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.339395984
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.423859499
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.632086413
log10 homair (insulin resistance index based on homa): 0.57333584
log10 homais (insulin secretion index based on homa): 2.215400993
log10 insulin area under the curve (ogtt) (pmol/l * min): 5.206804296
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 5.175395831
log10 matsuda insulin sensitivity index: 0.282185572
lg10 serum c-reactive protein (mg/l): 0.529173603
lg10 plasma adiponectin (mg/l): 0.662757832
ogtt fasting plasma free fatty acid (mmol/l): 0.35
log10 il1 receptor antagonist (pg/ml): 2.484641445
log10 ogtt fasting plasma insulin (mu/l): 1.193124598
ogtt 30 min plasma insulin (mu/l): 2.558708571
ogtt 120 min plasma insulin (mu/l): 2.035029282
ogtt 30 min plasma proinsulin (pm/l): 1.759667845
ogtt 120 min plasma proinsulin (pm/l): 1.808885867
log10 serum alanine aminotransfrase (u/l): 1.477121255
log10 total cholesterol (mmol/l): 0.744292983
log10 ldl cholesterol (mmol/l): 0.394451681
log10 total triglycerides (mmol/l): 0.758911892
log10 urinary albumin excretion rate (ug/min): 0.95248423
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 5.971589741
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.51279523
plasma free fatty acids under the curve ogtt (mmol/l * min): 18.6
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.35645197
log10 homair (insulin resistance index based on homa): -0.360956442
log10 homais (insulin secretion index based on homa): 1.455931956
log10 insulin area under the curve (ogtt) (pmol/l * min): 3.990072335
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.920853496
log10 matsuda insulin sensitivity index: 1.390450291
lg10 serum c-reactive protein (mg/l): 0.682325619
lg10 plasma adiponectin (mg/l): 1.187520721
ogtt fasting plasma free fatty acid (mmol/l): 0.2
ogtt 30 min plasma glucose (mmol/l): 6.4
ogtt 120 min plasma glucose (mmol/l): 4.4
log10 il1 receptor antagonist (pg/ml): 2.091209565
log10 ogtt fasting plasma insulin (mu/l): 0.301029996
ogtt 30 min plasma insulin (mu/l): 1.359835482
ogtt 120 min plasma insulin (mu/l): 0.698970004
log10 ogtt fasting plasma proinsulin (pm/l): 0.924279286
ogtt 30 min plasma proinsulin (pm/l): 1.100370545
ogtt 120 min plasma proinsulin (pm/l): 1.149219113
log10 serum alanine aminotransfrase (u/l): 1.041392685
log10 total cholesterol (mmol/l): 0.692846919
log10 ldl cholesterol (mmol/l): 0.450249108
log10 hdl cholesterol (mmol/l): 0.247973266
log10 total triglycerides (mmol/l): -0.119186408
log10 urinary albumin excretion rate (ug/min): 0.752552832
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.68421978
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.031315588
plasma free fatty acids under the curve ogtt (mmol/l * min): 11.25
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.401946124
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 16.5
log10 homair (insulin resistance index based on homa): 0.187520721
log10 homais (insulin secretion index based on homa): 1.799340549
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.571032996
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.514627432
log10 matsuda insulin sensitivity index: 0.826593247
lg10 serum c-reactive protein (mg/l): 0.35545152
lg10 plasma adiponectin (mg/l): 0.819543936
ogtt fasting plasma free fatty acid (mmol/l): 0.16
ogtt 30 min plasma free fatty acid (mmol/l): 0.08
ogtt 30 min plasma glucose (mmol/l): 7.2
log10 il1 receptor antagonist (pg/ml): 2.047664195
log10 ogtt fasting plasma insulin (mu/l): 0.799340549
ogtt 30 min plasma insulin (mu/l): 1.99343623
ogtt 120 min plasma insulin (mu/l): 0.653212514
log10 ogtt fasting plasma proinsulin (pm/l): 1.08278537
ogtt 120 min plasma proinsulin (pm/l): 1.133538908
log10 total cholesterol (mmol/l): 0.665580991
log10 total triglycerides (mmol/l): -0.086186148
log10 urinary albumin excretion rate (ug/min): 1.164264052
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.526495272
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.167338599
plasma free fatty acids under the curve ogtt (mmol/l * min): 29.55
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.949097156
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 280.5
log10 homair (insulin resistance index based on homa): 0.683487317
log10 homais (insulin secretion index based on homa): 2.185636577
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.937282125
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.865133598
log10 matsuda insulin sensitivity index: 0.281999031
lg10 serum c-reactive protein (mg/l): -0.209714836
lg10 plasma adiponectin (mg/l): 0.86923172
ogtt 30 min plasma glucose (mmol/l): 8.7
ogtt 120 min plasma glucose (mmol/l): 8.4
log10 il1 receptor antagonist (pg/ml): 2.211200662
log10 ogtt fasting plasma insulin (mu/l): 1.264817823
ogtt 30 min plasma insulin (mu/l): 1.942999593
ogtt 120 min plasma insulin (mu/l): 2.2955671
log10 ogtt fasting plasma proinsulin (pm/l): 1.46834733
ogtt 30 min plasma proinsulin (pm/l): 1.706717782
ogtt 120 min plasma proinsulin (pm/l): 1.980457892
log10 serum alanine aminotransfrase (u/l): 1.681241237
log10 total cholesterol (mmol/l): 0.630427875
log10 ldl cholesterol (mmol/l): 0.382017043
log10 hdl cholesterol (mmol/l): 0.190331698
log10 total triglycerides (mmol/l): 0.08278537
log10 urinary albumin excretion rate (ug/min): 0.798602876
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.171115448
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.602931318
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.430452552
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 42
log10 homais (insulin secretion index based on homa): 1.746552264
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.779213971
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.750747461
log10 matsuda insulin sensitivity index: 0.76782338
lg10 serum c-reactive protein (mg/l): 0.124830149
ogtt 120 min plasma free fatty acid (mmol/l): 0.06
log10 il1 receptor antagonist (pg/ml): 2.067554377
log10 ogtt fasting plasma insulin (mu/l): 0.72427587
ogtt 30 min plasma insulin (mu/l): 2.20871002
ogtt 120 min plasma insulin (mu/l): 0.73239376
ogtt 30 min plasma proinsulin (pm/l): 1.589949601
ogtt 120 min plasma proinsulin (pm/l): 1.298853076
log10 total cholesterol (mmol/l): 0.814913181
log10 ldl cholesterol (mmol/l): 0.652246341
log10 hdl cholesterol (mmol/l): 0.149219113
log10 total triglycerides (mmol/l): 0.26245109
log10 urinary albumin excretion rate (ug/min): 0.304490528
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.656291109
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.800841523
plasma free fatty acids under the curve ogtt (mmol/l * min): 12.6
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.811374694
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 202.5
log10 homair (insulin resistance index based on homa): 0.151608165
log10 homais (insulin secretion index based on homa): 1.679664849
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.23482088
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.120968565
log10 matsuda insulin sensitivity index: 0.951756747
lg10 serum c-reactive protein (mg/l): -0.54515514
ogtt 30 min plasma free fatty acid (mmol/l): 0.11
ogtt 30 min plasma glucose (mmol/l): 11.2
ogtt 120 min plasma glucose (mmol/l): 3.1
log10 il1 receptor antagonist (pg/ml): 2.313761796
log10 ogtt fasting plasma insulin (mu/l): 0.740362689
ogtt 30 min plasma insulin (mu/l): 1.596597096
ogtt 120 min plasma insulin (mu/l): 0.959041392
log10 ogtt fasting plasma proinsulin (pm/l): 0.880813592
ogtt 30 min plasma proinsulin (pm/l): 1.170261715
ogtt 120 min plasma proinsulin (pm/l): 1.257678575
log10 ldl cholesterol (mmol/l): 0.471291711
log10 total triglycerides (mmol/l): -0.107905397
log10 urinary albumin excretion rate (ug/min): 0.551754873
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.359654801
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.416505697
plasma free fatty acids under the curve ogtt (mmol/l * min): 29.1
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.742309436
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 256.5
log10 homair (insulin resistance index based on homa): -0.08501079
log10 homais (insulin secretion index based on homa): 1.693140461
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.295281141
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.23230984
log10 matsuda insulin sensitivity index: 1.046350387
lg10 serum c-reactive protein (mg/l): -0.554395797
lg10 plasma adiponectin (mg/l): 0.72427587
ogtt fasting plasma free fatty acid (mmol/l): 0.66
ogtt 120 min plasma glucose (mmol/l): 5.9
log10 il1 receptor antagonist (pg/ml): 2.167346878
ogtt 30 min plasma insulin (mu/l): 1.603144373
ogtt 120 min plasma insulin (mu/l): 1.264817823
ogtt 120 min plasma proinsulin (pm/l): 1.426511261
log10 serum alanine aminotransfrase (u/l): 1.662757832
log10 total cholesterol (mmol/l): 0.6599162
log10 ldl cholesterol (mmol/l): 0.354108439
log10 hdl cholesterol (mmol/l): 0.334453751
log10 total triglycerides (mmol/l): -0.214670165
log10 urinary albumin excretion rate (ug/min): 0.454106891
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.553885977
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.619779709
plasma free fatty acids under the curve ogtt (mmol/l * min): 34.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.842350343
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 186
log10 homair (insulin resistance index based on homa): 0.114388554
log10 homais (insulin secretion index based on homa): 1.567297885
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.374363358
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.305845582
log10 matsuda insulin sensitivity index: 0.87703081
lg10 serum c-reactive protein (mg/l): 0.550350672
lg10 plasma adiponectin (mg/l): 0.556302501
ogtt 30 min plasma free fatty acid (mmol/l): 0.41
ogtt fasting plasma glucose (mmol/l): 6.1
ogtt 30 min plasma glucose (mmol/l): 9.2
ogtt 120 min plasma glucose (mmol/l): 6.1
log10 il1 receptor antagonist (pg/ml): 2.317917154
log10 ogtt fasting plasma insulin (mu/l): 0.681241237
ogtt 30 min plasma insulin (mu/l): 1.584331224
ogtt 120 min plasma insulin (mu/l): 1.542825427
ogtt 30 min plasma proinsulin (pm/l): 1.257678575
ogtt 120 min plasma proinsulin (pm/l): 1.615950052
log10 serum alanine aminotransfrase (u/l): 1.51851394
log10 total cholesterol (mmol/l): 0.726727209
log10 ldl cholesterol (mmol/l): 0.561101384
log10 hdl cholesterol (mmol/l): 0.086359831
log10 total triglycerides (mmol/l): -0.036212173
log10 urinary albumin excretion rate (ug/min): 0.86923172
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.392120527
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.738230244
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.940313597
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 226.5
log10 homair (insulin resistance index based on homa): 0.605520523
log10 homais (insulin secretion index based on homa): 2.012234456
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.529545843
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.370716589
log10 matsuda insulin sensitivity index: 0.532221588
lg10 serum c-reactive protein (mg/l): 0.301029996
ogtt fasting plasma free fatty acid (mmol/l): 0.42
ogtt 30 min plasma free fatty acid (mmol/l): 0.23
ogtt fasting plasma glucose (mmol/l): 6.3
ogtt 30 min plasma glucose (mmol/l): 10.3
log10 il1 receptor antagonist (pg/ml): 2.60148417
log10 ogtt fasting plasma insulin (mu/l): 1.158362492
ogtt 30 min plasma insulin (mu/l): 1.736396502
ogtt 120 min plasma insulin (mu/l): 1.680335513
log10 ogtt fasting plasma proinsulin (pm/l): 1.152288344
ogtt 30 min plasma proinsulin (pm/l): 1.318063335
ogtt 120 min plasma proinsulin (pm/l): 1.51851394
log10 serum alanine aminotransfrase (u/l): 1.579783597
log10 total cholesterol (mmol/l): 0.749736316
log10 ldl cholesterol (mmol/l): 0.640481437
log10 hdl cholesterol (mmol/l): -0.036212173
log10 total triglycerides (mmol/l): 0.309630167
log10 urinary albumin excretion rate (ug/min): 0.712884519
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.748807692
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.144046278
plasma free fatty acids under the curve ogtt (mmol/l * min): 28.35
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.703903573
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 150
log10 homair (insulin resistance index based on homa): 0.385963571
log10 homais (insulin secretion index based on homa): 1.940878548
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.608804064
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.527810282
log10 matsuda insulin sensitivity index: 0.668479802
lg10 serum c-reactive protein (mg/l): -0.160521953
lg10 plasma adiponectin (mg/l): 0.698970004
ogtt fasting plasma glucose (mmol/l): 5.7
ogtt 30 min plasma glucose (mmol/l): 9.4
ogtt 120 min plasma glucose (mmol/l): 4.1
log10 il1 receptor antagonist (pg/ml): 2.395169075
ogtt 30 min plasma insulin (mu/l): 2.02325246
log10 ogtt fasting plasma proinsulin (pm/l): 1.086359831
ogtt 30 min plasma proinsulin (pm/l): 1.645422269
ogtt 120 min plasma proinsulin (pm/l): 1.403120521
log10 serum bilirubin (umol/l): 1.544068044
log10 total cholesterol (mmol/l): 0.655138435
log10 ldl cholesterol (mmol/l): 0.480006943
log10 total triglycerides (mmol/l): 0.164352856
log10 urinary albumin excretion rate (ug/min): 0.934498451
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.278526307
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.251888771
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.582141982
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 58.5
log10 homair (insulin resistance index based on homa): 0.218010043
log10 homais (insulin secretion index based on homa): 1.720159303
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.389449613
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.300595484
log10 matsuda insulin sensitivity index: 0.871543768
lg10 serum c-reactive protein (mg/l): -0.368556231
ogtt fasting plasma free fatty acid (mmol/l): 0.41
log10 il1 receptor antagonist (pg/ml): 2.20199762
ogtt 30 min plasma insulin (mu/l): 1.786751422
ogtt 120 min plasma insulin (mu/l): 0.851258349
log10 ogtt fasting plasma proinsulin (pm/l): 0.929418926
ogtt 30 min plasma proinsulin (pm/l): 1.392696953
ogtt 120 min plasma proinsulin (pm/l): 1.488550717
log10 serum bilirubin (umol/l): 1.079181246
log10 ldl cholesterol (mmol/l): 0.563481085
log10 hdl cholesterol (mmol/l): 0.173186268
log10 total triglycerides (mmol/l): 0.037426498
log10 urinary albumin excretion rate (ug/min): 1.152118399
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.425060246
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.600699475
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.3
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.839991071
log10 homair (insulin resistance index based on homa): -0.067751784
log10 homais (insulin secretion index based on homa): 1.544068044
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.570402822
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.539928788
log10 matsuda insulin sensitivity index: 0.876235596
lg10 serum c-reactive protein (mg/l): 0.60075515
ogtt 120 min plasma glucose (mmol/l): 6.4
log10 il1 receptor antagonist (pg/ml): 2.250810204
log10 ogtt fasting plasma insulin (mu/l): 0.544068044
ogtt 30 min plasma insulin (mu/l): 1.745855195
ogtt 120 min plasma insulin (mu/l): 1.794488047
log10 ogtt fasting plasma proinsulin (pm/l): 1.017033339
ogtt 30 min plasma proinsulin (pm/l): 1.264817823
ogtt 120 min plasma proinsulin (pm/l): 1.648360011
log10 serum bilirubin (umol/l): 1.041392685
log10 serum alanine aminotransfrase (u/l): 1.414973348
log10 total cholesterol (mmol/l): 0.631443769
log10 ldl cholesterol (mmol/l): 0.440909082
log10 hdl cholesterol (mmol/l): -0.050609993
log10 total triglycerides (mmol/l): -0.060480747
log10 urinary albumin excretion rate (ug/min): 0.756156957
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.496686471
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.459195841
plasma free fatty acids under the curve ogtt (mmol/l * min): 11.1
log10 homair (insulin resistance index based on homa): 0.025305865
log10 homais (insulin secretion index based on homa): 1.698970004
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.288696261
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.209515015
log10 matsuda insulin sensitivity index: 1.016750866
lg10 plasma adiponectin (mg/l): 1.004321374
ogtt 30 min plasma free fatty acid (mmol/l): 0.12
log10 il1 receptor antagonist (pg/ml): 2.247899651
log10 ogtt fasting plasma insulin (mu/l): 0.653212514
ogtt 120 min plasma insulin (mu/l): 1.409933123
log10 ogtt fasting plasma proinsulin (pm/l): 0.919078092
ogtt 30 min plasma proinsulin (pm/l): 1.130333768
ogtt 120 min plasma proinsulin (pm/l): 1.46686762
log10 serum bilirubin (umol/l): 1.146128036
log10 ldl cholesterol (mmol/l): 0.574031268
log10 hdl cholesterol (mmol/l): 0.243038049
log10 total triglycerides (mmol/l): 0.049218023
log10 urinary albumin excretion rate (ug/min): 0.562041415
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.655647312
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.065821111
plasma free fatty acids under the curve ogtt (mmol/l * min): 12.3
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.747353829
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 103.5
log10 homair (insulin resistance index based on homa): 0.232487866
log10 homais (insulin secretion index based on homa): 1.639201799
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.391675953
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.306425028
log10 matsuda insulin sensitivity index: 0.816468919
lg10 serum c-reactive protein (mg/l): 0.112939976
lg10 plasma adiponectin (mg/l): 0.505149978
ogtt fasting plasma free fatty acid (mmol/l): 0.18
ogtt 30 min plasma glucose (mmol/l): 8.1
log10 il1 receptor antagonist (pg/ml): 2.138302698
log10 ogtt fasting plasma insulin (mu/l): 0.785329835
ogtt 30 min plasma insulin (mu/l): 1.611723308
ogtt 120 min plasma insulin (mu/l): 1.540329475
ogtt 30 min plasma proinsulin (pm/l): 1.201397124
ogtt 120 min plasma proinsulin (pm/l): 1.515873844
log10 serum bilirubin (umol/l): 1.204119983
log10 ldl cholesterol (mmol/l): 0.488550717
log10 hdl cholesterol (mmol/l): 0.053078443
log10 total triglycerides (mmol/l): 0.025305865
log10 urinary albumin excretion rate (ug/min): 0.77003336
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.421557173
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 5.877749085
plasma free fatty acids under the curve ogtt (mmol/l * min): 16.95
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.08081753
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 363
log10 homair (insulin resistance index based on homa): 0.158362492
log10 homais (insulin secretion index based on homa): 1.635483747
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.713305698
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.679337031
log10 matsuda insulin sensitivity index: 0.688709281
lg10 plasma adiponectin (mg/l): 1.113943352
ogtt 30 min plasma glucose (mmol/l): 13.1
ogtt 120 min plasma glucose (mmol/l): 4.6
log10 il1 receptor antagonist (pg/ml): 2.183696809
ogtt 30 min plasma insulin (mu/l): 2.113609151
ogtt 120 min plasma insulin (mu/l): 1.214843848
ogtt 30 min plasma proinsulin (pm/l): 1.46686762
ogtt 120 min plasma proinsulin (pm/l): 1.411619706
log10 ldl cholesterol (mmol/l): 0.507855872
log10 hdl cholesterol (mmol/l): 0.29666519
log10 total triglycerides (mmol/l): 0.267171728
log10 urinary albumin excretion rate (ug/min): 0.773742131
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.617168971
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.647337353
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.6
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.849405101
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 214.5
log10 homair (insulin resistance index based on homa): 0.12623967
log10 homais (insulin secretion index based on homa): 1.62838893
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.369549802
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.295479133
log10 matsuda insulin sensitivity index: 0.873622119
lg10 serum c-reactive protein (mg/l): 0.725012725
lg10 plasma adiponectin (mg/l): 1.049218023
log10 il1 receptor antagonist (pg/ml): 2.21285319
log10 ogtt fasting plasma insulin (mu/l): 0.707570176
ogtt 30 min plasma insulin (mu/l): 1.588831726
ogtt 120 min plasma insulin (mu/l): 1.522444234
ogtt 30 min plasma proinsulin (pm/l): 1.359835482
ogtt 120 min plasma proinsulin (pm/l): 1.646403726
log10 serum bilirubin (umol/l): 1.113943352
log10 total cholesterol (mmol/l): 0.671172843
log10 ldl cholesterol (mmol/l): 0.338456494
log10 hdl cholesterol (mmol/l): 0.390935107
log10 total triglycerides (mmol/l): -0.207608311
log10 urinary albumin excretion rate (ug/min): 0.879860146
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.291799537
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.502500249
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.796850795
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 181.5
log10 homair (insulin resistance index based on homa): 0.108865574
log10 homais (insulin secretion index based on homa): 1.611014834
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.432375938
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.371714203
log10 matsuda insulin sensitivity index: 0.860605238
lg10 serum c-reactive protein (mg/l): 0.116939647
lg10 plasma adiponectin (mg/l): 0.963787827
log10 il1 receptor antagonist (pg/ml): 2.498834149
ogtt 30 min plasma insulin (mu/l): 1.661812686
ogtt 120 min plasma insulin (mu/l): 1.572871602
ogtt 30 min plasma proinsulin (pm/l): 1.376576957
ogtt 120 min plasma proinsulin (pm/l): 1.655138435
log10 serum bilirubin (umol/l): 1.591064607
log10 ldl cholesterol (mmol/l): 0.411619706
log10 total triglycerides (mmol/l): 0.096910013
log10 urinary albumin excretion rate (ug/min): 0.61196828
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.905597511
plasma free fatty acids under the curve ogtt (mmol/l * min): 26.85
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.31458324
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 493.5
log10 homair (insulin resistance index based on homa): 0.159700843
log10 homais (insulin secretion index based on homa): 1.522878745
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.267054336
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.173040508
log10 matsuda insulin sensitivity index: 0.829928213
lg10 serum c-reactive protein (mg/l): 0.815112658
lg10 plasma adiponectin (mg/l): 0.838849091
ogtt 30 min plasma free fatty acid (mmol/l): 0.31
ogtt fasting plasma glucose (mmol/l): 6.5
ogtt 30 min plasma glucose (mmol/l): 10.9
ogtt 120 min plasma glucose (mmol/l): 11.6
log10 il1 receptor antagonist (pg/ml): 2.649305645
ogtt 30 min plasma insulin (mu/l): 1.342422681
ogtt 120 min plasma insulin (mu/l): 1.574031268
log10 ogtt fasting plasma proinsulin (pm/l): 1.037426498
ogtt 120 min plasma proinsulin (pm/l): 1.511883361
log10 serum bilirubin (umol/l): 1.322219295
log10 serum alanine aminotransfrase (u/l): 1.785329835
log10 total cholesterol (mmol/l): 0.656098202
log10 ldl cholesterol (mmol/l): 0.376576957
log10 hdl cholesterol (mmol/l): 0.318063335
log10 total triglycerides (mmol/l): -0.167491087
log10 urinary albumin excretion rate (ug/min): 0.919731658
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.537146159
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.676510436
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.95
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.909143047
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 253.5
log10 homair (insulin resistance index based on homa): 0.281992354
log10 homais (insulin secretion index based on homa): 1.784141614
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.513310843
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.43697321
log10 matsuda insulin sensitivity index: 0.71490465
lg10 serum c-reactive protein (mg/l): -0.351639989
lg10 plasma adiponectin (mg/l): 0.633468456
ogtt 120 min plasma glucose (mmol/l): 7.4
log10 il1 receptor antagonist (pg/ml): 2.380807986
log10 ogtt fasting plasma insulin (mu/l): 0.86332286
ogtt 30 min plasma insulin (mu/l): 1.7355989
ogtt 120 min plasma insulin (mu/l): 1.660865478
log10 ogtt fasting plasma proinsulin (pm/l): 1.240549248
ogtt 30 min plasma proinsulin (pm/l): 1.671172843
ogtt 120 min plasma proinsulin (pm/l): 1.826074803
log10 total cholesterol (mmol/l): 0.688419822
log10 ldl cholesterol (mmol/l): 0.45484486
log10 hdl cholesterol (mmol/l): 0.193124598
log10 total triglycerides (mmol/l): 0.167317335
log10 urinary albumin excretion rate (ug/min): 1.032184683
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.22740466
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.013549143
plasma free fatty acids under the curve ogtt (mmol/l * min): 12.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.346513733
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 39
log10 homair (insulin resistance index based on homa): -0.167491087
log10 homais (insulin secretion index based on homa): 1.574031268
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.332276832
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.286276786
log10 matsuda insulin sensitivity index: 1.12951172
lg10 plasma adiponectin (mg/l): 0.681241237
ogtt fasting plasma free fatty acid (mmol/l): 0.21
ogtt 30 min plasma glucose (mmol/l): 6.8
log10 il1 receptor antagonist (pg/ml): 2.313360951
log10 ogtt fasting plasma insulin (mu/l): 0.477121255
ogtt 30 min plasma insulin (mu/l): 1.720159303
ogtt 120 min plasma insulin (mu/l): 0.934498451
log10 ogtt fasting plasma proinsulin (pm/l): 1.012837225
ogtt 120 min plasma proinsulin (pm/l): 1.356025857
log10 serum alanine aminotransfrase (u/l): 1.380211242
log10 total cholesterol (mmol/l): 0.764176132
log10 ldl cholesterol (mmol/l): 0.564666064
log10 hdl cholesterol (mmol/l): 0.23299611
log10 total triglycerides (mmol/l): -0.13667714
log10 urinary albumin excretion rate (ug/min): 0.693567076
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.475108188
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.414990444
plasma free fatty acids under the curve ogtt (mmol/l * min): 10.2
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 175.5
log10 homair (insulin resistance index based on homa): 0.419772231
log10 homais (insulin secretion index based on homa): 1.782950133
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.505692507
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.406335758
log10 matsuda insulin sensitivity index: 0.657467551
lg10 serum c-reactive protein (mg/l): -0.503070352
ogtt fasting plasma free fatty acid (mmol/l): 0.23
ogtt 30 min plasma free fatty acid (mmol/l): 0.09
ogtt 30 min plasma glucose (mmol/l): 10.4
ogtt 120 min plasma glucose (mmol/l): 5.2
log10 il1 receptor antagonist (pg/ml): 2.158995377
log10 ogtt fasting plasma insulin (mu/l): 0.959041392
ogtt 30 min plasma insulin (mu/l): 1.8162413
ogtt 120 min plasma insulin (mu/l): 1.451786436
log10 ogtt fasting plasma proinsulin (pm/l): 1.451786436
ogtt 30 min plasma proinsulin (pm/l): 1.596597096
ogtt 120 min plasma proinsulin (pm/l): 1.638489257
log10 serum bilirubin (umol/l): 0.84509804
log10 total cholesterol (mmol/l): 0.835690571
log10 ldl cholesterol (mmol/l): 0.669316881
log10 total triglycerides (mmol/l): 0.093421685
log10 urinary albumin excretion rate (ug/min): 1.180890142
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.66866566
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.508170937
plasma free fatty acids under the curve ogtt (mmol/l * min): 21.75
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.512740463
log10 homair (insulin resistance index based on homa): -0.189021143
log10 homais (insulin secretion index based on homa): 1.393784049
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.068185862
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.992465148
log10 matsuda insulin sensitivity index: 1.229341053
ogtt fasting plasma free fatty acid (mmol/l): 0.52
log10 il1 receptor antagonist (pg/ml): 2.056790548
log10 ogtt fasting plasma insulin (mu/l): 0.414973348
ogtt 30 min plasma insulin (mu/l): 1.344392274
log10 ogtt fasting plasma proinsulin (pm/l): 0.69019608
ogtt 120 min plasma proinsulin (pm/l): 1.414973348
log10 total cholesterol (mmol/l): 0.762678564
log10 ldl cholesterol (mmol/l): 0.445604203
log10 hdl cholesterol (mmol/l): 0.369215857
log10 total triglycerides (mmol/l): -0.15490196
log10 urinary albumin excretion rate (ug/min): 1.248323645
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.392910911
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.719388821
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 171
log10 homair (insulin resistance index based on homa): 0.299095496
log10 homais (insulin secretion index based on homa): 1.881900688
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.556736578
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.481098497
log10 matsuda insulin sensitivity index: 0.734518713
lg10 serum c-reactive protein (mg/l): 0.435685138
log10 il1 receptor antagonist (pg/ml): 2.627550188
log10 ogtt fasting plasma insulin (mu/l): 0.903089987
ogtt 30 min plasma insulin (mu/l): 1.949877704
ogtt 120 min plasma insulin (mu/l): 1.079181246
log10 ogtt fasting plasma proinsulin (pm/l): 1.096910013
ogtt 30 min plasma proinsulin (pm/l): 1.606381365
ogtt 120 min plasma proinsulin (pm/l): 1.612783857
log10 serum bilirubin (umol/l): 1.301029996
log10 total cholesterol (mmol/l): 0.741939078
log10 ldl cholesterol (mmol/l): 0.51851394
log10 hdl cholesterol (mmol/l): 0.004321374
log10 total triglycerides (mmol/l): 0.338456494
log10 urinary albumin excretion rate (ug/min): 0.857162551
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.260527536
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.5061315
plasma free fatty acids under the curve ogtt (mmol/l * min): 10.8
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.791976821
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 190.5
log10 homair (insulin resistance index based on homa): 0.230789411
log10 homais (insulin secretion index based on homa): 1.758846095
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.498186452
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.427145161
log10 matsuda insulin sensitivity index: 0.785091732
lg10 serum c-reactive protein (mg/l): 0.380211242
ogtt fasting plasma free fatty acid (mmol/l): 0.15
log10 il1 receptor antagonist (pg/ml): 2.429929836
ogtt 30 min plasma insulin (mu/l): 1.880813592
ogtt 120 min plasma insulin (mu/l): 1.117271296
log10 ogtt fasting plasma proinsulin (pm/l): 0.857332496
ogtt 120 min plasma proinsulin (pm/l): 1.260071388
log10 total cholesterol (mmol/l): 0.758911892
log10 ldl cholesterol (mmol/l): 0.56937391
log10 urinary albumin excretion rate (ug/min): 1.05270635
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 7.120312714
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.3156401
plasma free fatty acids under the curve ogtt (mmol/l * min): 24
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.25915477
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 397.5
log10 homair (insulin resistance index based on homa): 0.808885867
log10 homais (insulin secretion index based on homa): 2.091770373
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.988630293
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.915378727
log10 matsuda insulin sensitivity index: 0.149691359
lg10 serum c-reactive protein (mg/l): -0.076238039
lg10 plasma adiponectin (mg/l): 0.77815125
ogtt fasting plasma free fatty acid (mmol/l): 0.49
ogtt 30 min plasma glucose (mmol/l): 12.1
ogtt 120 min plasma glucose (mmol/l): 8.8
log10 il1 receptor antagonist (pg/ml): 2.501251022
log10 ogtt fasting plasma insulin (mu/l): 1.322219295
ogtt 30 min plasma insulin (mu/l): 1.935003151
ogtt 120 min plasma insulin (mu/l): 2.378397901
log10 ogtt fasting plasma proinsulin (pm/l): 1.503790683
ogtt 30 min plasma proinsulin (pm/l): 1.720159303
ogtt 120 min plasma proinsulin (pm/l): 1.984077034
log10 serum alanine aminotransfrase (u/l): 1.832508913
log10 total cholesterol (mmol/l): 0.906873535
log10 ldl cholesterol (mmol/l): 0.72916479
log10 urinary albumin excretion rate (ug/min): 0.798521898
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.686623353
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.732760914
plasma free fatty acids under the curve ogtt (mmol/l * min): 11.85
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.677719642
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 75
log10 homair (insulin resistance index based on homa): 0.147779347
log10 homais (insulin secretion index based on homa): 1.577236408
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.312938609
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.227475343
log10 matsuda insulin sensitivity index: 0.927466773
lg10 serum c-reactive protein (mg/l): -0.450996738
ogtt fasting plasma glucose (mmol/l): 6.2
log10 il1 receptor antagonist (pg/ml): 2.17912073
ogtt 30 min plasma insulin (mu/l): 1.671172843
ogtt 120 min plasma insulin (mu/l): 1.075546961
ogtt 30 min plasma proinsulin (pm/l): 1.537819095
ogtt 120 min plasma proinsulin (pm/l): 1.574031268
log10 total cholesterol (mmol/l): 0.564666064
log10 ldl cholesterol (mmol/l): 0.326335861
log10 hdl cholesterol (mmol/l): -0.004364805
log10 total triglycerides (mmol/l): 0.214843848
log10 urinary albumin excretion rate (ug/min): 0.810180579
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.801017968
plasma free fatty acids under the curve ogtt (mmol/l * min): 42.15
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.868050854
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 262.5
log10 homair (insulin resistance index based on homa): 0.094975513
log10 homais (insulin secretion index based on homa): 1.677780705
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.189518386
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.074487305
log10 matsuda insulin sensitivity index: 0.976146889
lg10 serum c-reactive protein (mg/l): -0.003488328
ogtt fasting plasma free fatty acid (mmol/l): 0.57
ogtt 30 min plasma free fatty acid (mmol/l): 0.5
ogtt 120 min plasma glucose (mmol/l): 6.9
log10 il1 receptor antagonist (pg/ml): 2.48207283
ogtt 30 min plasma insulin (mu/l): 1.437750563
ogtt 120 min plasma insulin (mu/l): 1.281033367
ogtt 30 min plasma proinsulin (pm/l): 1.440909082
ogtt 120 min plasma proinsulin (pm/l): 1.650307523
log10 total cholesterol (mmol/l): 0.887054378
log10 ldl cholesterol (mmol/l): 0.7355989
log10 hdl cholesterol (mmol/l): 0.326335861
log10 total triglycerides (mmol/l): 0.064457989
log10 urinary albumin excretion rate (ug/min): 1.313650938
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.600779512
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.521616776
plasma free fatty acids under the curve ogtt (mmol/l * min): 25.35
log10 homair (insulin resistance index based on homa): 0.112456041
log10 homais (insulin secretion index based on homa): 1.72427587
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.335898992
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.251784177
log10 matsuda insulin sensitivity index: 0.896028713
lg10 serum c-reactive protein (mg/l): 0.602059991
lg10 plasma adiponectin (mg/l): 0.986771734
log10 il1 receptor antagonist (pg/ml): 2.282576801
ogtt 30 min plasma insulin (mu/l): 1.401400541
ogtt 120 min plasma insulin (mu/l): 1.652246341
ogtt 30 min plasma proinsulin (pm/l): 1.328379603
ogtt 120 min plasma proinsulin (pm/l): 1.789580712
log10 serum bilirubin (umol/l): 1.176091259
log10 total cholesterol (mmol/l): 0.728353782
log10 total triglycerides (mmol/l): -0.017728767
log10 urinary albumin excretion rate (ug/min): 0.949694882
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.666941996
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.852710764
plasma free fatty acids under the curve ogtt (mmol/l * min): 21
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.73978061
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 147
log10 homair (insulin resistance index based on homa): 0.174544349
log10 homais (insulin secretion index based on homa): 1.67669361
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.627632088
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.583448167
log10 matsuda insulin sensitivity index: 0.730670091
lg10 serum c-reactive protein (mg/l): -0.175223538
ogtt 120 min plasma glucose (mmol/l): 4.5
log10 il1 receptor antagonist (pg/ml): 2.199837422
log10 ogtt fasting plasma insulin (mu/l): 0.755874856
ogtt 30 min plasma insulin (mu/l): 1.700703717
ogtt 120 min plasma insulin (mu/l): 1.945960704
log10 ogtt fasting plasma proinsulin (pm/l): 1.1430148
ogtt 30 min plasma proinsulin (pm/l): 1.387389826
ogtt 120 min plasma proinsulin (pm/l): 1.790988475
log10 total cholesterol (mmol/l): 0.802773725
log10 ldl cholesterol (mmol/l): 0.6599162
log10 hdl cholesterol (mmol/l): 0.139879086
log10 urinary albumin excretion rate (ug/min): 1.111365929
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.542253687
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.929550479
plasma free fatty acids under the curve ogtt (mmol/l * min): 36.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.737247343
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 157.5
log10 homair (insulin resistance index based on homa): 0.355728148
log10 homais (insulin secretion index based on homa): 1.883784832
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.835969445
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.793846239
log10 matsuda insulin sensitivity index: 0.557825389
lg10 serum c-reactive protein (mg/l): 0.331427297
lg10 plasma adiponectin (mg/l): 0.69019608
ogtt 30 min plasma free fatty acid (mmol/l): 0.4
ogtt 120 min plasma free fatty acid (mmol/l): 0.07
ogtt 30 min plasma glucose (mmol/l): 8.5
ogtt 120 min plasma glucose (mmol/l): 5.7
log10 il1 receptor antagonist (pg/ml): 2.421274791
log10 ogtt fasting plasma insulin (mu/l): 0.944482672
ogtt 30 min plasma insulin (mu/l): 2.186673867
ogtt 120 min plasma insulin (mu/l): 1.662757832
log10 ogtt fasting plasma proinsulin (pm/l): 1.361727836
ogtt 30 min plasma proinsulin (pm/l): 1.851258349
ogtt 120 min plasma proinsulin (pm/l): 1.973127854
log10 serum bilirubin (umol/l): 1.602059991
log10 serum alanine aminotransfrase (u/l): 1.763427994
log10 total cholesterol (mmol/l): 0.686636269
log10 total triglycerides (mmol/l): 0.352182518
log10 urinary albumin excretion rate (ug/min): 1.021189299
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.385885025
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.76156832
plasma free fatty acids under the curve ogtt (mmol/l * min): 55.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.44604941
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 531
log10 homair (insulin resistance index based on homa): 0.660486016
log10 homais (insulin secretion index based on homa): 1.888164309
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.60260252
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.473545359
log10 matsuda insulin sensitivity index: 0.398433097
lg10 serum c-reactive protein (mg/l): 0.08350262
lg10 plasma adiponectin (mg/l): 1.041392685
ogtt fasting plasma free fatty acid (mmol/l): 0.89
ogtt 30 min plasma free fatty acid (mmol/l): 0.62
ogtt fasting plasma glucose (mmol/l): 7.2
ogtt 30 min plasma glucose (mmol/l): 13.5
ogtt 120 min plasma glucose (mmol/l): 10.6
log10 il1 receptor antagonist (pg/ml): 2.280601132
log10 ogtt fasting plasma insulin (mu/l): 1.155336037
ogtt 30 min plasma insulin (mu/l): 1.783903579
ogtt 120 min plasma insulin (mu/l): 1.795880017
log10 ogtt fasting plasma proinsulin (pm/l): 1.409933123
ogtt 30 min plasma proinsulin (pm/l): 1.627365857
log10 serum bilirubin (umol/l): 1.230448921
log10 total cholesterol (mmol/l): 0.853698212
log10 hdl cholesterol (mmol/l): 0.100370545
log10 total triglycerides (mmol/l): 0.72916479
log10 urinary albumin excretion rate (ug/min): 0.605614946
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.511211783
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.244708617
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.579315938
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 57
log10 homair (insulin resistance index based on homa): -0.201119265
log10 homais (insulin secretion index based on homa): 1.301029996
log10 insulin area under the curve (ogtt) (pmol/l * min): 3.976670881
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.889245661
log10 matsuda insulin sensitivity index: 1.268699938
lg10 serum c-reactive protein (mg/l): -0.410050399
lg10 plasma adiponectin (mg/l): 0.875061263
ogtt fasting plasma free fatty acid (mmol/l): 0.27
log10 il1 receptor antagonist (pg/ml): 2.240748878
ogtt 30 min plasma insulin (mu/l): 1.26245109
ogtt 120 min plasma insulin (mu/l): 0.995635195
log10 ogtt fasting plasma proinsulin (pm/l): 0.944482672
ogtt 30 min plasma proinsulin (pm/l): 1.206825876
ogtt 120 min plasma proinsulin (pm/l): 1.264817823
log10 serum alanine aminotransfrase (u/l): 1
log10 ldl cholesterol (mmol/l): 0.481442629
log10 hdl cholesterol (mmol/l): 0.278753601
log10 urinary albumin excretion rate (ug/min): 0.801914447
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.521311649
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.680077586
plasma free fatty acids under the curve ogtt (mmol/l * min): 30.45
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.00281502
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 342
log10 homair (insulin resistance index based on homa): 0.29578694
log10 homais (insulin secretion index based on homa): 1.850701918
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.776410589
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.733550337
log10 matsuda insulin sensitivity index: 0.569131479
lg10 serum c-reactive protein (mg/l): -0.244125144
lg10 plasma adiponectin (mg/l): 0.51851394
ogtt fasting plasma free fatty acid (mmol/l): 0.51
ogtt 30 min plasma free fatty acid (mmol/l): 0.32
log10 il1 receptor antagonist (pg/ml): 2.287465805
log10 ogtt fasting plasma insulin (mu/l): 0.892094603
ogtt 30 min plasma insulin (mu/l): 1.986771734
ogtt 120 min plasma insulin (mu/l): 1.951337519
ogtt 30 min plasma proinsulin (pm/l): 1.739572344
ogtt 120 min plasma proinsulin (pm/l): 1.960946196
log10 serum bilirubin (umol/l): 1.397940009
log10 total cholesterol (mmol/l): 0.775974331
log10 ldl cholesterol (mmol/l): 0.562292864
log10 total triglycerides (mmol/l): 0.586587305
log10 urinary albumin excretion rate (ug/min): 0.615978253
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.548199059
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.358365399
plasma free fatty acids under the curve ogtt (mmol/l * min): 30.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.931476234
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 184.5
log10 homair (insulin resistance index based on homa): 0.480198642
log10 homais (insulin secretion index based on homa): 1.822505527
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.325495139
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.138081546
log10 matsuda insulin sensitivity index: 0.703550682
lg10 serum c-reactive protein (mg/l): 0.849910558
lg10 plasma adiponectin (mg/l): 0.591064607
ogtt 30 min plasma free fatty acid (mmol/l): 0.38
ogtt fasting plasma glucose (mmol/l): 6.6
ogtt 30 min plasma glucose (mmol/l): 10.2
log10 il1 receptor antagonist (pg/ml): 2.433609843
log10 ogtt fasting plasma insulin (mu/l): 1.012837225
ogtt 30 min plasma insulin (mu/l): 1.645422269
ogtt 120 min plasma insulin (mu/l): 1.204119983
ogtt 30 min plasma proinsulin (pm/l): 1.33243846
ogtt 120 min plasma proinsulin (pm/l): 1.53529412
log10 serum bilirubin (umol/l): 1.505149978
log10 total cholesterol (mmol/l): 0.733999287
log10 ldl cholesterol (mmol/l): 0.597695186
log10 total triglycerides (mmol/l): 0.28780173
log10 urinary albumin excretion rate (ug/min): 1.168082612
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.425563154
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.573596607
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.957827561
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 322.5
log10 homair (insulin resistance index based on homa): 0.492915522
log10 homais (insulin secretion index based on homa): 2.075720714
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.628184508
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.524785449
log10 matsuda insulin sensitivity index: 0.551520623
lg10 serum c-reactive protein (mg/l): -0.467245621
lg10 plasma adiponectin (mg/l): 0.146128036
ogtt fasting plasma free fatty acid (mmol/l): 0.32
log10 il1 receptor antagonist (pg/ml): 2.205204364
log10 ogtt fasting plasma insulin (mu/l): 1.096910013
ogtt 30 min plasma insulin (mu/l): 1.911157609
ogtt 120 min plasma insulin (mu/l): 1.648360011
ogtt 30 min plasma proinsulin (pm/l): 1.133538908
ogtt 120 min plasma proinsulin (pm/l): 1.392696953
log10 total cholesterol (mmol/l): 0.654176542
log10 ldl cholesterol (mmol/l): 0.409933123
log10 total triglycerides (mmol/l): 0.198657087
log10 urinary albumin excretion rate (ug/min): 0.931691785
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.46520479
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.635255458
plasma free fatty acids under the curve ogtt (mmol/l * min): 16.5
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.09671515
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 207
log10 homair (insulin resistance index based on homa): 0.336593137
log10 homais (insulin secretion index based on homa): 1.529509324
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.119783586
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.925518358
log10 matsuda insulin sensitivity index: 0.840102059
lg10 serum c-reactive protein (mg/l): 0.079904468
lg10 plasma adiponectin (mg/l): 1.012837225
ogtt fasting plasma free fatty acid (mmol/l): 0.29
ogtt fasting plasma glucose (mmol/l): 7.4
log10 il1 receptor antagonist (pg/ml): 2.210425542
ogtt 30 min plasma insulin (mu/l): 1.217483944
ogtt 30 min plasma proinsulin (pm/l): 1.397940009
ogtt 120 min plasma proinsulin (pm/l): 1.813580989
log10 ldl cholesterol (mmol/l): 0.557507202
log10 total triglycerides (mmol/l): 0.301029996
log10 urinary albumin excretion rate (ug/min): 0.800105826
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.75408472
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.916007293
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.927037169
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 205.5
log10 homair (insulin resistance index based on homa): -0.027488604
log10 homais (insulin secretion index based on homa): 1.357145938
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.010002974
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.895256753
log10 matsuda insulin sensitivity index: 1.130449848
lg10 serum c-reactive protein (mg/l): -0.077793723
lg10 plasma adiponectin (mg/l): 1.056904851
ogtt fasting plasma glucose (mmol/l): 6.4
ogtt 30 min plasma glucose (mmol/l): 10.5
log10 il1 receptor antagonist (pg/ml): 1.932270776
ogtt 30 min plasma insulin (mu/l): 1.374748346
ogtt 120 min plasma insulin (mu/l): 0.716003344
log10 ogtt fasting plasma proinsulin (pm/l): 0.826074803
ogtt 120 min plasma proinsulin (pm/l): 1.021189299
log10 serum alanine aminotransfrase (u/l): 1.602059991
log10 ldl cholesterol (mmol/l): 0.392696953
log10 hdl cholesterol (mmol/l): 0.367355921
log10 total triglycerides (mmol/l): -0.26760624
log10 urinary albumin excretion rate (ug/min): 1.187385025
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.74771644
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.710474183
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.00702727
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 369
log10 homair (insulin resistance index based on homa): 0.452638161
log10 homais (insulin secretion index based on homa): 2.064457989
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.781353197
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.716771032
log10 matsuda insulin sensitivity index: 0.480077272
lg10 serum c-reactive protein (mg/l): 0.479719235
lg10 plasma adiponectin (mg/l): 0.939519253
ogtt fasting plasma free fatty acid (mmol/l): 0.62
ogtt 120 min plasma glucose (mmol/l): 7.7
log10 il1 receptor antagonist (pg/ml): 2.230448921
log10 ogtt fasting plasma insulin (mu/l): 1.064457989
ogtt 30 min plasma insulin (mu/l): 1.890421019
ogtt 120 min plasma insulin (mu/l): 2.06595298
ogtt 30 min plasma proinsulin (pm/l): 1.752048448
ogtt 120 min plasma proinsulin (pm/l): 1.990338855
log10 total cholesterol (mmol/l): 0.872156273
log10 ldl cholesterol (mmol/l): 0.717670503
log10 total triglycerides (mmol/l): 0.322219295
log10 urinary albumin excretion rate (ug/min): 1.061017763
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.553362644
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.681414034
plasma free fatty acids under the curve ogtt (mmol/l * min): 28.2
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.21249639
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 478.5
log10 homair (insulin resistance index based on homa): 0.529259204
log10 homais (insulin secretion index based on homa): 2.031408464
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.914427786
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.862298384
log10 matsuda insulin sensitivity index: 0.357558815
lg10 serum c-reactive protein (mg/l): -0.107348966
ogtt 30 min plasma free fatty acid (mmol/l): 0.33
ogtt 30 min plasma glucose (mmol/l): 11.7
log10 il1 receptor antagonist (pg/ml): 2.205826659
log10 ogtt fasting plasma insulin (mu/l): 1.11058971
ogtt 30 min plasma insulin (mu/l): 2.1430148
ogtt 120 min plasma insulin (mu/l): 2.058805487
log10 ogtt fasting plasma proinsulin (pm/l): 1.382017043
ogtt 30 min plasma proinsulin (pm/l): 1.809559715
ogtt 120 min plasma proinsulin (pm/l): 2.174931594
log10 total cholesterol (mmol/l): 0.840733235
log10 ldl cholesterol (mmol/l): 0.679427897
log10 hdl cholesterol (mmol/l): 0.120573931
log10 total triglycerides (mmol/l): 0.480006943
log10 urinary albumin excretion rate (ug/min): 0.600721641
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.51621818
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.63545403
plasma free fatty acids under the curve ogtt (mmol/l * min): 5.25
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.292321633
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -21
log10 homair (insulin resistance index based on homa): 0.128399269
log10 homais (insulin secretion index based on homa): 1.770464422
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.417239121
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.344470872
log10 matsuda insulin sensitivity index: 0.927031951
lg10 serum c-reactive protein (mg/l): 0.216957207
lg10 plasma adiponectin (mg/l): 0.934498451
ogtt fasting plasma free fatty acid (mmol/l): 0.13
ogtt 30 min plasma free fatty acid (mmol/l): 0.04
ogtt 30 min plasma glucose (mmol/l): 5.8
log10 il1 receptor antagonist (pg/ml): 2.138618434
ogtt 120 min plasma insulin (mu/l): 1.350248018
ogtt 30 min plasma proinsulin (pm/l): 1.418301291
ogtt 120 min plasma proinsulin (pm/l): 1.5774918
log10 total cholesterol (mmol/l): 0.790988475
log10 ldl cholesterol (mmol/l): 0.580924976
log10 hdl cholesterol (mmol/l): 0.303196057
log10 urinary albumin excretion rate (ug/min): 0.655218496
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.328130476
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.816160727
plasma free fatty acids under the curve ogtt (mmol/l * min): 22.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.476746204
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 112.5
log10 homair (insulin resistance index based on homa): 0.139179176
log10 homais (insulin secretion index based on homa): 1.917330426
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.678108474
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.635393259
log10 matsuda insulin sensitivity index: 0.785164788
lg10 serum c-reactive protein (mg/l): -0.024568191
lg10 plasma adiponectin (mg/l): 0.908485019
log10 il1 receptor antagonist (pg/ml): 2.191730393
log10 ogtt fasting plasma insulin (mu/l): 0.792391689
ogtt 30 min plasma insulin (mu/l): 2.057285644
ogtt 120 min plasma insulin (mu/l): 1.348304863
log10 ogtt fasting plasma proinsulin (pm/l): 1.146128036
ogtt 30 min plasma proinsulin (pm/l): 1.657055853
ogtt 120 min plasma proinsulin (pm/l): 1.657055853
log10 serum bilirubin (umol/l): 1.477121255
log10 serum alanine aminotransfrase (u/l): 1.462397998
log10 total cholesterol (mmol/l): 0.835056102
log10 ldl cholesterol (mmol/l): 0.695481676
log10 total triglycerides (mmol/l): 0.394451681
log10 urinary albumin excretion rate (ug/min): 0.839703008
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.838816248
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.8587581
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 232.5
log10 homair (insulin resistance index based on homa): -0.057275608
log10 homais (insulin secretion index based on homa): 1.470781077
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.004235366
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.883661435
log10 matsuda insulin sensitivity index: 1.136934161
lg10 serum c-reactive protein (mg/l): -0.441291429
log10 il1 receptor antagonist (pg/ml): 2.232614983
log10 ogtt fasting plasma insulin (mu/l): 0.531478917
ogtt 30 min plasma insulin (mu/l): 1.127104798
ogtt 30 min plasma proinsulin (pm/l): 1.294466226
ogtt 120 min plasma proinsulin (pm/l): 1.635483747
log10 serum alanine aminotransfrase (u/l): 1.146128036
log10 total triglycerides (mmol/l): -0.259637311
log10 urinary albumin excretion rate (ug/min): 0.62324929
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.397147031
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.435113409
plasma free fatty acids under the curve ogtt (mmol/l * min): 27
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.19229281
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 390
log10 homair (insulin resistance index based on homa): 0.246060674
log10 homais (insulin secretion index based on homa): 1.609238576
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.514268758
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.45158689
log10 matsuda insulin sensitivity index: 0.685639426
lg10 serum c-reactive protein (mg/l): 0.533772058
ogtt 120 min plasma glucose (mmol/l): 9.3
log10 il1 receptor antagonist (pg/ml): 2.157093949
ogtt 30 min plasma insulin (mu/l): 1.607455023
ogtt 120 min plasma insulin (mu/l): 1.812913357
ogtt 30 min plasma proinsulin (pm/l): 1.348304863
ogtt 120 min plasma proinsulin (pm/l): 1.701567985
log10 total cholesterol (mmol/l): 0.805500858
log10 ldl cholesterol (mmol/l): 0.633468456
log10 total triglycerides (mmol/l): 0.209515015
log10 urinary albumin excretion rate (ug/min): 0.542262243
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.83148599
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.876907474
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.15
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.488844346
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 34.5
log10 homair (insulin resistance index based on homa): -0.052239618
log10 homais (insulin secretion index based on homa): 1.502675359
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.389927647
log10 matsuda insulin sensitivity index: 1.00329206
lg10 serum c-reactive protein (mg/l): -0.375717904
lg10 plasma adiponectin (mg/l): 0.748188027
log10 il1 receptor antagonist (pg/ml): 2.133123575
ogtt 30 min plasma insulin (mu/l): 1.82672252
ogtt 120 min plasma insulin (mu/l): 0.982271233
ogtt 120 min plasma proinsulin (pm/l): 1.225309282
log10 serum alanine aminotransfrase (u/l): 1.079181246
log10 hdl cholesterol (mmol/l): 0.10720997
log10 total triglycerides (mmol/l): -0.022276395
log10 urinary albumin excretion rate (ug/min): 0.995972511
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.106357611
plasma free fatty acids under the curve ogtt (mmol/l * min): 32.25
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.11048331
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 301.5
log10 homair (insulin resistance index based on homa): 0.629228322
log10 homais (insulin secretion index based on homa): 1.951216055
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.919679409
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.862244711
log10 matsuda insulin sensitivity index: 0.293811986
lg10 serum c-reactive protein (mg/l): 0.2509077
ogtt fasting plasma glucose (mmol/l): 6.7
ogtt 120 min plasma glucose (mmol/l): 8.6
log10 il1 receptor antagonist (pg/ml): 2.208924831
ogtt 30 min plasma insulin (mu/l): 1.86923172
ogtt 120 min plasma insulin (mu/l): 2.310480891
log10 ogtt fasting plasma proinsulin (pm/l): 1.643452676
ogtt 30 min plasma proinsulin (pm/l): 1.900913068
ogtt 120 min plasma proinsulin (pm/l): 2.301247089
log10 serum bilirubin (umol/l): 1.380211242
log10 total cholesterol (mmol/l): 0.747411808
log10 hdl cholesterol (mmol/l): 0.257678575
log10 total triglycerides (mmol/l): -0.004364805
log10 urinary albumin excretion rate (ug/min): 0.984466492
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.330401821
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.463300239
plasma free fatty acids under the curve ogtt (mmol/l * min): 9.9
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 121.5
log10 homair (insulin resistance index based on homa): -0.188424994
log10 homais (insulin secretion index based on homa): 1.453640159
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.092545208
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.018325945
log10 matsuda insulin sensitivity index: 1.219531313
lg10 serum c-reactive protein (mg/l): 1.210612766
log10 il1 receptor antagonist (pg/ml): 2.38790569
log10 ogtt fasting plasma insulin (mu/l): 0.431363764
ogtt 30 min plasma insulin (mu/l): 1.447158031
log10 ogtt fasting plasma proinsulin (pm/l): 0.763427994
ogtt 30 min plasma proinsulin (pm/l): 1.190331698
ogtt 120 min plasma proinsulin (pm/l): 1.23299611
log10 serum alanine aminotransfrase (u/l): 1.278753601
log10 total cholesterol (mmol/l): 0.695481676
log10 total triglycerides (mmol/l): 0.068185862
log10 urinary albumin excretion rate (ug/min): 0.524173216
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.701436771
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.102011059
plasma free fatty acids under the curve ogtt (mmol/l * min): 10.95
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.243173983
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 6
log10 homair (insulin resistance index based on homa): 0.296177493
log10 homais (insulin secretion index based on homa): 2.074328743
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.804337104
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.758313758
log10 matsuda insulin sensitivity index: 0.678437918
lg10 serum c-reactive protein (mg/l): 0.514946005
lg10 plasma adiponectin (mg/l): 0.643452676
ogtt 30 min plasma glucose (mmol/l): 6.3
log10 il1 receptor antagonist (pg/ml): 2.308841761
log10 ogtt fasting plasma insulin (mu/l): 0.949390007
ogtt 30 min plasma insulin (mu/l): 2.219584526
ogtt 30 min plasma proinsulin (pm/l): 1.828015064
ogtt 120 min plasma proinsulin (pm/l): 1.729974286
log10 serum bilirubin (umol/l): 0.954242509
log10 serum alanine aminotransfrase (u/l): 1.72427587
log10 total cholesterol (mmol/l): 0.715167358
log10 total triglycerides (mmol/l): 0.056904851
log10 urinary albumin excretion rate (ug/min): 1.004021274
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.635274288
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.771993308
plasma free fatty acids under the curve ogtt (mmol/l * min): 15.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.329796338
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 19.5
log10 homair (insulin resistance index based on homa): 0.035918683
log10 homais (insulin secretion index based on homa): 1.742678932
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.077113432
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.932423026
log10 matsuda insulin sensitivity index: 1.123139524
lg10 serum c-reactive protein (mg/l): -0.278189385
ogtt 30 min plasma glucose (mmol/l): 5.9
log10 il1 receptor antagonist (pg/ml): 2.198849453
ogtt 30 min plasma insulin (mu/l): 1.294466226
log10 ogtt fasting plasma proinsulin (pm/l): 0.908485019
ogtt 30 min plasma proinsulin (pm/l): 1.012837225
log10 total cholesterol (mmol/l): 0.720985744
log10 ldl cholesterol (mmol/l): 0.553883027
log10 hdl cholesterol (mmol/l): 0.113943352
log10 total triglycerides (mmol/l): -0.187086643
log10 urinary albumin excretion rate (ug/min): 0.529443953
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.781997935
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.439979165
plasma free fatty acids under the curve ogtt (mmol/l * min): 14.4
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.05663772
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 513
log10 homair (insulin resistance index based on homa): -0.036212173
log10 homais (insulin secretion index based on homa): 1.912849824
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.136942413
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.019822224
log10 matsuda insulin sensitivity index: 1.071467197
lg10 serum c-reactive protein (mg/l): 0.02201574
lg10 plasma adiponectin (mg/l): 1.281033367
ogtt fasting plasma glucose (mmol/l): 4.6
ogtt 30 min plasma glucose (mmol/l): 13.3
log10 il1 receptor antagonist (pg/ml): 2.167966813
ogtt 30 min plasma insulin (mu/l): 1.496929648
ogtt 120 min plasma insulin (mu/l): 0.86923172
log10 total cholesterol (mmol/l): 0.678518379
log10 hdl cholesterol (mmol/l): 0.389166084
log10 total triglycerides (mmol/l): -0.244125144
log10 urinary albumin excretion rate (ug/min): 0.633822004
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.945923049
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.179080503
plasma free fatty acids under the curve ogtt (mmol/l * min): 18.3
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.955649908
log10 homair (insulin resistance index based on homa): 0.045062063
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.243162115
log10 matsuda insulin sensitivity index: 0.925955413
lg10 serum c-reactive protein (mg/l): -0.064492734
lg10 plasma adiponectin (mg/l): 0.897627091
log10 il1 receptor antagonist (pg/ml): 2.328990855
ogtt 30 min plasma insulin (mu/l): 1.491361694
log10 ogtt fasting plasma proinsulin (pm/l): 1.217483944
ogtt 30 min plasma proinsulin (pm/l): 1.567026366
ogtt 120 min plasma proinsulin (pm/l): 1.844477176
log10 ldl cholesterol (mmol/l): 0.58546073
log10 urinary albumin excretion rate (ug/min): 0.486076097
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.592582972
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.093259407
plasma free fatty acids under the curve ogtt (mmol/l * min): 14.55
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.764871591
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 174
log10 homair (insulin resistance index based on homa): 0.471943316
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.615865919
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.518671836
log10 matsuda insulin sensitivity index: 0.605773602
lg10 serum c-reactive protein (mg/l): -0.387216143
lg10 plasma adiponectin (mg/l): 0.73239376
ogtt 30 min plasma glucose (mmol/l): 9.3
log10 il1 receptor antagonist (pg/ml): 2.382539323
log10 ogtt fasting plasma insulin (mu/l): 1.06069784
ogtt 30 min plasma insulin (mu/l): 1.999565488
ogtt 120 min plasma insulin (mu/l): 1.201397124
log10 ogtt fasting plasma proinsulin (pm/l): 1.136720567
ogtt 30 min plasma proinsulin (pm/l): 1.618048097
ogtt 120 min plasma proinsulin (pm/l): 1.501059262
log10 serum bilirubin (umol/l): 1.255272505
log10 serum alanine aminotransfrase (u/l): 1.806179974
log10 total cholesterol (mmol/l): 0.758154622
log10 ldl cholesterol (mmol/l): 0.607455023
log10 hdl cholesterol (mmol/l): 0.075546961
log10 total triglycerides (mmol/l): 0.149219113
log10 urinary albumin excretion rate (ug/min): -0.114284109
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.617519331
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.880035694
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.553629294
log10 homair (insulin resistance index based on homa): -0.064828745
log10 homais (insulin secretion index based on homa): 1.490086232
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.511027292
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.476947502
log10 matsuda insulin sensitivity index: 0.960575615
lg10 serum c-reactive protein (mg/l): -0.170053304
ogtt 30 min plasma glucose (mmol/l): 8.4
log10 il1 receptor antagonist (pg/ml): 2.606875578
ogtt 30 min plasma insulin (mu/l): 1.880241776
ogtt 120 min plasma insulin (mu/l): 1.250420002
log10 ogtt fasting plasma proinsulin (pm/l): 0.973127854
ogtt 30 min plasma proinsulin (pm/l): 1.460897843
ogtt 120 min plasma proinsulin (pm/l): 1.580924976
log10 serum bilirubin (umol/l): 1.431363764
log10 ldl cholesterol (mmol/l): 0.522444234
log10 hdl cholesterol (mmol/l): 0.158362492
log10 urinary albumin excretion rate (ug/min): 0.618048097
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.518575523
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.639803829
plasma free fatty acids under the curve ogtt (mmol/l * min): 24.6
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.706496018
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 199.5
log10 homair (insulin resistance index based on homa): 0.034851183
log10 homais (insulin secretion index based on homa): 1.708515322
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.329540248
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.256356886
log10 matsuda insulin sensitivity index: 0.956161572
lg10 serum c-reactive protein (mg/l): -0.54668166
log10 il1 receptor antagonist (pg/ml): 2.228349021
log10 ogtt fasting plasma insulin (mu/l): 0.662757832
ogtt 30 min plasma insulin (mu/l): 1.505149978
ogtt 30 min plasma proinsulin (pm/l): 1.021189299
ogtt 120 min plasma proinsulin (pm/l): 1.5289167
log10 hdl cholesterol (mmol/l): 0.195899652
log10 total triglycerides (mmol/l): 0.161368002
log10 urinary albumin excretion rate (ug/min): 0.898617296
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.601836376
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.049394709
plasma free fatty acids under the curve ogtt (mmol/l * min): 21.6
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.897845456
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 210
log10 homair (insulin resistance index based on homa): 0.493287615
log10 homais (insulin secretion index based on homa): 1.922744675
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.613112102
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.517129891
log10 matsuda insulin sensitivity index: 0.543760768
lg10 serum c-reactive protein (mg/l): -0.120330794
lg10 plasma adiponectin (mg/l): 0.716003344
log10 il1 receptor antagonist (pg/ml): 2.173069664
log10 ogtt fasting plasma insulin (mu/l): 1.053078443
ogtt 120 min plasma insulin (mu/l): 1.974050903
ogtt 30 min plasma proinsulin (pm/l): 1.227886705
ogtt 120 min plasma proinsulin (pm/l): 1.586587305
log10 total cholesterol (mmol/l): 0.745074792
log10 hdl cholesterol (mmol/l): 0.152288344
log10 total triglycerides (mmol/l): 0.079181246
log10 urinary albumin excretion rate (ug/min): 0.579783597
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.830373043
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.108435981
plasma free fatty acids under the curve ogtt (mmol/l * min): 12
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.607330314
log10 homair (insulin resistance index based on homa): 0.19657531
log10 homais (insulin secretion index based on homa): 1.724631995
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.470645658
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.400779677
log10 matsuda insulin sensitivity index: 0.840071746
lg10 serum c-reactive protein (mg/l): 0.348304863
lg10 plasma adiponectin (mg/l): 0.982271233
log10 il1 receptor antagonist (pg/ml): 2.120211868
ogtt 120 min plasma insulin (mu/l): 1.136720567
ogtt 30 min plasma proinsulin (pm/l): 1.330413773
log10 total cholesterol (mmol/l): 0.825426118
log10 ldl cholesterol (mmol/l): 0.57054294
log10 hdl cholesterol (mmol/l): 0.274157849
log10 total triglycerides (mmol/l): 0.281033367
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.246235106
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.743723019
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.46454575
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 82.5
log10 homair (insulin resistance index based on homa): 0.35945602
log10 homais (insulin secretion index based on homa): 2.066216269
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.554016449
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.457624573
log10 matsuda insulin sensitivity index: 0.731711247
lg10 serum c-reactive protein (mg/l): -0.140261434
ogtt 120 min plasma glucose (mmol/l): 3.3
log10 il1 receptor antagonist (pg/ml): 2.406812593
log10 ogtt fasting plasma insulin (mu/l): 0.995635195
ogtt 30 min plasma insulin (mu/l): 1.904174368
log10 ogtt fasting plasma proinsulin (pm/l): 1.093421685
ogtt 30 min plasma proinsulin (pm/l): 1.51851394
ogtt 120 min plasma proinsulin (pm/l): 1.661812686
log10 ldl cholesterol (mmol/l): 0.62324929
log10 urinary albumin excretion rate (ug/min): 0.857872328
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.62351565
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.35
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.754887502
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.419476604
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.35958887
log10 matsuda insulin sensitivity index: 0.895535625
lg10 serum c-reactive protein (mg/l): 0.057285644
lg10 plasma adiponectin (mg/l): 0.886490725
log10 il1 receptor antagonist (pg/ml): 2.034146977
ogtt 30 min plasma insulin (mu/l): 1.64246452
ogtt 120 min plasma insulin (mu/l): 1.57054294
ogtt 120 min plasma proinsulin (pm/l): 1.610660163
log10 total cholesterol (mmol/l): 0.730782276
log10 ldl cholesterol (mmol/l): 0.552668216
log10 hdl cholesterol (mmol/l): 0.161368002
log10 total triglycerides (mmol/l): -0.142667504
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.86687903
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.14583956
plasma free fatty acids under the curve ogtt (mmol/l * min): 17.25
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.918117851
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 271.5
log10 homair (insulin resistance index based on homa): 0.554260276
log10 homais (insulin secretion index based on homa): 2.08231696
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.727955835
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.637919808
log10 matsuda insulin sensitivity index: 0.480664132
lg10 serum c-reactive protein (mg/l): -0.539102157
ogtt 30 min plasma glucose (mmol/l): 10.1
log10 il1 receptor antagonist (pg/ml): 2.144013466
log10 ogtt fasting plasma insulin (mu/l): 1.1430148
ogtt 120 min plasma insulin (mu/l): 1.691965103
ogtt 120 min plasma proinsulin (pm/l): 1.597695186
log10 total cholesterol (mmol/l): 0.646403726
log10 ldl cholesterol (mmol/l): 0.421603927
log10 hdl cholesterol (mmol/l): 0.11058971
log10 total triglycerides (mmol/l): 0.017033339
log10 urinary albumin excretion rate (ug/min): 0.491577171
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.4965775
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.835208183
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.667111542
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 141
log10 homair (insulin resistance index based on homa): -0.0019345
log10 homais (insulin secretion index based on homa): 1.580870692
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.324014798
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.260238392
log10 matsuda insulin sensitivity index: 0.984903437
lg10 serum c-reactive protein (mg/l): -0.171340103
ogtt 120 min plasma glucose (mmol/l): 5.4
log10 il1 receptor antagonist (pg/ml): 2.190723787
ogtt 30 min plasma insulin (mu/l): 1.525044807
ogtt 120 min plasma insulin (mu/l): 1.506505032
ogtt 120 min plasma proinsulin (pm/l): 1.669316881
log10 serum bilirubin (umol/l): 1.278753601
log10 total cholesterol (mmol/l): 0.698100546
log10 ldl cholesterol (mmol/l): 0.534026106
log10 hdl cholesterol (mmol/l): 0.079181246
log10 total triglycerides (mmol/l): -0.040958608
log10 urinary albumin excretion rate (ug/min): 1.189680981
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.414234205
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.036198439
plasma free fatty acids under the curve ogtt (mmol/l * min): 28.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.777255315
log10 homair (insulin resistance index based on homa): 0.506595219
log10 homais (insulin secretion index based on homa): 2.089400411
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.515343893
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.370550096
log10 matsuda insulin sensitivity index: 0.599401322
lg10 serum c-reactive protein (mg/l): -0.056505484
ogtt 120 min plasma glucose (mmol/l): 7.1
log10 il1 receptor antagonist (pg/ml): 2.392556268
ogtt 30 min plasma insulin (mu/l): 1.550228353
ogtt 120 min plasma insulin (mu/l): 1.843232778
log10 ogtt fasting plasma proinsulin (pm/l): 1.201397124
ogtt 30 min plasma proinsulin (pm/l): 1.390935107
ogtt 120 min plasma proinsulin (pm/l): 1.851869601
log10 ldl cholesterol (mmol/l): 0.501059262
log10 hdl cholesterol (mmol/l): 0.041392685
log10 total triglycerides (mmol/l): 0.274157849
log10 urinary albumin excretion rate (ug/min): 0.808114474
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.874160185
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.681584994
plasma free fatty acids under the curve ogtt (mmol/l * min): 13.8
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 148.5
log10 homair (insulin resistance index based on homa): -0.040852566
log10 homais (insulin secretion index based on homa): 1.343781976
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.284453294
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.229092829
log10 matsuda insulin sensitivity index: 1.015466625
lg10 plasma adiponectin (mg/l): 1.029383778
log10 il1 receptor antagonist (pg/ml): 2.130301597
ogtt 30 min plasma insulin (mu/l): 1.627365857
log10 ogtt fasting plasma proinsulin (pm/l): 1.068185862
ogtt 30 min plasma proinsulin (pm/l): 1.536558443
ogtt 120 min plasma proinsulin (pm/l): 1.602059991
log10 total cholesterol (mmol/l): 0.789580712
log10 hdl cholesterol (mmol/l): 0.574031268
log10 total triglycerides (mmol/l): -0.337242168
log10 urinary albumin excretion rate (ug/min): 0.522579129
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.758382361
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.153855187
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.13185696
log10 homair (insulin resistance index based on homa): 0.428782511
log10 homais (insulin secretion index based on homa): 1.881691842
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.476686743
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.358734127
log10 matsuda insulin sensitivity index: 0.616634639
log10 il1 receptor antagonist (pg/ml): 2.309672743
ogtt 30 min plasma insulin (mu/l): 1.498310554
ogtt 120 min plasma insulin (mu/l): 1.81756537
log10 ogtt fasting plasma proinsulin (pm/l): 1.227886705
ogtt 30 min plasma proinsulin (pm/l): 1.426511261
ogtt 120 min plasma proinsulin (pm/l): 1.805500858
log10 serum alanine aminotransfrase (u/l): 1.73239376
log10 total cholesterol (mmol/l): 0.681241237
log10 ldl cholesterol (mmol/l): 0.474216264
log10 hdl cholesterol (mmol/l): 0.025305865
log10 urinary albumin excretion rate (ug/min): 1.397940009
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.433481472
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.967569867
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 399
log10 homair (insulin resistance index based on homa): 0.573954053
log10 homais (insulin secretion index based on homa): 2.12886903
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.551498792
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.397035735
log10 matsuda insulin sensitivity index: 0.508096077
lg10 serum c-reactive protein (mg/l): 0.465531557
ogtt 30 min plasma glucose (mmol/l): 8.9
ogtt 120 min plasma glucose (mmol/l): 10.3
log10 il1 receptor antagonist (pg/ml): 2.719289845
log10 ogtt fasting plasma insulin (mu/l): 1.170261715
ogtt 30 min plasma insulin (mu/l): 1.633468456
ogtt 120 min plasma insulin (mu/l): 1.84260924
log10 ogtt fasting plasma proinsulin (pm/l): 1.139879086
ogtt 30 min plasma proinsulin (pm/l): 1.439332694
ogtt 120 min plasma proinsulin (pm/l): 1.771587481
log10 serum alanine aminotransfrase (u/l): 2.045322979
log10 ldl cholesterol (mmol/l): 0.371067862
log10 hdl cholesterol (mmol/l): 0.294466226
log10 urinary albumin excretion rate (ug/min): 1.221153322
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.805953314
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.787902468
plasma free fatty acids under the curve ogtt (mmol/l * min): 7.95
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.285402219
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 48
log10 homair (insulin resistance index based on homa): -0.239577517
log10 homais (insulin secretion index based on homa): 1.618450408
log10 insulin area under the curve (ogtt) (pmol/l * min): 3.865400118
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.731669332
log10 matsuda insulin sensitivity index: 1.381152143
lg10 serum c-reactive protein (mg/l): -0.542118103
ogtt 30 min plasma free fatty acid (mmol/l): 0.06
ogtt 30 min plasma glucose (mmol/l): 6.2
log10 il1 receptor antagonist (pg/ml): 1.965765964
ogtt 30 min plasma insulin (mu/l): 1.10720997
ogtt 120 min plasma insulin (mu/l): 0.963787827
log10 ogtt fasting plasma proinsulin (pm/l): 0.740362689
ogtt 30 min plasma proinsulin (pm/l): 0.84509804
ogtt 120 min plasma proinsulin (pm/l): 1.071882007
log10 serum bilirubin (umol/l): 0.77815125
log10 ldl cholesterol (mmol/l): 0.378397901
log10 hdl cholesterol (mmol/l): 0.365487985
log10 total triglycerides (mmol/l): -0.283996656
log10 urinary albumin excretion rate (ug/min): 0.948638632
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.466969775
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.666944316
plasma free fatty acids under the curve ogtt (mmol/l * min): 10.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.59058705
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 87
log10 homair (insulin resistance index based on homa): 0.093888418
log10 homais (insulin secretion index based on homa): 1.648803395
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.657619878
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.62253522
log10 matsuda insulin sensitivity index: 0.802099391
lg10 serum c-reactive protein (mg/l): -0.294992041
log10 il1 receptor antagonist (pg/ml): 2.140759371
ogtt 30 min plasma insulin (mu/l): 2.038620162
ogtt 120 min plasma insulin (mu/l): 1.322219295
ogtt 30 min plasma proinsulin (pm/l): 1.519827994
log10 total cholesterol (mmol/l): 0.683947131
log10 ldl cholesterol (mmol/l): 0.45331834
log10 hdl cholesterol (mmol/l): 0.170261715
log10 urinary albumin excretion rate (ug/min): 0.653212514
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.512775985
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.458624917
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.509775004
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -3
log10 homair (insulin resistance index based on homa): 0.056396607
log10 homais (insulin secretion index based on homa): 1.509305938
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.429332313
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.377488383
log10 matsuda insulin sensitivity index: 0.946951921
lg10 serum c-reactive protein (mg/l): -0.303643611
lg10 plasma adiponectin (mg/l): 0.903089987
ogtt 30 min plasma glucose (mmol/l): 8.3
log10 il1 receptor antagonist (pg/ml): 2.171023996
log10 ogtt fasting plasma insulin (mu/l): 0.62324929
ogtt 30 min plasma proinsulin (pm/l): 1.527629901
ogtt 120 min plasma proinsulin (pm/l): 1.320146286
log10 total cholesterol (mmol/l): 0.77815125
log10 ldl cholesterol (mmol/l): 0.492760389
log10 total triglycerides (mmol/l): -0.013228266
log10 urinary albumin excretion rate (ug/min): 0.763079582
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.464670105
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.661239616
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.5
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.550746785
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 78
log10 homair (insulin resistance index based on homa): 0.2936326
log10 homais (insulin secretion index based on homa): 1.876437792
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.439821986
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.339312286
log10 matsuda insulin sensitivity index: 0.797833303
lg10 serum c-reactive protein (mg/l): 0.651665604
lg10 plasma adiponectin (mg/l): 0.792391689
log10 il1 receptor antagonist (pg/ml): 2.207391978
log10 ogtt fasting plasma insulin (mu/l): 0.897627091
ogtt 30 min plasma insulin (mu/l): 1.713490543
ogtt 120 min plasma insulin (mu/l): 1.482873584
ogtt 30 min plasma proinsulin (pm/l): 1.456366033
ogtt 120 min plasma proinsulin (pm/l): 1.621176282
log10 total cholesterol (mmol/l): 0.668385917
log10 ldl cholesterol (mmol/l): 0.472756449
log10 urinary albumin excretion rate (ug/min): 0.698970004
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.906546965
plasma free fatty acids under the curve ogtt (mmol/l * min): 26.55
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 315
log10 homair (insulin resistance index based on homa): 0.325424435
log10 homais (insulin secretion index based on homa): 1.908229627
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.531504463
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.445323923
log10 matsuda insulin sensitivity index: 0.669428844
lg10 serum c-reactive protein (mg/l): 0.108903128
log10 il1 receptor antagonist (pg/ml): 2.34190912
log10 ogtt fasting plasma insulin (mu/l): 0.929418926
ogtt 30 min plasma insulin (mu/l): 1.632457292
ogtt 120 min plasma insulin (mu/l): 1.818885415
ogtt 30 min plasma proinsulin (pm/l): 1.320146286
ogtt 120 min plasma proinsulin (pm/l): 1.668385917
log10 total cholesterol (mmol/l): 0.78604121
log10 ldl cholesterol (mmol/l): 0.624282096
log10 urinary albumin excretion rate (ug/min): 0.819543936
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.811870022
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.782782396
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.436711542
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 9
log10 homais (insulin secretion index based on homa): 1.729459326
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.367038938
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.279552881
log10 matsuda insulin sensitivity index: 0.900297685
lg10 serum c-reactive protein (mg/l): 0.366796383
lg10 plasma adiponectin (mg/l): 1.017033339
ogtt fasting plasma free fatty acid (mmol/l): 0.26
log10 il1 receptor antagonist (pg/ml): 2.50847585
ogtt 30 min plasma insulin (mu/l): 1.599883072
ogtt 120 min plasma insulin (mu/l): 1.494154594
log10 ogtt fasting plasma proinsulin (pm/l): 1.071882007
ogtt 30 min plasma proinsulin (pm/l): 1.491361694
ogtt 120 min plasma proinsulin (pm/l): 1.687528961
log10 total cholesterol (mmol/l): 0.674861141
log10 ldl cholesterol (mmol/l): 0.51054501
log10 urinary albumin excretion rate (ug/min): 1.081621109
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.406923157
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.666340488
plasma free fatty acids under the curve ogtt (mmol/l * min): 31.35
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.772314574
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 310.5
log10 homair (insulin resistance index based on homa): -0.202963405
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.29666519
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.246498581
log10 matsuda insulin sensitivity index: 1.101718914
lg10 serum c-reactive protein (mg/l): 0.445292769
log10 il1 receptor antagonist (pg/ml): 2.219139002
ogtt 30 min plasma insulin (mu/l): 1.582063363
ogtt 120 min plasma insulin (mu/l): 1.330413773
ogtt 30 min plasma proinsulin (pm/l): 1.184691431
ogtt 120 min plasma proinsulin (pm/l): 1.484299839
log10 serum bilirubin (umol/l): 1.447158031
log10 total cholesterol (mmol/l): 0.667452953
log10 hdl cholesterol (mmol/l): 0.071882007
log10 urinary albumin excretion rate (ug/min): 0.73488256
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.032070299
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.082059391
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.274960472
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 7.5
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.224455364
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.149311506
log10 matsuda insulin sensitivity index: 1.145294407
lg10 serum c-reactive protein (mg/l): -0.493494968
log10 il1 receptor antagonist (pg/ml): 1.491361694
ogtt 30 min plasma insulin (mu/l): 1.622214023
ogtt 30 min plasma proinsulin (pm/l): 1.45331834
ogtt 120 min plasma proinsulin (pm/l): 1.36361198
log10 ldl cholesterol (mmol/l): 0.514547753
log10 hdl cholesterol (mmol/l): 0.184691431
log10 urinary albumin excretion rate (ug/min): 0.438724864
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.601614851
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.595498422
plasma free fatty acids under the curve ogtt (mmol/l * min): 20.55
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.727069558
log10 homair (insulin resistance index based on homa): 0.151063253
log10 homais (insulin secretion index based on homa): 1.793128406
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.422737534
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.346763599
log10 matsuda insulin sensitivity index: 0.857454925
ogtt 30 min plasma glucose (mmol/l): 8.8
log10 il1 receptor antagonist (pg/ml): 2.296709056
ogtt 30 min plasma insulin (mu/l): 1.674861141
ogtt 120 min plasma insulin (mu/l): 1.51851394
log10 ogtt fasting plasma proinsulin (pm/l): 1.225309282
ogtt 30 min plasma proinsulin (pm/l): 1.609594409
ogtt 120 min plasma proinsulin (pm/l): 1.746634199
log10 total cholesterol (mmol/l): 0.820201459
log10 ldl cholesterol (mmol/l): 0.689308859
log10 urinary albumin excretion rate (ug/min): 0.78612018
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.663659264
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.897285928
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.33315535
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 498
log10 homair (insulin resistance index based on homa): 0.819543936
log10 homais (insulin secretion index based on homa): 2.16185082
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.84011237
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.724284064
log10 matsuda insulin sensitivity index: 0.203786946
lg10 serum c-reactive protein (mg/l): 0.899765802
ogtt 120 min plasma glucose (mmol/l): 13
log10 il1 receptor antagonist (pg/ml): 2.173565018
log10 ogtt fasting plasma insulin (mu/l): 1.352182518
ogtt 30 min plasma insulin (mu/l): 1.873320602
ogtt 120 min plasma insulin (mu/l): 2.173768823
ogtt 30 min plasma proinsulin (pm/l): 1.178976947
ogtt 120 min plasma proinsulin (pm/l): 1.559906625
log10 total cholesterol (mmol/l): 0.73239376
log10 ldl cholesterol (mmol/l): 0.602059991
log10 hdl cholesterol (mmol/l): -0.107905397
log10 total triglycerides (mmol/l): 0.354108439
log10 urinary albumin excretion rate (ug/min): 0.706188361
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.826563739
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.974462784
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.45532722
log10 homair (insulin resistance index based on homa): 0.050938003
log10 homais (insulin secretion index based on homa): 1.662757832
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.31160554
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.235048438
log10 matsuda insulin sensitivity index: 0.984728748
lg10 serum c-reactive protein (mg/l): 0.341236623
lg10 plasma adiponectin (mg/l): 1.127104798
ogtt 120 min plasma glucose (mmol/l): 4.3
log10 il1 receptor antagonist (pg/ml): 2.152380087
ogtt 30 min plasma insulin (mu/l): 1.444044796
ogtt 120 min plasma insulin (mu/l): 1.571708832
log10 ogtt fasting plasma proinsulin (pm/l): 1.06069784
ogtt 120 min plasma proinsulin (pm/l): 1.660865478
log10 ldl cholesterol (mmol/l): 0.436162647
log10 hdl cholesterol (mmol/l): 0.562292864
log10 urinary albumin excretion rate (ug/min): 1.190731785
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.176694037
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.378411341
plasma free fatty acids under the curve ogtt (mmol/l * min): 25.8
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.801708359
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.416640507
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.357706211
log10 matsuda insulin sensitivity index: 0.893726147
lg10 serum c-reactive protein (mg/l): -0.274905479
log10 il1 receptor antagonist (pg/ml): 2.142264291
ogtt 30 min plasma insulin (mu/l): 1.553883027
ogtt 120 min plasma insulin (mu/l): 1.675778342
log10 ogtt fasting plasma proinsulin (pm/l): 0.963787827
ogtt 120 min plasma proinsulin (pm/l): 1.727541257
log10 total cholesterol (mmol/l): 0.689308859
log10 ldl cholesterol (mmol/l): 0.525044807
log10 urinary albumin excretion rate (ug/min): 0.897486109
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.052998278
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.228774653
log10 homair (insulin resistance index based on homa): -0.040005162
log10 homais (insulin secretion index based on homa): 1.602059991
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.265572462
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.19578899
log10 matsuda insulin sensitivity index: 1.027680246
lg10 serum c-reactive protein (mg/l): 0.375846436
log10 il1 receptor antagonist (pg/ml): 1.996248915
log10 ogtt fasting plasma insulin (mu/l): 0.579783597
ogtt 30 min plasma insulin (mu/l): 1.477121255
ogtt 120 min plasma insulin (mu/l): 1.431363764
log10 ogtt fasting plasma proinsulin (pm/l): 0.806179974
ogtt 120 min plasma proinsulin (pm/l): 1.278753601
log10 total cholesterol (mmol/l): 0.866877814
log10 ldl cholesterol (mmol/l): 0.728353782
log10 total triglycerides (mmol/l): 0.029383778
log10 urinary albumin excretion rate (ug/min): 0.948847478
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.347610464
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.60975696
plasma free fatty acids under the curve ogtt (mmol/l * min): 27.45
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 216
log10 homair (insulin resistance index based on homa): 0.103575685
log10 homais (insulin secretion index based on homa): 1.686380877
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.560516363
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.514268758
log10 matsuda insulin sensitivity index: 0.80207722
lg10 serum c-reactive protein (mg/l): 0.763877031
log10 il1 receptor antagonist (pg/ml): 2.647940153
ogtt 30 min plasma insulin (mu/l): 1.802089258
ogtt 120 min plasma insulin (mu/l): 1.684845362
ogtt 120 min plasma proinsulin (pm/l): 1.649334859
log10 total cholesterol (mmol/l): 0.822821645
log10 ldl cholesterol (mmol/l): 0.681241237
log10 total triglycerides (mmol/l): 0.181843588
log10 urinary albumin excretion rate (ug/min): 0.654996067
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.390807277
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.652578116
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.744833837
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 282
log10 homair (insulin resistance index based on homa): 0.16790781
log10 homais (insulin secretion index based on homa): 2.025935734
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.385606274
log10 matsuda insulin sensitivity index: 0.870467892
lg10 serum c-reactive protein (mg/l): 0.183839037
lg10 plasma adiponectin (mg/l): 0.812913357
log10 il1 receptor antagonist (pg/ml): 1.994405147
log10 ogtt fasting plasma insulin (mu/l): 0.838849091
ogtt 30 min plasma insulin (mu/l): 1.683947131
ogtt 120 min plasma insulin (mu/l): 1.367355921
ogtt 30 min plasma proinsulin (pm/l): 1.164352856
ogtt 120 min plasma proinsulin (pm/l): 1.338456494
log10 total cholesterol (mmol/l): 0.629409599
log10 ldl cholesterol (mmol/l): 0.36361198
log10 total triglycerides (mmol/l): 0.11058971
log10 urinary albumin excretion rate (ug/min): 0.802723434
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.688366794
plasma free fatty acids under the curve ogtt (mmol/l * min): 21.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.23959853
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 561
log10 homair (insulin resistance index based on homa): 0.199755177
log10 homais (insulin secretion index based on homa): 1.84182033
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.50776145
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.438399934
log10 matsuda insulin sensitivity index: 0.727385358
lg10 serum c-reactive protein (mg/l): -0.017728767
lg10 plasma adiponectin (mg/l): 0.62324929
ogtt fasting plasma free fatty acid (mmol/l): 0.37
ogtt 30 min plasma glucose (mmol/l): 13.4
ogtt 120 min plasma glucose (mmol/l): 7.2
log10 il1 receptor antagonist (pg/ml): 1.767304317
ogtt 30 min plasma insulin (mu/l): 1.742725131
ogtt 120 min plasma insulin (mu/l): 1.636487896
log10 ogtt fasting plasma proinsulin (pm/l): 1.004321374
ogtt 120 min plasma proinsulin (pm/l): 1.487138375
log10 ldl cholesterol (mmol/l): 0.544068044
log10 hdl cholesterol (mmol/l): -0.008773924
log10 total triglycerides (mmol/l): 0.201397124
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.22018118
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.491065354
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.847057346
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 261
log10 homair (insulin resistance index based on homa): 0.220689084
log10 homais (insulin secretion index based on homa): 1.832508913
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.58334616
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.523967459
log10 matsuda insulin sensitivity index: 0.726196008
log10 il1 receptor antagonist (pg/ml): 2.425974161
log10 ogtt fasting plasma insulin (mu/l): 0.832508913
ogtt 30 min plasma insulin (mu/l): 1.812244697
ogtt 120 min plasma insulin (mu/l): 1.725094521
log10 ogtt fasting plasma proinsulin (pm/l): 1.173186268
ogtt 30 min plasma proinsulin (pm/l): 1.557507202
ogtt 120 min plasma proinsulin (pm/l): 1.814913181
log10 total cholesterol (mmol/l): 0.761175813
log10 total triglycerides (mmol/l): 0.23299611
log10 urinary albumin excretion rate (ug/min): 0.67815016
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.465179539
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.508352975
log10 homair (insulin resistance index based on homa): 0.277634678
log10 homais (insulin secretion index based on homa): 1.984394927
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.46478752
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.366535019
log10 matsuda insulin sensitivity index: 0.765561141
lg10 serum c-reactive protein (mg/l): 0.144262774
log10 il1 receptor antagonist (pg/ml): 1.966376423
log10 ogtt fasting plasma insulin (mu/l): 0.913813852
ogtt 30 min plasma insulin (mu/l): 1.536558443
ogtt 120 min plasma insulin (mu/l): 1.773786445
log10 ogtt fasting plasma proinsulin (pm/l): 1.274157849
ogtt 30 min plasma proinsulin (pm/l): 1.434568904
ogtt 120 min plasma proinsulin (pm/l): 1.765668555
log10 ldl cholesterol (mmol/l): 0.540329475
log10 total triglycerides (mmol/l): 0.29666519
log10 urinary albumin excretion rate (ug/min): 1.098925304
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.574845136
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.752817126
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.1792871
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 307.5
log10 homair (insulin resistance index based on homa): 0.716559775
log10 homais (insulin secretion index based on homa): 1.962211439
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.744738786
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.640252801
log10 matsuda insulin sensitivity index: 0.351745386
lg10 serum c-reactive protein (mg/l): 0.26245109
lg10 plasma adiponectin (mg/l): 0.491361694
ogtt fasting plasma glucose (mmol/l): 7.1
log10 il1 receptor antagonist (pg/ml): 2.192316505
log10 ogtt fasting plasma insulin (mu/l): 1.217483944
ogtt 30 min plasma insulin (mu/l): 2.075546961
ogtt 120 min plasma insulin (mu/l): 1.619093331
log10 ogtt fasting plasma proinsulin (pm/l): 1.432969291
ogtt 30 min plasma proinsulin (pm/l): 1.748962861
log10 total cholesterol (mmol/l): 0.743509765
log10 hdl cholesterol (mmol/l): 0.064457989
log10 total triglycerides (mmol/l): 0.403120521
log10 urinary albumin excretion rate (ug/min): 1.691706671
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.511062263
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.637530552
log10 homair (insulin resistance index based on homa): 0.167120331
log10 homais (insulin secretion index based on homa): 1.722035308
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.192288613
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.056676215
log10 matsuda insulin sensitivity index: 0.963886771
lg10 serum c-reactive protein (mg/l): 0.881441722
log10 il1 receptor antagonist (pg/ml): 1.920436407
log10 ogtt fasting plasma insulin (mu/l): 0.763427994
ogtt 30 min plasma insulin (mu/l): 1.432969291
ogtt 120 min plasma insulin (mu/l): 1.292256071
ogtt 30 min plasma proinsulin (pm/l): 1.222716471
ogtt 120 min plasma proinsulin (pm/l): 1.556302501
log10 total cholesterol (mmol/l): 0.790285164
log10 ldl cholesterol (mmol/l): 0.635483747
log10 urinary albumin excretion rate (ug/min): 0.716003344
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.470101791
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.609264248
plasma free fatty acids under the curve ogtt (mmol/l * min): 18.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.547858506
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 76.5
log10 homair (insulin resistance index based on homa): 0.241103549
log10 homais (insulin secretion index based on homa): 1.823908741
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.469453814
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.388012343
log10 matsuda insulin sensitivity index: 0.803289985
lg10 serum c-reactive protein (mg/l): 0.05804623
lg10 plasma adiponectin (mg/l): 0.806179974
log10 il1 receptor antagonist (pg/ml): 2.286119503
log10 ogtt fasting plasma insulin (mu/l): 0.84509804
ogtt 30 min plasma insulin (mu/l): 1.692846919
ogtt 120 min plasma insulin (mu/l): 1.613841822
ogtt 30 min plasma proinsulin (pm/l): 1.271841607
ogtt 120 min plasma proinsulin (pm/l): 1.547774705
log10 total cholesterol (mmol/l): 0.660865478
log10 ldl cholesterol (mmol/l): 0.413299764
log10 urinary albumin excretion rate (ug/min): 0.772883254
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.265940316
plasma free fatty acids under the curve ogtt (mmol/l * min): 17.1
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.767356854
log10 homair (insulin resistance index based on homa): 0.144193536
log10 homais (insulin secretion index based on homa): 1.726998728
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.545863548
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.492941889
log10 matsuda insulin sensitivity index: 0.808126333
log10 il1 receptor antagonist (pg/ml): 1.831293744
ogtt 30 min plasma insulin (mu/l): 1.895422546
ogtt 120 min plasma insulin (mu/l): 1.371067862
ogtt 30 min plasma proinsulin (pm/l): 1.465382851
ogtt 120 min plasma proinsulin (pm/l): 1.539076099
log10 total cholesterol (mmol/l): 0.764922985
log10 total triglycerides (mmol/l): -0.096910013
log10 urinary albumin excretion rate (ug/min): 0.748188027
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.921856925
plasma free fatty acids under the curve ogtt (mmol/l * min): 22.8
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.906890596
log10 homair (insulin resistance index based on homa): 0.547419141
log10 homais (insulin secretion index based on homa): 1.976876201
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.802801082
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.734703842
log10 matsuda insulin sensitivity index: 0.435651372
lg10 serum c-reactive protein (mg/l): 0.386677284
log10 il1 receptor antagonist (pg/ml): 2.015527404
log10 ogtt fasting plasma insulin (mu/l): 1.10720997
ogtt 30 min plasma insulin (mu/l): 1.990782692
ogtt 120 min plasma insulin (mu/l): 2.001733713
log10 ogtt fasting plasma proinsulin (pm/l): 1.247973266
ogtt 120 min plasma proinsulin (pm/l): 1.859138297
log10 serum alanine aminotransfrase (u/l): 0.84509804
log10 total cholesterol (mmol/l): 0.816903839
log10 ldl cholesterol (mmol/l): 0.615950052
log10 total triglycerides (mmol/l): 0.252853031
log10 urinary albumin excretion rate (ug/min): 1.935924869
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.56346251
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.585358929
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.942514505
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 312
log10 homair (insulin resistance index based on homa): 0.208918866
log10 homais (insulin secretion index based on homa): 1.791724058
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.606392115
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.552923608
log10 matsuda insulin sensitivity index: 0.697180682
lg10 serum c-reactive protein (mg/l): 0.081347308
log10 il1 receptor antagonist (pg/ml): 2.08817154
log10 ogtt fasting plasma insulin (mu/l): 0.812913357
ogtt 30 min plasma insulin (mu/l): 1.696356389
ogtt 120 min plasma insulin (mu/l): 1.909556029
log10 ogtt fasting plasma proinsulin (pm/l): 1.117271296
ogtt 30 min plasma proinsulin (pm/l): 1.31386722
ogtt 120 min plasma proinsulin (pm/l): 1.766412847
log10 total cholesterol (mmol/l): 0.7930916
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.405357412
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.716381171
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.828136484
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 237
log10 homair (insulin resistance index based on homa): 0.545224622
log10 homais (insulin secretion index based on homa): 2.128029814
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.736930078
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.647529666
log10 matsuda insulin sensitivity index: 0.488595229
ogtt fasting plasma free fatty acid (mmol/l): 0.53
ogtt 30 min plasma free fatty acid (mmol/l): 0.27
log10 il1 receptor antagonist (pg/ml): 2.371990911
log10 ogtt fasting plasma insulin (mu/l): 1.149219113
ogtt 30 min plasma insulin (mu/l): 2.009875634
ogtt 120 min plasma insulin (mu/l): 1.785329835
log10 ogtt fasting plasma proinsulin (pm/l): 1.243038049
ogtt 30 min plasma proinsulin (pm/l): 1.6599162
log10 total cholesterol (mmol/l): 0.653212514
log10 ldl cholesterol (mmol/l): 0.457881897
log10 total triglycerides (mmol/l): -0.070581074
log10 urinary albumin excretion rate (ug/min): 0.831734078
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.027063902
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.509142232
plasma free fatty acids under the curve ogtt (mmol/l * min): 20.7
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 94.5
log10 homair (insulin resistance index based on homa): 0.204119983
log10 homais (insulin secretion index based on homa): 1.982271233
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.495821753
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.417239121
log10 matsuda insulin sensitivity index: 0.833009944
lg10 serum c-reactive protein (mg/l): 0.065206128
log10 il1 receptor antagonist (pg/ml): 2.303865349
log10 ogtt fasting plasma insulin (mu/l): 0.857332496
ogtt 30 min plasma insulin (mu/l): 1.775974331
ogtt 120 min plasma insulin (mu/l): 1.531478917
log10 ogtt fasting plasma proinsulin (pm/l): 0.939519253
ogtt 30 min plasma proinsulin (pm/l): 1.385606274
ogtt 120 min plasma proinsulin (pm/l): 1.64738297
log10 serum alanine aminotransfrase (u/l): 1.707570176
log10 total cholesterol (mmol/l): 0.802089258
log10 ldl cholesterol (mmol/l): 0.575187845
log10 hdl cholesterol (mmol/l): 0.271841607
log10 urinary albumin excretion rate (ug/min): 1.165804685
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.649133951
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.792506468
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.782179194
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 100.5
log10 homair (insulin resistance index based on homa): 0.113943352
log10 homais (insulin secretion index based on homa): 1.477121255
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.542065681
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.499673339
log10 matsuda insulin sensitivity index: 0.801906972
lg10 serum c-reactive protein (mg/l): -0.552841969
log10 il1 receptor antagonist (pg/ml): 1.963126441
ogtt 30 min plasma insulin (mu/l): 1.765668555
ogtt 120 min plasma insulin (mu/l): 1.697229343
ogtt 120 min plasma proinsulin (pm/l): 1.943494516
log10 total cholesterol (mmol/l): 0.804139432
log10 urinary albumin excretion rate (ug/min): 0.895989647
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.425976305
plasma free fatty acids under the curve ogtt (mmol/l * min): 3.15
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.108524457
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -120
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.216693599
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.133219457
log10 matsuda insulin sensitivity index: 1.121763326
lg10 serum c-reactive protein (mg/l): -0.21395879
ogtt fasting plasma free fatty acid (mmol/l): 0.07
ogtt 30 min plasma free fatty acid (mmol/l): 0.02
ogtt 30 min plasma glucose (mmol/l): 5.7
ogtt 120 min plasma glucose (mmol/l): 2.8
log10 il1 receptor antagonist (pg/ml): 1.950413539
ogtt 30 min plasma insulin (mu/l): 1.606381365
ogtt 120 min plasma insulin (mu/l): 0.763427994
log10 ogtt fasting plasma proinsulin (pm/l): 0.707570176
ogtt 120 min plasma proinsulin (pm/l): 0.939519253
log10 total cholesterol (mmol/l): 0.754348336
log10 ldl cholesterol (mmol/l): 0.523746467
log10 hdl cholesterol (mmol/l): 0.187520721
log10 urinary albumin excretion rate (ug/min): 1.286065129
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.362966508
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.395534135
log10 homair (insulin resistance index based on homa): -0.079876674
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.154819436
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.059752694
log10 matsuda insulin sensitivity index: 1.157029579
lg10 serum c-reactive protein (mg/l): 0.019531685
log10 il1 receptor antagonist (pg/ml): 1.932930143
log10 ogtt fasting plasma insulin (mu/l): 0.591064607
log10 ogtt fasting plasma proinsulin (pm/l): 1.008600172
ogtt 30 min plasma proinsulin (pm/l): 1.378397901
ogtt 120 min plasma proinsulin (pm/l): 1.372912003
log10 total cholesterol (mmol/l): 0.788875116
log10 hdl cholesterol (mmol/l): 0.354108439
log10 total triglycerides (mmol/l): 0.06069784
log10 urinary albumin excretion rate (ug/min): 1.213585283
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.296721789
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.896289059
plasma free fatty acids under the curve ogtt (mmol/l * min): 36.6
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.73470962
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 228
log10 homair (insulin resistance index based on homa): 0.706243506
log10 homais (insulin secretion index based on homa): 2.413003755
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.836425397
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.722436471
log10 matsuda insulin sensitivity index: 0.379606257
lg10 serum c-reactive protein (mg/l): 0.705692697
lg10 plasma adiponectin (mg/l): 0.973127854
ogtt 30 min plasma free fatty acid (mmol/l): 0.44
log10 il1 receptor antagonist (pg/ml): 2.542339841
log10 ogtt fasting plasma insulin (mu/l): 1.342422681
ogtt 30 min plasma insulin (mu/l): 2.183839037
ogtt 120 min plasma insulin (mu/l): 1.635483747
ogtt 30 min plasma proinsulin (pm/l): 1.607455023
ogtt 120 min plasma proinsulin (pm/l): 1.810904281
log10 ldl cholesterol (mmol/l): 0.582063363
log10 hdl cholesterol (mmol/l): 0.06069784
log10 urinary albumin excretion rate (ug/min): 1.068523178
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.454927697
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.922418135
plasma free fatty acids under the curve ogtt (mmol/l * min): 22.2
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.12023788
log10 homair (insulin resistance index based on homa): 0.29666519
log10 homais (insulin secretion index based on homa): 1.908485019
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.694052108
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.639536291
log10 matsuda insulin sensitivity index: 0.576841583
lg10 serum c-reactive protein (mg/l): -0.18243463
ogtt 120 min plasma glucose (mmol/l): 10.5
log10 il1 receptor antagonist (pg/ml): 2.08174325
log10 ogtt fasting plasma insulin (mu/l): 0.908485019
ogtt 30 min plasma insulin (mu/l): 1.667452953
ogtt 120 min plasma insulin (mu/l): 2.073351702
log10 ogtt fasting plasma proinsulin (pm/l): 1.269512944
ogtt 30 min plasma proinsulin (pm/l): 1.57054294
ogtt 120 min plasma proinsulin (pm/l): 1.892094603
log10 total cholesterol (mmol/l): 0.751279104
log10 ldl cholesterol (mmol/l): 0.59439255
log10 urinary albumin excretion rate (ug/min): 0.965004339
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.406090767
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.370626497
plasma free fatty acids under the curve ogtt (mmol/l * min): 26.1
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.77478706
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 204
log10 homair (insulin resistance index based on homa): 0.456703349
log10 homais (insulin secretion index based on homa): 2.039508541
log10 insulin area under the curve (ogtt) (pmol/l * min): 5.051465102
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 5.018288472
log10 matsuda insulin sensitivity index: 0.385560038
lg10 serum c-reactive protein (mg/l): 0.373647472
log10 il1 receptor antagonist (pg/ml): 2.263754389
ogtt 30 min plasma insulin (mu/l): 2.311117843
ogtt 120 min plasma insulin (mu/l): 2.146748014
log10 ogtt fasting plasma proinsulin (pm/l): 1.305351369
ogtt 30 min plasma proinsulin (pm/l): 1.804820679
ogtt 120 min plasma proinsulin (pm/l): 1.984527313
log10 total cholesterol (mmol/l): 0.710117365
log10 ldl cholesterol (mmol/l): 0.558708571
log10 urinary albumin excretion rate (ug/min): 0.556302501
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.507089067
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.464018176
plasma free fatty acids under the curve ogtt (mmol/l * min): 18.75
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 106.5
log10 homair (insulin resistance index based on homa): -0.096910013
log10 homais (insulin secretion index based on homa): 1.681241237
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.212879792
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.137797043
log10 matsuda insulin sensitivity index: 1.125689382
lg10 serum c-reactive protein (mg/l): -0.222573178
log10 il1 receptor antagonist (pg/ml): 2.05709529
ogtt 30 min plasma insulin (mu/l): 1.521138084
ogtt 120 min plasma insulin (mu/l): 1.176091259
ogtt 30 min plasma proinsulin (pm/l): 1.394451681
ogtt 120 min plasma proinsulin (pm/l): 1.506505032
log10 total cholesterol (mmol/l): 0.712649702
log10 ldl cholesterol (mmol/l): 0.567026366
log10 total triglycerides (mmol/l): 0.071882007
log10 urinary albumin excretion rate (ug/min): 0.878266403
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.083358352
log10 homair (insulin resistance index based on homa): 0.337836263
log10 homais (insulin secretion index based on homa): 1.767293323
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.286276786
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.134941711
log10 matsuda insulin sensitivity index: 0.82058713
lg10 serum c-reactive protein (mg/l): 0.581835924
ogtt fasting plasma free fatty acid (mmol/l): 0.54
ogtt 30 min plasma glucose (mmol/l): 10.6
log10 il1 receptor antagonist (pg/ml): 2.527436552
ogtt 30 min plasma insulin (mu/l): 1.658011397
ogtt 120 min plasma insulin (mu/l): 0.919078092
log10 ogtt fasting plasma proinsulin (pm/l): 1.206825876
ogtt 30 min plasma proinsulin (pm/l): 1.492760389
log10 total cholesterol (mmol/l): 0.812913357
log10 ldl cholesterol (mmol/l): 0.644438589
log10 urinary albumin excretion rate (ug/min): 0.719398939
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.291476642
plasma free fatty acids under the curve ogtt (mmol/l * min): 24.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.856425529
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 219
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.228400359
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.126845441
log10 matsuda insulin sensitivity index: 0.935384417
lg10 serum c-reactive protein (mg/l): -0.145693958
lg10 plasma adiponectin (mg/l): 0.995635195
log10 il1 receptor antagonist (pg/ml): 2.300443302
ogtt 30 min plasma insulin (mu/l): 1.257678575
ogtt 120 min plasma insulin (mu/l): 1.567026366
ogtt 30 min plasma proinsulin (pm/l): 0.908485019
ogtt 120 min plasma proinsulin (pm/l): 1.383815366
log10 total cholesterol (mmol/l): 0.679427897
log10 urinary albumin excretion rate (ug/min): 0.750713002
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.753896583
plasma free fatty acids under the curve ogtt (mmol/l * min): 24.15
log10 homair (insulin resistance index based on homa): 0.546542663
log10 homais (insulin secretion index based on homa): 2.158362492
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.826223863
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.753238244
log10 matsuda insulin sensitivity index: 0.430513043
log10 il1 receptor antagonist (pg/ml): 2.161278139
ogtt 120 min plasma insulin (mu/l): 2.135132651
ogtt 30 min plasma proinsulin (pm/l): 1.350248018
ogtt 120 min plasma proinsulin (pm/l): 1.770852012
log10 total cholesterol (mmol/l): 0.707570176
log10 total triglycerides (mmol/l): 0.374748346
log10 urinary albumin excretion rate (ug/min): 0.993174596
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 5.996232093
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.143839455
plasma free fatty acids under the curve ogtt (mmol/l * min): 7.5
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 90
log10 homair (insulin resistance index based on homa): 0.180571861
log10 homais (insulin secretion index based on homa): 1.610028921
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.378797486
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.300204051
log10 matsuda insulin sensitivity index: 0.862961273
ogtt fasting plasma free fatty acid (mmol/l): 0.12
log10 il1 receptor antagonist (pg/ml): 2.149496233
ogtt 30 min plasma insulin (mu/l): 1.693726949
ogtt 120 min plasma insulin (mu/l): 1.320146286
log10 ogtt fasting plasma proinsulin (pm/l): 1.29666519
ogtt 30 min plasma proinsulin (pm/l): 1.615950052
ogtt 120 min plasma proinsulin (pm/l): 1.742725131
log10 total cholesterol (mmol/l): 0.58546073
log10 ldl cholesterol (mmol/l): 0.303196057
log10 total triglycerides (mmol/l): 0.113943352
log10 urinary albumin excretion rate (ug/min): 0.576505887
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.096974819
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.194191319
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.825753833
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 259.5
log10 homair (insulin resistance index based on homa): 0.324693914
log10 homais (insulin secretion index based on homa): 1.966759067
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.418135498
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.297848018
log10 matsuda insulin sensitivity index: 0.757773977
lg10 plasma adiponectin (mg/l): 0.431363764
ogtt 120 min plasma free fatty acid (mmol/l): 0.12
ogtt 30 min plasma glucose (mmol/l): 9.8
log10 il1 receptor antagonist (pg/ml): 2.633952979
ogtt 30 min plasma insulin (mu/l): 1.677606953
ogtt 120 min plasma insulin (mu/l): 1.485721426
ogtt 30 min plasma proinsulin (pm/l): 1.056904851
ogtt 120 min plasma proinsulin (pm/l): 1.374748346
log10 total cholesterol (mmol/l): 0.846955325
log10 ldl cholesterol (mmol/l): 0.662757832
log10 urinary albumin excretion rate (ug/min): 0.84509804
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.530514625
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.832890014
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 144
log10 homair (insulin resistance index based on homa): 0.10720997
log10 homais (insulin secretion index based on homa): 1.491844512
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.329906123
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.25851756
log10 matsuda insulin sensitivity index: 0.900831072
lg10 serum c-reactive protein (mg/l): -0.28567024
log10 il1 receptor antagonist (pg/ml): 2.119486836
ogtt 30 min plasma insulin (mu/l): 1.544068044
ogtt 120 min plasma insulin (mu/l): 1.491361694
ogtt 120 min plasma proinsulin (pm/l): 1.447158031
log10 ldl cholesterol (mmol/l): 0.606381365
log10 hdl cholesterol (mmol/l): 0.08278537
log10 urinary albumin excretion rate (ug/min): 0.994009636
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.283532704
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.530918856
plasma free fatty acids under the curve ogtt (mmol/l * min): 21.3
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.893301531
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 255
log10 homair (insulin resistance index based on homa): -0.008970928
log10 homais (insulin secretion index based on homa): 1.519085756
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.413182371
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.364682296
log10 matsuda insulin sensitivity index: 0.931283927
lg10 serum c-reactive protein (mg/l): 0.005609445
log10 il1 receptor antagonist (pg/ml): 2.44557307
ogtt 30 min plasma insulin (mu/l): 1.749736316
ogtt 120 min plasma insulin (mu/l): 1.294466226
ogtt 30 min plasma proinsulin (pm/l): 1.511883361
ogtt 120 min plasma proinsulin (pm/l): 1.695481676
log10 serum alanine aminotransfrase (u/l): 1.113943352
log10 total cholesterol (mmol/l): 0.796574333
log10 ldl cholesterol (mmol/l): 0.613841822
log10 total triglycerides (mmol/l): 0.243038049
log10 urinary albumin excretion rate (ug/min): 0.484946592
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.723094172
plasma free fatty acids under the curve ogtt (mmol/l * min): 30
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.1376316
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 358.5
log10 homair (insulin resistance index based on homa): 0.491423954
log10 homais (insulin secretion index based on homa): 1.876058496
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.661897833
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.580480195
log10 matsuda insulin sensitivity index: 0.496833332
lg10 serum c-reactive protein (mg/l): 0.008174184
ogtt 120 min plasma glucose (mmol/l): 9.7
log10 il1 receptor antagonist (pg/ml): 2.615297594
log10 ogtt fasting plasma insulin (mu/l): 1.037426498
ogtt 30 min plasma insulin (mu/l): 1.81756537
ogtt 120 min plasma insulin (mu/l): 1.896526217
log10 ogtt fasting plasma proinsulin (pm/l): 1.285557309
ogtt 30 min plasma proinsulin (pm/l): 1.649334859
ogtt 120 min plasma proinsulin (pm/l): 1.959041392
log10 serum alanine aminotransfrase (u/l): 1.857332496
log10 total cholesterol (mmol/l): 0.673020907
log10 total triglycerides (mmol/l): 0.178976947
log10 urinary albumin excretion rate (ug/min): 0.988520182
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.319697249
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.101353554
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.835260919
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 265.5
log10 homair (insulin resistance index based on homa): 0.401400541
log10 homais (insulin secretion index based on homa): 2.043465694
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.795977288
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.739999309
log10 matsuda insulin sensitivity index: 0.53533941
lg10 serum c-reactive protein (mg/l): -0.369572125
log10 il1 receptor antagonist (pg/ml): 2.473457773
log10 ogtt fasting plasma insulin (mu/l): 1.021189299
ogtt 30 min plasma insulin (mu/l): 2.071882007
ogtt 120 min plasma insulin (mu/l): 1.849419414
log10 ogtt fasting plasma proinsulin (pm/l): 1.120573931
ogtt 30 min plasma proinsulin (pm/l): 1.655138435
ogtt 120 min plasma proinsulin (pm/l): 1.806179974
log10 total cholesterol (mmol/l): 0.662757832
log10 ldl cholesterol (mmol/l): 0.404833717
log10 urinary albumin excretion rate (ug/min): 0.841007324
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.132615804
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.254470268
plasma free fatty acids under the curve ogtt (mmol/l * min): 24.3
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 168
log10 homair (insulin resistance index based on homa): -0.013128782
log10 homais (insulin secretion index based on homa): 1.489020478
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.291302236
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.227706782
log10 matsuda insulin sensitivity index: 0.998144248
lg10 serum c-reactive protein (mg/l): 0.033021445
ogtt 120 min plasma glucose (mmol/l): 6.3
log10 il1 receptor antagonist (pg/ml): 2.292765404
ogtt 30 min plasma insulin (mu/l): 1.5774918
ogtt 120 min plasma insulin (mu/l): 1.318063335
ogtt 30 min plasma proinsulin (pm/l): 1.281033367
log10 total cholesterol (mmol/l): 0.657055853
log10 ldl cholesterol (mmol/l): 0.505149978
log10 hdl cholesterol (mmol/l): -0.080921908
log10 urinary albumin excretion rate (ug/min): 0.584447206
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.322656165
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.640784241
plasma free fatty acids under the curve ogtt (mmol/l * min): 25.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.596189756
log10 homair (insulin resistance index based on homa): 0.143639235
log10 homais (insulin secretion index based on homa): 1.671695919
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.225154149
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.110791661
log10 matsuda insulin sensitivity index: 0.965479674
lg10 serum c-reactive protein (mg/l): -0.223298816
log10 il1 receptor antagonist (pg/ml): 2.300312818
ogtt 30 min plasma insulin (mu/l): 1.485721426
ogtt 30 min plasma proinsulin (pm/l): 1.309630167
ogtt 120 min plasma proinsulin (pm/l): 1.557507202
log10 serum bilirubin (umol/l): 1.491361694
log10 total cholesterol (mmol/l): 0.632457292
log10 ldl cholesterol (mmol/l): 0.408239965
log10 hdl cholesterol (mmol/l): 0.214843848
log10 total triglycerides (mmol/l): -0.22184875
log10 urinary albumin excretion rate (ug/min): 0.812704511
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.43621404
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.696627483
log10 homair (insulin resistance index based on homa): 0.157557497
log10 homais (insulin secretion index based on homa): 1.499864382
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.408782494
log10 matsuda insulin sensitivity index: 0.836066685
lg10 serum c-reactive protein (mg/l): -0.016824928
lg10 plasma adiponectin (mg/l): 0.653212514
log10 il1 receptor antagonist (pg/ml): 2.531951275
ogtt 30 min plasma insulin (mu/l): 1.610660163
ogtt 120 min plasma insulin (mu/l): 1.589949601
ogtt 30 min plasma proinsulin (pm/l): 1.195899652
ogtt 120 min plasma proinsulin (pm/l): 1.609594409
log10 total cholesterol (mmol/l): 0.612783857
log10 urinary albumin excretion rate (ug/min): 1.273986699
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.320124728
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.536787711
plasma free fatty acids under the curve ogtt (mmol/l * min): 16.2
log10 homair (insulin resistance index based on homa): -0.142667504
log10 homais (insulin secretion index based on homa): 1.499397649
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.158090973
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.087461966
log10 matsuda insulin sensitivity index: 1.160980214
lg10 serum c-reactive protein (mg/l): -0.355561411
ogtt 30 min plasma glucose (mmol/l): 6.7
log10 il1 receptor antagonist (pg/ml): 2.313888302
ogtt 30 min plasma insulin (mu/l): 1.369215857
ogtt 120 min plasma proinsulin (pm/l): 1.399673721
log10 total cholesterol (mmol/l): 0.766412847
log10 hdl cholesterol (mmol/l): 0.206825876
log10 urinary albumin excretion rate (ug/min): 0.757875294
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.250764396
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.355292058
plasma free fatty acids under the curve ogtt (mmol/l * min): 13.65
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 49.5
log10 homair (insulin resistance index based on homa): 0.037160793
log10 homais (insulin secretion index based on homa): 1.59207577
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.28425021
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.208064948
log10 matsuda insulin sensitivity index: 1.026440046
lg10 serum c-reactive protein (mg/l): -0.132532512
lg10 plasma adiponectin (mg/l): 1.10720997
ogtt 120 min plasma glucose (mmol/l): 3.2
log10 il1 receptor antagonist (pg/ml): 2.620302659
log10 ogtt fasting plasma insulin (mu/l): 0.633468456
ogtt 30 min plasma insulin (mu/l): 1.684845362
ogtt 120 min plasma insulin (mu/l): 0.72427587
log10 ogtt fasting plasma proinsulin (pm/l): 0.748188027
ogtt 120 min plasma proinsulin (pm/l): 1.31386722
log10 ldl cholesterol (mmol/l): 0.656098202
log10 urinary albumin excretion rate (ug/min): 0.713425921
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.700688735
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.595388241
plasma free fatty acids under the curve ogtt (mmol/l * min): 12.75
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.539158811
log10 homair (insulin resistance index based on homa): 0.021648627
log10 homais (insulin secretion index based on homa): 1.633468456
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.456533037
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.406795573
log10 matsuda insulin sensitivity index: 0.929288788
lg10 serum c-reactive protein (mg/l): 0.505149978
ogtt 30 min plasma glucose (mmol/l): 7.5
log10 il1 receptor antagonist (pg/ml): 2.274781123
ogtt 30 min plasma insulin (mu/l): 1.705863712
ogtt 120 min plasma insulin (mu/l): 1.565847819
ogtt 120 min plasma proinsulin (pm/l): 1.702430536
log10 total cholesterol (mmol/l): 0.828659897
log10 ldl cholesterol (mmol/l): 0.62838893
log10 hdl cholesterol (mmol/l): 0.230448921
log10 urinary albumin excretion rate (ug/min): 0.776172684
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.506289531
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.534454111
plasma free fatty acids under the curve ogtt (mmol/l * min): 27.9
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.67507492
log10 homair (insulin resistance index based on homa): 0.364488457
log10 homais (insulin secretion index based on homa): 1.947293649
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.617660722
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.541167218
log10 matsuda insulin sensitivity index: 0.656212077
lg10 serum c-reactive protein (mg/l): 0.079181246
log10 il1 receptor antagonist (pg/ml): 2.49280228
log10 ogtt fasting plasma insulin (mu/l): 0.968482949
ogtt 30 min plasma insulin (mu/l): 1.877946952
log10 ogtt fasting plasma proinsulin (pm/l): 1.209515015
ogtt 30 min plasma proinsulin (pm/l): 1.629409599
ogtt 120 min plasma proinsulin (pm/l): 1.782472624
log10 total cholesterol (mmol/l): 0.687528961
log10 ldl cholesterol (mmol/l): 0.439332694
log10 urinary albumin excretion rate (ug/min): 1.279544106
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.86219625
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.924812504
log10 homair (insulin resistance index based on homa): -0.098844513
log10 homais (insulin secretion index based on homa): 1.285790029
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.004622266
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.908002201
log10 matsuda insulin sensitivity index: 1.160798768
log10 il1 receptor antagonist (pg/ml): 2.378107063
ogtt 120 min plasma insulin (mu/l): 1.053078443
log10 ogtt fasting plasma proinsulin (pm/l): 0.662757832
ogtt 120 min plasma proinsulin (pm/l): 1.283301229
log10 total cholesterol (mmol/l): 0.773054693
log10 ldl cholesterol (mmol/l): 0.506505032
log10 total triglycerides (mmol/l): -0.050609993
log10 urinary albumin excretion rate (ug/min): 0.702846328
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.958110157
plasma free fatty acids under the curve ogtt (mmol/l * min): 7.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.52160044
log10 homair (insulin resistance index based on homa): -0.0205528
log10 homais (insulin secretion index based on homa): 1.507503884
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.07415792
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.963693405
log10 matsuda insulin sensitivity index: 1.140861475
lg10 serum c-reactive protein (mg/l): 0.427972714
lg10 plasma adiponectin (mg/l): 0.785329835
ogtt 30 min plasma glucose (mmol/l): 6.9
log10 il1 receptor antagonist (pg/ml): 2.378361557
ogtt 30 min plasma insulin (mu/l): 1.411619706
log10 ogtt fasting plasma proinsulin (pm/l): 0.851258349
ogtt 30 min plasma proinsulin (pm/l): 1.220108088
ogtt 120 min plasma proinsulin (pm/l): 1.305351369
log10 ldl cholesterol (mmol/l): 0.503790683
log10 total triglycerides (mmol/l): -0.031517051
log10 urinary albumin excretion rate (ug/min): 0.701444624
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.569922884
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.560644292
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.716819461
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 169.5
log10 homais (insulin secretion index based on homa): 1.711204461
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.384962397
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.309118932
log10 matsuda insulin sensitivity index: 0.888553184
lg10 serum c-reactive protein (mg/l): -0.482804102
log10 il1 receptor antagonist (pg/ml): 2.329194415
ogtt 30 min plasma insulin (mu/l): 1.646403726
log10 ogtt fasting plasma proinsulin (pm/l): 0.949390007
ogtt 30 min plasma proinsulin (pm/l): 1.372912003
ogtt 120 min plasma proinsulin (pm/l): 1.57863921
log10 total cholesterol (mmol/l): 0.638489257
log10 total triglycerides (mmol/l): 0.120573931
log10 urinary albumin excretion rate (ug/min): 0.821185883
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.954260854
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.964340868
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 195
log10 homair (insulin resistance index based on homa): 0.979042263
log10 homais (insulin secretion index based on homa): 2.301029996
log10 insulin area under the curve (ogtt) (pmol/l * min): 5.133564454
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 5.05295544
log10 matsuda insulin sensitivity index: 0.039439851
lg10 serum c-reactive protein (mg/l): 0.573451822
log10 il1 receptor antagonist (pg/ml): 2.265289626
log10 ogtt fasting plasma insulin (mu/l): 1.505149978
ogtt 30 min plasma insulin (mu/l): 2.265053789
ogtt 120 min plasma insulin (mu/l): 2.39375064
log10 ogtt fasting plasma proinsulin (pm/l): 1.426511261
ogtt 30 min plasma proinsulin (pm/l): 1.742725131
ogtt 120 min plasma proinsulin (pm/l): 1.950364854
log10 total cholesterol (mmol/l): 0.781755375
log10 hdl cholesterol (mmol/l): 0.123851641
log10 urinary albumin excretion rate (ug/min): 0.718224804
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.353567711
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.519040794
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 198
log10 homair (insulin resistance index based on homa): 0.561101384
log10 homais (insulin secretion index based on homa): 1.967815317
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.587003398
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.466526573
log10 matsuda insulin sensitivity index: 0.526049836
lg10 serum c-reactive protein (mg/l): 0.666705136
ogtt 120 min plasma glucose (mmol/l): 7.5
log10 il1 receptor antagonist (pg/ml): 2.428361605
log10 ogtt fasting plasma insulin (mu/l): 1.113943352
ogtt 30 min plasma insulin (mu/l): 1.733999287
ogtt 120 min plasma insulin (mu/l): 1.822821645
ogtt 120 min plasma proinsulin (pm/l): 1.69019608
log10 total cholesterol (mmol/l): 0.691081492
log10 hdl cholesterol (mmol/l): 0.146128036
log10 total triglycerides (mmol/l): -0.026872146
log10 urinary albumin excretion rate (ug/min): 1.605445587
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.738992868
plasma free fatty acids under the curve ogtt (mmol/l * min): 6.75
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 73.5
log10 homair (insulin resistance index based on homa): 0.315270435
log10 homais (insulin secretion index based on homa): 1.744727495
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.544638457
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.471966104
log10 matsuda insulin sensitivity index: 0.722676048
lg10 serum c-reactive protein (mg/l): -0.071604148
ogtt fasting plasma free fatty acid (mmol/l): 0.19
ogtt 30 min plasma free fatty acid (mmol/l): 0.05
log10 il1 receptor antagonist (pg/ml): 2.137955124
ogtt 30 min plasma insulin (mu/l): 1.902002891
log10 total cholesterol (mmol/l): 0.666517981
log10 total triglycerides (mmol/l): -0.055517328
log10 urinary albumin excretion rate (ug/min): 0.949186638
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.994353345
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 247.5
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.3029367
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.25002945
log10 matsuda insulin sensitivity index: 1.081966087
lg10 serum c-reactive protein (mg/l): 0.345961542
ogtt 120 min plasma glucose (mmol/l): 3.5
log10 il1 receptor antagonist (pg/ml): 2.435573644
ogtt 120 min plasma insulin (mu/l): 0.643452676
ogtt 30 min plasma proinsulin (pm/l): 1.463892989
log10 total cholesterol (mmol/l): 0.88422877
log10 ldl cholesterol (mmol/l): 0.720159303
log10 total triglycerides (mmol/l): 0.238046103
log10 urinary albumin excretion rate (ug/min): 0.711872093
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.957409505
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.504109502
plasma free fatty acids under the curve ogtt (mmol/l * min): 46.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.983706193
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 388.5
log10 homair (insulin resistance index based on homa): -0.002710719
log10 homais (insulin secretion index based on homa): 1.70404953
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.394521723
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.336619813
log10 matsuda insulin sensitivity index: 0.915125661
lg10 serum c-reactive protein (mg/l): 0.949194774
ogtt 120 min plasma free fatty acid (mmol/l): 0.17
log10 il1 receptor antagonist (pg/ml): 2.691991583
ogtt 30 min plasma insulin (mu/l): 1.618048097
ogtt 120 min plasma insulin (mu/l): 1.545307116
ogtt 120 min plasma proinsulin (pm/l): 1.960470778
log10 serum alanine aminotransfrase (u/l): 1.913813852
log10 hdl cholesterol (mmol/l): 0.456366033
log10 urinary albumin excretion rate (ug/min): 0.872541066
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.636085368
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.826376616
log10 homair (insulin resistance index based on homa): 0.077246746
log10 homais (insulin secretion index based on homa): 1.660051938
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.344824388
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.271051261
log10 matsuda insulin sensitivity index: 0.920724689
lg10 serum c-reactive protein (mg/l): 0.630020851
log10 il1 receptor antagonist (pg/ml): 2.439064138
ogtt 30 min plasma insulin (mu/l): 1.53529412
ogtt 120 min plasma insulin (mu/l): 1.539076099
ogtt 30 min plasma proinsulin (pm/l): 1.481442629
ogtt 120 min plasma proinsulin (pm/l): 1.747411808
log10 total cholesterol (mmol/l): 0.597695186
log10 urinary albumin excretion rate (ug/min): 0.952076448
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.419127718
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.195955526
plasma free fatty acids under the curve ogtt (mmol/l * min): 9.3
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.82336724
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 234
log10 homair (insulin resistance index based on homa): 0.417194808
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.708514378
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.638998132
log10 matsuda insulin sensitivity index: 0.56431174
lg10 serum c-reactive protein (mg/l): 1.608547427
ogtt 30 min plasma free fatty acid (mmol/l): 0.03
log10 il1 receptor antagonist (pg/ml): 2.299834041
ogtt 30 min plasma insulin (mu/l): 1.951337519
ogtt 120 min plasma insulin (mu/l): 1.823474229
ogtt 30 min plasma proinsulin (pm/l): 1.505149978
ogtt 120 min plasma proinsulin (pm/l): 1.935507266
log10 urinary albumin excretion rate (ug/min): 0.927913571
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.706372582
log10 homair (insulin resistance index based on homa): 0.553073531
log10 homais (insulin secretion index based on homa): 2.030194785
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.915378727
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.861223663
log10 matsuda insulin sensitivity index: 0.406122096
log10 il1 receptor antagonist (pg/ml): 2.239024047
log10 ogtt fasting plasma insulin (mu/l): 1.127104798
ogtt 30 min plasma insulin (mu/l): 2.256958153
log10 ogtt fasting plasma proinsulin (pm/l): 1.478566496
ogtt 30 min plasma proinsulin (pm/l): 1.864511081
ogtt 120 min plasma proinsulin (pm/l): 2.086359831
log10 serum alanine aminotransfrase (u/l): 1.698970004
log10 total cholesterol (mmol/l): 0.716003344
log10 total triglycerides (mmol/l): 0.089905111
log10 urinary albumin excretion rate (ug/min): 0.70775937
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.951609967
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.974411969
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.784634846
log10 homair (insulin resistance index based on homa): 0.081427325
log10 homais (insulin secretion index based on homa): 1.583576586
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.025018972
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.862191031
log10 matsuda insulin sensitivity index: 1.0683719
lg10 serum c-reactive protein (mg/l): 0.220369632
log10 il1 receptor antagonist (pg/ml): 2.076021142
ogtt 120 min plasma insulin (mu/l): 1.195899652
log10 ogtt fasting plasma proinsulin (pm/l): 0.913813852
ogtt 30 min plasma proinsulin (pm/l): 1.089905111
log10 total cholesterol (mmol/l): 0.716837723
log10 urinary albumin excretion rate (ug/min): 0.524762889
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.678942752
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.890859659
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 52.5
log10 homair (insulin resistance index based on homa): 0.375033303
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.462502815
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.349918295
log10 matsuda insulin sensitivity index: 0.741058136
lg10 serum c-reactive protein (mg/l): 0.038620162
log10 il1 receptor antagonist (pg/ml): 2.338277161
log10 ogtt fasting plasma insulin (mu/l): 0.963787827
ogtt 30 min plasma insulin (mu/l): 1.738780558
ogtt 120 min plasma insulin (mu/l): 1.495544338
ogtt 30 min plasma proinsulin (pm/l): 1.371067862
ogtt 120 min plasma proinsulin (pm/l): 1.682145076
log10 serum bilirubin (umol/l): 0.903089987
log10 total cholesterol (mmol/l): 0.756636108
log10 hdl cholesterol (mmol/l): -0.193820026
log10 total triglycerides (mmol/l): 0.509202522
log10 urinary albumin excretion rate (ug/min): 0.669006781
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.498395033
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.005320074
plasma free fatty acids under the curve ogtt (mmol/l * min): 32.4
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.02375435
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 357
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.860954566
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.825990528
log10 matsuda insulin sensitivity index: 0.535886342
lg10 serum c-reactive protein (mg/l): 0.506775537
lg10 plasma adiponectin (mg/l): 0.544068044
ogtt 120 min plasma glucose (mmol/l): 6.7
log10 il1 receptor antagonist (pg/ml): 2.372599051
ogtt 30 min plasma insulin (mu/l): 2.147367108
ogtt 120 min plasma insulin (mu/l): 1.898176483
ogtt 30 min plasma proinsulin (pm/l): 1.680335513
ogtt 120 min plasma proinsulin (pm/l): 1.92890769
log10 total cholesterol (mmol/l): 0.763427994
log10 ldl cholesterol (mmol/l): 0.57863921
log10 urinary albumin excretion rate (ug/min): 0.961603609
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.879959722
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.19471946
plasma free fatty acids under the curve ogtt (mmol/l * min): 17.55
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 72
log10 homair (insulin resistance index based on homa): 0.437680112
log10 homais (insulin secretion index based on homa): 1.759667845
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.751440779
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.69720318
log10 matsuda insulin sensitivity index: 0.554709764
lg10 serum c-reactive protein (mg/l): 0.566437492
lg10 plasma adiponectin (mg/l): 0.944482672
log10 il1 receptor antagonist (pg/ml): 2.447344118
ogtt 30 min plasma insulin (mu/l): 2.161068385
ogtt 120 min plasma insulin (mu/l): 1.103803721
ogtt 30 min plasma proinsulin (pm/l): 1.546542663
ogtt 120 min plasma proinsulin (pm/l): 1.408239965
log10 ldl cholesterol (mmol/l): 0.478566496
log10 hdl cholesterol (mmol/l): 0.167317335
log10 total triglycerides (mmol/l): -0.229147988
log10 urinary albumin excretion rate (ug/min): 1.079181246
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.492595495
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.047795062
plasma free fatty acids under the curve ogtt (mmol/l * min): 18.45
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.789533645
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 189
log10 homair (insulin resistance index based on homa): 0.280477195
log10 homais (insulin secretion index based on homa): 1.808533879
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.609573067
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.54863506
log10 matsuda insulin sensitivity index: 0.686035817
lg10 serum c-reactive protein (mg/l): 0.293141483
log10 il1 receptor antagonist (pg/ml): 2.485139138
log10 ogtt fasting plasma insulin (mu/l): 0.86923172
ogtt 30 min plasma insulin (mu/l): 1.849419414
ogtt 120 min plasma insulin (mu/l): 1.73239376
ogtt 120 min plasma proinsulin (pm/l): 1.7084209
log10 serum alanine aminotransfrase (u/l): 1.826074803
log10 total triglycerides (mmol/l): 0.130333768
log10 urinary albumin excretion rate (ug/min): 0.865728042
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50287596
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.64814536
plasma free fatty acids under the curve ogtt (mmol/l * min): 7.8
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -64.5
log10 homair (insulin resistance index based on homa): -0.082669574
log10 homais (insulin secretion index based on homa): 1.394451681
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.190527787
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.12303453
log10 matsuda insulin sensitivity index: 1.144027476
lg10 serum c-reactive protein (mg/l): -0.485452247
ogtt 30 min plasma free fatty acid (mmol/l): 0.07
log10 il1 receptor antagonist (pg/ml): 2.199535781
ogtt 30 min plasma insulin (mu/l): 1.567026366
ogtt 120 min plasma insulin (mu/l): 0.857332496
ogtt 120 min plasma proinsulin (pm/l): 1.357934847
log10 total cholesterol (mmol/l): 0.720159303
log10 ldl cholesterol (mmol/l): 0.521138084
log10 hdl cholesterol (mmol/l): 0.260071388
log10 urinary albumin excretion rate (ug/min): 0.990739639
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.472656693
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.134352882
plasma free fatty acids under the curve ogtt (mmol/l * min): 23.55
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.04234338
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 286.5
log10 homair (insulin resistance index based on homa): 0.853671177
log10 homais (insulin secretion index based on homa): 2.238305719
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.985812542
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.896051982
log10 matsuda insulin sensitivity index: 0.161516111
lg10 serum c-reactive protein (mg/l): 0.311329952
ogtt 120 min plasma glucose (mmol/l): 8.9
log10 il1 receptor antagonist (pg/ml): 2.696478708
log10 ogtt fasting plasma insulin (mu/l): 1.399673721
ogtt 30 min plasma insulin (mu/l): 2.090963077
ogtt 120 min plasma insulin (mu/l): 2.268811904
log10 ogtt fasting plasma proinsulin (pm/l): 1.641474111
ogtt 30 min plasma proinsulin (pm/l): 1.868644438
ogtt 120 min plasma proinsulin (pm/l): 1.957128198
log10 ldl cholesterol (mmol/l): 0.579783597
log10 hdl cholesterol (mmol/l): 0.021189299
log10 total triglycerides (mmol/l): 0.294466226
log10 urinary albumin excretion rate (ug/min): 0.81957659
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.199113459
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.749756497
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.65
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.913637428
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.111699278
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 3.931508722
log10 matsuda insulin sensitivity index: 0.921968465
lg10 serum c-reactive protein (mg/l): -0.322393047
lg10 plasma adiponectin (mg/l): 1.149219113
log10 il1 receptor antagonist (pg/ml): 2.261691003
ogtt 30 min plasma proinsulin (pm/l): 1.238046103
ogtt 120 min plasma proinsulin (pm/l): 1.45331834
log10 serum alanine aminotransfrase (u/l): 1.77815125
log10 total cholesterol (mmol/l): 0.757396029
log10 hdl cholesterol (mmol/l): 0.328379603
log10 urinary albumin excretion rate (ug/min): 0.910038847
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.309001269
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.899795349
plasma free fatty acids under the curve ogtt (mmol/l * min): 35.7
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 252
log10 homair (insulin resistance index based on homa): 0.421603927
log10 homais (insulin secretion index based on homa): 1.898725182
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.342343711
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.172252552
log10 matsuda insulin sensitivity index: 0.722590609
lg10 serum c-reactive protein (mg/l): 0.670060217
ogtt fasting plasma free fatty acid (mmol/l): 0.61
ogtt 30 min plasma free fatty acid (mmol/l): 0.36
log10 il1 receptor antagonist (pg/ml): 2.294686624
ogtt 120 min plasma insulin (mu/l): 1.40654018
log10 ogtt fasting plasma proinsulin (pm/l): 1.303196057
ogtt 30 min plasma proinsulin (pm/l): 1.46834733
ogtt 120 min plasma proinsulin (pm/l): 1.625312451
log10 serum alanine aminotransfrase (u/l): 1.633468456
log10 ldl cholesterol (mmol/l): 0.565847819
log10 total triglycerides (mmol/l): 0.292256071
log10 urinary albumin excretion rate (ug/min): 1.159401226
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.452953858
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.901550678
log10 homair (insulin resistance index based on homa): 0.03145335
log10 homais (insulin secretion index based on homa): 1.533602611
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.595220567
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.561375714
log10 matsuda insulin sensitivity index: 0.83435416
lg10 plasma adiponectin (mg/l): 1.008600172
log10 il1 receptor antagonist (pg/ml): 2.256693698
log10 ogtt fasting plasma insulin (mu/l): 0.612783857
ogtt 30 min plasma insulin (mu/l): 1.980457892
ogtt 120 min plasma insulin (mu/l): 1.230448921
ogtt 30 min plasma proinsulin (pm/l): 1.459392488
ogtt 120 min plasma proinsulin (pm/l): 1.376576957
log10 ldl cholesterol (mmol/l): 0.460897843
log10 total triglycerides (mmol/l): -0.292429824
log10 urinary albumin excretion rate (ug/min): 1.365487985
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.966982949
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.115713435
log10 homair (insulin resistance index based on homa): 0.335524762
log10 homais (insulin secretion index based on homa): 1.863581446
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.664190526
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.603187692
log10 matsuda insulin sensitivity index: 0.642786189
lg10 serum c-reactive protein (mg/l): 0.207365037
log10 il1 receptor antagonist (pg/ml): 2.140036411
log10 ogtt fasting plasma insulin (mu/l): 0.924279286
ogtt 30 min plasma insulin (mu/l): 1.98811284
ogtt 120 min plasma insulin (mu/l): 1.584331224
log10 ogtt fasting plasma proinsulin (pm/l): 1.488550717
ogtt 30 min plasma proinsulin (pm/l): 1.761927838
ogtt 120 min plasma proinsulin (pm/l): 1.873320602
log10 ldl cholesterol (mmol/l): 0.487138375
log10 hdl cholesterol (mmol/l): 0.26245109
log10 urinary albumin excretion rate (ug/min): 0.86232778
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.375208909
plasma free fatty acids under the curve ogtt (mmol/l * min): 32.7
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.902375114
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 225
log10 homair (insulin resistance index based on homa): 0.560252115
log10 homais (insulin secretion index based on homa): 2.013161446
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.658736206
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.555433042
log10 matsuda insulin sensitivity index: 0.506696474
lg10 serum c-reactive protein (mg/l): 0.472756449
lg10 plasma adiponectin (mg/l): 0.602059991
log10 il1 receptor antagonist (pg/ml): 2.246818521
ogtt 30 min plasma insulin (mu/l): 1.933993164
ogtt 30 min plasma proinsulin (pm/l): 1.681241237
ogtt 120 min plasma proinsulin (pm/l): 1.847572659
log10 serum bilirubin (umol/l): 1.51851394
log10 total cholesterol (mmol/l): 0.831869774
log10 ldl cholesterol (mmol/l): 0.663700925
log10 total triglycerides (mmol/l): 0.359835482
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.685091663
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 270
log10 homair (insulin resistance index based on homa): -0.318356824
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.222586423
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.177218959
log10 matsuda insulin sensitivity index: 1.18991955
lg10 plasma adiponectin (mg/l): 0.913813852
log10 il1 receptor antagonist (pg/ml): 2.114544267
log10 ogtt fasting plasma insulin (mu/l): 0.361727836
ogtt 30 min plasma insulin (mu/l): 1.320146286
ogtt 120 min plasma insulin (mu/l): 1.521138084
log10 ogtt fasting plasma proinsulin (pm/l): 0.875061263
ogtt 30 min plasma proinsulin (pm/l): 1.340444115
ogtt 120 min plasma proinsulin (pm/l): 1.889861721
log10 total cholesterol (mmol/l): 0.893206753
log10 ldl cholesterol (mmol/l): 0.701567985
log10 hdl cholesterol (mmol/l): 0.285557309
log10 total triglycerides (mmol/l): 0.195899652
log10 urinary albumin excretion rate (ug/min): 0.927284796
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.607753084
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.080684217
log10 homair (insulin resistance index based on homa): 0.159433502
log10 homais (insulin secretion index based on homa): 1.687490187
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.679091597
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.640789409
log10 matsuda insulin sensitivity index: 0.756057086
lg10 serum c-reactive protein (mg/l): 0.525951341
log10 il1 receptor antagonist (pg/ml): 2.088419617
ogtt 30 min plasma insulin (mu/l): 2.109915863
ogtt 120 min plasma insulin (mu/l): 0.51851394
log10 ogtt fasting plasma proinsulin (pm/l): 1.133538908
ogtt 30 min plasma proinsulin (pm/l): 1.788168371
ogtt 120 min plasma proinsulin (pm/l): 1.340444115
log10 total cholesterol (mmol/l): 0.852479994
log10 ldl cholesterol (mmol/l): 0.709269961
log10 hdl cholesterol (mmol/l): 0.1430148
log10 urinary albumin excretion rate (ug/min): 1.012234457
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.542995253
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.642833338
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.863411959
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 223.5
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.461018046
log10 matsuda insulin sensitivity index: 0.83759594
log10 il1 receptor antagonist (pg/ml): 2.042142183
ogtt 30 min plasma insulin (mu/l): 1.911690159
ogtt 120 min plasma insulin (mu/l): 0.986771734
log10 ogtt fasting plasma proinsulin (pm/l): 0.968482949
ogtt 30 min plasma proinsulin (pm/l): 1.580924976
log10 total cholesterol (mmol/l): 0.742725131
log10 ldl cholesterol (mmol/l): 0.42975228
log10 hdl cholesterol (mmol/l): 0.397940009
log10 urinary albumin excretion rate (ug/min): 0.84226875
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.425950451
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.96823083
log10 homair (insulin resistance index based on homa): 0.334453751
log10 homais (insulin secretion index based on homa): 1.811575006
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.615960567
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.549848944
log10 matsuda insulin sensitivity index: 0.635510293
lg10 serum c-reactive protein (mg/l): 0.290257269
log10 il1 receptor antagonist (pg/ml): 2.352568386
ogtt 30 min plasma insulin (mu/l): 1.824776462
ogtt 120 min plasma insulin (mu/l): 1.786751422
log10 ogtt fasting plasma proinsulin (pm/l): 1.301029996
ogtt 30 min plasma proinsulin (pm/l): 1.480006943
log10 ldl cholesterol (mmol/l): 0.625312451
log10 total triglycerides (mmol/l): 0.136720567
log10 urinary albumin excretion rate (ug/min): 1.045583738
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.382194157
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.713048473
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 1.5
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.626617488
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.551828011
log10 matsuda insulin sensitivity index: 0.702016197
log10 il1 receptor antagonist (pg/ml): 2.130333768
ogtt 30 min plasma insulin (mu/l): 2.026941628
ogtt 120 min plasma insulin (mu/l): 1.071882007
ogtt 30 min plasma proinsulin (pm/l): 1.669316881
log10 total cholesterol (mmol/l): 0.725094521
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.696284635
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.604518427
plasma free fatty acids under the curve ogtt (mmol/l * min): 8.1
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.0175044
log10 homair (insulin resistance index based on homa): 0.329962558
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.524084409
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.448675408
log10 matsuda insulin sensitivity index: 0.655282359
lg10 serum c-reactive protein (mg/l): 0.004321374
lg10 plasma adiponectin (mg/l): 1.064457989
log10 il1 receptor antagonist (pg/ml): 1.976670881
ogtt 30 min plasma insulin (mu/l): 1.519827994
ogtt 120 min plasma insulin (mu/l): 1.8876173
ogtt 30 min plasma proinsulin (pm/l): 1.416640507
ogtt 120 min plasma proinsulin (pm/l): 1.895422546
log10 urinary albumin excretion rate (ug/min): 1.491361694
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.141913953
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.344412393
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.970824901
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.621228228
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.573022534
log10 matsuda insulin sensitivity index: 0.677050564
lg10 serum c-reactive protein (mg/l): -0.102372909
log10 il1 receptor antagonist (pg/ml): 2.281078841
ogtt 30 min plasma insulin (mu/l): 1.835056102
ogtt 120 min plasma insulin (mu/l): 1.789580712
ogtt 30 min plasma proinsulin (pm/l): 1.673941999
ogtt 120 min plasma proinsulin (pm/l): 1.897627091
log10 total cholesterol (mmol/l): 0.793790385
log10 ldl cholesterol (mmol/l): 0.609594409
log10 urinary albumin excretion rate (ug/min): 0.928395852
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.420219358
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.565064702
plasma free fatty acids under the curve ogtt (mmol/l * min): 17.7
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.10656294
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 394.5
log10 homair (insulin resistance index based on homa): 0.734639839
log10 homais (insulin secretion index based on homa): 2.236789099
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.923285477
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.838244434
log10 matsuda insulin sensitivity index: 0.251851391
lg10 serum c-reactive protein (mg/l): 0.922725458
log10 il1 receptor antagonist (pg/ml): 2.390493527
log10 ogtt fasting plasma insulin (mu/l): 1.315970345
ogtt 30 min plasma insulin (mu/l): 2.054613055
ogtt 120 min plasma insulin (mu/l): 2.182699903
log10 ogtt fasting plasma proinsulin (pm/l): 1.418301291
ogtt 30 min plasma proinsulin (pm/l): 1.598790507
ogtt 120 min plasma proinsulin (pm/l): 1.883093359
log10 total cholesterol (mmol/l): 0.685741739
log10 ldl cholesterol (mmol/l): 0.469822016
log10 hdl cholesterol (mmol/l): 0.008600172
log10 total triglycerides (mmol/l): 0.285557309
log10 urinary albumin excretion rate (ug/min): 1.124282703
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.381044137
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.333436702
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.87958325
log10 homair (insulin resistance index based on homa): 0.188397198
log10 homais (insulin secretion index based on homa): 1.77120239
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.431797842
log10 matsuda insulin sensitivity index: 0.769064012
lg10 serum c-reactive protein (mg/l): 0.212187604
log10 il1 receptor antagonist (pg/ml): 2.595628474
ogtt 30 min plasma insulin (mu/l): 1.63748973
ogtt 120 min plasma insulin (mu/l): 1.753583059
log10 ogtt fasting plasma proinsulin (pm/l): 1.238046103
ogtt 120 min plasma proinsulin (pm/l): 1.911690159
log10 serum alanine aminotransfrase (u/l): 2.071882007
log10 total cholesterol (mmol/l): 0.800717078
log10 ldl cholesterol (mmol/l): 0.612783857
log10 urinary albumin excretion rate (ug/min): 0.755487266
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.767579447
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.937603777
log10 homair (insulin resistance index based on homa): 0.505451467
log10 homais (insulin secretion index based on homa): 2.117271296
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.910314846
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.856789289
log10 matsuda insulin sensitivity index: 0.432215057
lg10 serum c-reactive protein (mg/l): 0.662757832
log10 il1 receptor antagonist (pg/ml): 2.678982471
ogtt 30 min plasma insulin (mu/l): 2.180412633
ogtt 120 min plasma insulin (mu/l): 1.977266212
log10 ogtt fasting plasma proinsulin (pm/l): 1.424881637
ogtt 30 min plasma proinsulin (pm/l): 1.868056362
ogtt 120 min plasma proinsulin (pm/l): 1.91750551
log10 total cholesterol (mmol/l): 0.832508913
log10 hdl cholesterol (mmol/l): -0.075720714
log10 total triglycerides (mmol/l): 0.383815366
log10 urinary albumin excretion rate (ug/min): 0.790759615
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.160711732
plasma free fatty acids under the curve ogtt (mmol/l * min): 16.35
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 172.5
log10 homair (insulin resistance index based on homa): 0.196820744
log10 homais (insulin secretion index based on homa): 1.673941999
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.434393235
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.360612345
log10 matsuda insulin sensitivity index: 0.830887163
lg10 serum c-reactive protein (mg/l): -0.494850022
lg10 plasma adiponectin (mg/l): 1.28780173
log10 il1 receptor antagonist (pg/ml): 2.230295614
ogtt 30 min plasma insulin (mu/l): 1.804139432
ogtt 120 min plasma insulin (mu/l): 1.139879086
log10 ogtt fasting plasma proinsulin (pm/l): 0.77815125
ogtt 30 min plasma proinsulin (pm/l): 1.230448921
ogtt 120 min plasma proinsulin (pm/l): 1.240549248
log10 hdl cholesterol (mmol/l): 0.103803721
log10 urinary albumin excretion rate (ug/min): 1.121145747
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.524492232
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.750072755
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.497851837
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 15
log10 homair (insulin resistance index based on homa): 0.020729485
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.168821463
log10 matsuda insulin sensitivity index: 1.081552736
lg10 serum c-reactive protein (mg/l): -0.37675071
log10 il1 receptor antagonist (pg/ml): 2.296423849
ogtt 30 min plasma insulin (mu/l): 1.522444234
ogtt 120 min plasma insulin (mu/l): 0.949390007
ogtt 120 min plasma proinsulin (pm/l): 1.44870632
log10 total cholesterol (mmol/l): 0.615950052
log10 ldl cholesterol (mmol/l): 0.418301291
log10 hdl cholesterol (mmol/l): 0.127104798
log10 total triglycerides (mmol/l): -0.161150909
log10 urinary albumin excretion rate (ug/min): 0.552574628
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.239936646
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.059702127
plasma free fatty acids under the curve ogtt (mmol/l * min): 32.1
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.818582177
log10 homais (insulin secretion index based on homa): 1.932053683
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.533225352
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.401555618
log10 matsuda insulin sensitivity index: 0.595214804
lg10 serum c-reactive protein (mg/l): 0.681241237
log10 il1 receptor antagonist (pg/ml): 2.980898323
log10 ogtt fasting plasma insulin (mu/l): 1.093421685
ogtt 30 min plasma insulin (mu/l): 1.919601024
ogtt 120 min plasma insulin (mu/l): 1.06069784
log10 ogtt fasting plasma proinsulin (pm/l): 1.315970345
ogtt 30 min plasma proinsulin (pm/l): 1.603144373
log10 serum bilirubin (umol/l): 1.342422681
log10 hdl cholesterol (mmol/l): -0.026872146
log10 total triglycerides (mmol/l): 0.440909082
log10 urinary albumin excretion rate (ug/min): NA
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.501448642
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.437773362
plasma free fatty acids under the curve ogtt (mmol/l * min): 22.35
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 321
log10 homair (insulin resistance index based on homa): 0.323595824
log10 homais (insulin secretion index based on homa): 1.800717078
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.489029868
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.400468911
log10 matsuda insulin sensitivity index: 0.678959223
lg10 serum c-reactive protein (mg/l): 0.071882007
log10 il1 receptor antagonist (pg/ml): 2.435716988
ogtt 30 min plasma insulin (mu/l): 1.56937391
ogtt 120 min plasma insulin (mu/l): 1.7930916
ogtt 120 min plasma proinsulin (pm/l): 1.910624405
log10 total cholesterol (mmol/l): 0.7355989
log10 urinary albumin excretion rate (ug/min): 0.764787289
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50062976688509
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.47079015248221
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.74483383749955
log10 homair (insulin resistance index based on homa): -0.500898235252165
log10 homais (insulin secretion index based on homa): 1.52287874523691
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.5520085915843
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.4160717760782
log10 matsuda insulin sensitivity index: 0.534404469414011
lg10 serum c-reactive protein (mg/l): NA
log10 il1 receptor antagonist (pg/ml): NA
log10 ogtt fasting plasma insulin (mu/l): 0.477121254719662
ogtt 30 min plasma insulin (mu/l): 1.63144376901317
ogtt 120 min plasma insulin (mu/l): 1.48995847942483
log10 ogtt fasting plasma proinsulin (pm/l): NA
ogtt 30 min plasma proinsulin (pm/l): NA
ogtt 120 min plasma proinsulin (pm/l): NA
log10 serum bilirubin (umol/l): 1.04139268515822
log10 serum alanine aminotransfrase (u/l): 1.43136376415899
log10 total cholesterol (mmol/l): 0.751279103983342
log10 total triglycerides (mmol/l): -0.0132282657337552
log10 urinary albumin excretion rate (ug/min): 0.949742008220188
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.263886322
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 5.997708097
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 142.5
log10 homair (insulin resistance index based on homa): -0.045114567
log10 homais (insulin secretion index based on homa): 1.661645681
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.232538718
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.154545692
log10 matsuda insulin sensitivity index: 1.085902215
lg10 plasma adiponectin (mg/l): 1.037426498
ogtt 120 min plasma glucose (mmol/l): 2.9
log10 il1 receptor antagonist (pg/ml): 2.080193419
ogtt 30 min plasma proinsulin (pm/l): 1.503790683
ogtt 120 min plasma proinsulin (pm/l): 1.613841822
log10 total cholesterol (mmol/l): 0.777426822
log10 ldl cholesterol (mmol/l): 0.571708832
log10 total triglycerides (mmol/l): 0.146128036
log10 urinary albumin excretion rate (ug/min): 1.329163104
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.661568137
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.781389161
log10 homair (insulin resistance index based on homa): 0.127248819
log10 homais (insulin secretion index based on homa): 1.655305503
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.502263204
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.447839958
log10 matsuda insulin sensitivity index: 0.830764204
lg10 serum c-reactive protein (mg/l): 0.133538908
lg10 plasma adiponectin (mg/l): 1.225309282
ogtt fasting plasma free fatty acid (mmol/l): 0.11
log10 il1 receptor antagonist (pg/ml): 2.209515015
log10 ogtt fasting plasma insulin (mu/l): 0.716003344
ogtt 30 min plasma insulin (mu/l): 1.815577748
ogtt 120 min plasma insulin (mu/l): 1.459392488
ogtt 30 min plasma proinsulin (pm/l): 1.285557309
ogtt 120 min plasma proinsulin (pm/l): 1.457881897
log10 total cholesterol (mmol/l): 0.643452676
log10 ldl cholesterol (mmol/l): 0.372912003
log10 urinary albumin excretion rate (ug/min): 0.943331206
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.408547286
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.356931614
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.911391988
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 291
log10 homair (insulin resistance index based on homa): -0.141596493
log10 homais (insulin secretion index based on homa): 1.441208699
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.218115186
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.159446873
log10 matsuda insulin sensitivity index: 1.067256369
lg10 serum c-reactive protein (mg/l): -0.468521083
log10 il1 receptor antagonist (pg/ml): 2.112806017
ogtt 30 min plasma insulin (mu/l): 1.243038049
ogtt 120 min plasma proinsulin (pm/l): 1.767897616
log10 total cholesterol (mmol/l): 0.79518459
log10 ldl cholesterol (mmol/l): 0.600972896
log10 urinary albumin excretion rate (ug/min): 1.000876478
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.824074583
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.066533729
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.813781191
log10 homair (insulin resistance index based on homa): -0.00154691
log10 homais (insulin secretion index based on homa): 1.500602351
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.125090713
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.0253878
log10 matsuda insulin sensitivity index: 1.073796653
lg10 serum c-reactive protein (mg/l): -0.48148606
lg10 plasma adiponectin (mg/l): 1.136720567
log10 il1 receptor antagonist (pg/ml): 2.201096565
ogtt 30 min plasma insulin (mu/l): 1.474216264
ogtt 120 min plasma insulin (mu/l): 0.924279286
ogtt 30 min plasma proinsulin (pm/l): 1.605305046
ogtt 120 min plasma proinsulin (pm/l): 1.596597096
log10 total cholesterol (mmol/l): 0.72916479
log10 urinary albumin excretion rate (ug/min): 1.124938736
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.361796869
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.640702401
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 151.5
log10 homair (insulin resistance index based on homa): 0.3680595
log10 homais (insulin secretion index based on homa): 1.870208761
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.603772075
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.528273777
log10 matsuda insulin sensitivity index: 0.647879221
lg10 serum c-reactive protein (mg/l): -0.031517051
lg10 plasma adiponectin (mg/l): 1.173186268
log10 il1 receptor antagonist (pg/ml): 2.273695588
ogtt 30 min plasma insulin (mu/l): 1.858537198
ogtt 120 min plasma insulin (mu/l): 1.694605199
ogtt 30 min plasma proinsulin (pm/l): 1.565847819
ogtt 120 min plasma proinsulin (pm/l): 1.745074792
log10 serum alanine aminotransfrase (u/l): 1.755874856
log10 total cholesterol (mmol/l): 0.874481818
log10 ldl cholesterol (mmol/l): 0.716003344
log10 total triglycerides (mmol/l): 0.387389826
log10 urinary albumin excretion rate (ug/min): 1.167136416
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.69162975
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.741064217
plasma free fatty acids under the curve ogtt (mmol/l * min): 9.15
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -1.5
log10 homair (insulin resistance index based on homa): 0.117639498
log10 homais (insulin secretion index based on homa): 1.619788758
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.2974541
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.210479043
log10 matsuda insulin sensitivity index: 0.96744496
lg10 serum c-reactive protein (mg/l): -0.124938737
lg10 plasma adiponectin (mg/l): 0.86332286
ogtt 30 min plasma glucose (mmol/l): 7.3
log10 il1 receptor antagonist (pg/ml): 2.145600358
ogtt 30 min plasma insulin (mu/l): 1.597695186
ogtt 120 min plasma insulin (mu/l): 1.278753601
log10 ogtt fasting plasma proinsulin (pm/l): 1.021189299
ogtt 30 min plasma proinsulin (pm/l): 1.413299764
ogtt 120 min plasma proinsulin (pm/l): 1.523746467
log10 total cholesterol (mmol/l): 0.769377326
log10 hdl cholesterol (mmol/l): 0.324282455
log10 urinary albumin excretion rate (ug/min): 0.920818754
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.92540635
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 7.124992201
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 10.04644195
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 421.5
log10 homair (insulin resistance index based on homa): 0.178273325
log10 homais (insulin secretion index based on homa): 1.851937465
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.364344586
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.267898856
log10 matsuda insulin sensitivity index: 0.829071452
lg10 serum c-reactive protein (mg/l): 0.033423755
ogtt fasting plasma free fatty acid (mmol/l): 0.76
ogtt 30 min plasma free fatty acid (mmol/l): 0.49
log10 il1 receptor antagonist (pg/ml): 2.465888243
log10 ogtt fasting plasma insulin (mu/l): 0.806179974
ogtt 30 min plasma insulin (mu/l): 1.63447727
ogtt 120 min plasma insulin (mu/l): 1.416640507
ogtt 30 min plasma proinsulin (pm/l): 1.369215857
ogtt 120 min plasma proinsulin (pm/l): 1.713490543
log10 serum alanine aminotransfrase (u/l): 1.748188027
log10 hdl cholesterol (mmol/l): 0.387389826
log10 urinary albumin excretion rate (ug/min): 1.412536907
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.090305286
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.447204097
plasma free fatty acids under the curve ogtt (mmol/l * min): 30.3
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.830515207
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 178.5
log10 homair (insulin resistance index based on homa): 0.26565623
log10 homais (insulin secretion index based on homa): 1.71856556
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.647177512
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.596410144
log10 matsuda insulin sensitivity index: 0.676142101
lg10 serum c-reactive protein (mg/l): 0.687528961
log10 il1 receptor antagonist (pg/ml): 2.415891078
ogtt 30 min plasma insulin (mu/l): 1.961421094
ogtt 120 min plasma insulin (mu/l): 1.603144373
log10 ogtt fasting plasma proinsulin (pm/l): 1.260071388
ogtt 30 min plasma proinsulin (pm/l): 1.640481437
ogtt 120 min plasma proinsulin (pm/l): 1.92992956
log10 total triglycerides (mmol/l): 0.103803721
log10 urinary albumin excretion rate (ug/min): 0.913979329
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.29129487
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.063351044
plasma free fatty acids under the curve ogtt (mmol/l * min): 16.05
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.47370575
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): -57
log10 homair (insulin resistance index based on homa): 0.087465911
log10 homais (insulin secretion index based on homa): 1.472100453
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.317666442
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.247605064
log10 matsuda insulin sensitivity index: 0.962807002
log10 il1 receptor antagonist (pg/ml): 1.920018916
ogtt 120 min plasma insulin (mu/l): 1.404833717
ogtt 30 min plasma proinsulin (pm/l): 1.298853076
ogtt 120 min plasma proinsulin (pm/l): 1.558708571
log10 total cholesterol (mmol/l): 0.673941999
log10 ldl cholesterol (mmol/l): 0.485721426
log10 urinary albumin excretion rate (ug/min): 0.717519207
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.352348725
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.546157171
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.640244936
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 126
log10 homair (insulin resistance index based on homa): -0.04769199
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.459663837
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.418732057
log10 matsuda insulin sensitivity index: 0.954161986
lg10 serum c-reactive protein (mg/l): 1.671635597
log10 il1 receptor antagonist (pg/ml): 2.253434935
log10 serum alanine aminotransfrase (u/l): 1.643452676
log10 total cholesterol (mmol/l): 0.831229694
log10 ldl cholesterol (mmol/l): 0.668385917
log10 urinary albumin excretion rate (ug/min): 0.794598101
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.50833036
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.562124232
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.656424863
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 159
log10 homair (insulin resistance index based on homa): 0.165541077
log10 homais (insulin secretion index based on homa): 1.80760623
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.452139252
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.378960847
log10 matsuda insulin sensitivity index: 0.851154631
lg10 plasma adiponectin (mg/l): 1.184691431
log10 il1 receptor antagonist (pg/ml): 1.988380565
ogtt 30 min plasma insulin (mu/l): 1.766412847
ogtt 120 min plasma insulin (mu/l): 1.397940009
ogtt 120 min plasma proinsulin (pm/l): 1.401400541
log10 serum bilirubin (umol/l): 1.414973348
log10 hdl cholesterol (mmol/l): 0.436162647
log10 urinary albumin excretion rate (ug/min): 0.688658402
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.516464277
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.982376966
plasma free fatty acids under the curve ogtt (mmol/l * min): 19.2
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.987974524
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 91.5
log10 homair (insulin resistance index based on homa): 0.965671971
log10 homais (insulin secretion index based on homa): 2.109144469
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.792398694
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.629011823
log10 matsuda insulin sensitivity index: 0.207130077
lg10 serum c-reactive protein (mg/l): 0.305351369
ogtt fasting plasma glucose (mmol/l): 7.7
log10 il1 receptor antagonist (pg/ml): 2.514786748
log10 ogtt fasting plasma insulin (mu/l): 1.431363764
ogtt 30 min plasma insulin (mu/l): 2.020361283
ogtt 120 min plasma insulin (mu/l): 1.907948522
log10 ogtt fasting plasma proinsulin (pm/l): 1.465382851
ogtt 120 min plasma proinsulin (pm/l): 1.790285164
log10 serum alanine aminotransfrase (u/l): 1.792391689
log10 urinary albumin excretion rate (ug/min): 1.402718583
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.729115454
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.625796971
log10 homair (insulin resistance index based on homa): 0.058763341
log10 homais (insulin secretion index based on homa): 1.641568533
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.406335758
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.345883213
log10 matsuda insulin sensitivity index: 0.894695546
lg10 serum c-reactive protein (mg/l): -0.537602002
log10 il1 receptor antagonist (pg/ml): 2.244722323
ogtt 120 min plasma insulin (mu/l): 1.544068044
ogtt 120 min plasma proinsulin (pm/l): 1.743509765
log10 total cholesterol (mmol/l): 0.618048097
log10 total triglycerides (mmol/l): 0.008600172
log10 urinary albumin excretion rate (ug/min): 1.068715812
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.457694434
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.505502737
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 108
log10 homair (insulin resistance index based on homa): -0.061702705
log10 homais (insulin secretion index based on homa): 1.391206626
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.20588073
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.138649995
log10 matsuda insulin sensitivity index: 1.059985451
lg10 serum c-reactive protein (mg/l): -0.086186148
lg10 plasma adiponectin (mg/l): 1.089905111
log10 il1 receptor antagonist (pg/ml): 2.03762567
ogtt 30 min plasma insulin (mu/l): 1.311753861
ogtt 120 min plasma insulin (mu/l): 1.492760389
ogtt 30 min plasma proinsulin (pm/l): 1.209515015
ogtt 120 min plasma proinsulin (pm/l): 1.725094521
log10 hdl cholesterol (mmol/l): 0.411619706
log10 urinary albumin excretion rate (ug/min): 0.854484654
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.197906938
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.474299238
plasma free fatty acids under the curve ogtt (mmol/l * min): 11.4
log10 homair (insulin resistance index based on homa): 0.260071388
log10 homais (insulin secretion index based on homa): 1.666785321
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.331548761
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.224688417
log10 matsuda insulin sensitivity index: 0.831199215
lg10 serum c-reactive protein (mg/l): 0.376576957
log10 il1 receptor antagonist (pg/ml): 2.190835748
ogtt 120 min plasma insulin (mu/l): 1.11058971
log10 ldl cholesterol (mmol/l): 0.517195898
log10 hdl cholesterol (mmol/l): 0.201397124
log10 urinary albumin excretion rate (ug/min): 0.707570176
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.932673993
plasma free fatty acids under the curve ogtt (mmol/l * min): 37.95
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 534
log10 homair (insulin resistance index based on homa): 0.669874502
log10 homais (insulin secretion index based on homa): 2.076588435
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.854882693
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.775034891
log10 matsuda insulin sensitivity index: 0.291652646
lg10 serum c-reactive protein (mg/l): 0.77524626
ogtt 30 min plasma free fatty acid (mmol/l): 0.42
ogtt 30 min plasma glucose (mmol/l): 12.2
log10 il1 receptor antagonist (pg/ml): 2.48248769
ogtt 30 min plasma insulin (mu/l): 2.045322979
ogtt 120 min plasma insulin (mu/l): 2.047664195
log10 ogtt fasting plasma proinsulin (pm/l): 1.571708832
ogtt 30 min plasma proinsulin (pm/l): 1.996949248
ogtt 120 min plasma proinsulin (pm/l): 2.253338005
log10 hdl cholesterol (mmol/l): -0.045757491
log10 total triglycerides (mmol/l): 0.781036939
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.345195522
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.556232233
plasma free fatty acids under the curve ogtt (mmol/l * min): 27.3
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 249
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.384640101
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.346939463
log10 matsuda insulin sensitivity index: 1.042419386
log10 il1 receptor antagonist (pg/ml): 2.29307514
ogtt 30 min plasma insulin (mu/l): 1.655138435
ogtt 120 min plasma insulin (mu/l): 1.456366033
log10 ogtt fasting plasma proinsulin (pm/l): 0.897627091
ogtt 120 min plasma proinsulin (pm/l): 1.593286067
log10 ldl cholesterol (mmol/l): 0.655138435
log10 urinary albumin excretion rate (ug/min): 0.745699227
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.611891944
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.649892647
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.938109326
log10 homair (insulin resistance index based on homa): 0.179551791
log10 homais (insulin secretion index based on homa): 1.586265724
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.455986239
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.392468317
log10 matsuda insulin sensitivity index: 0.79182238
lg10 serum c-reactive protein (mg/l): -0.142667504
log10 il1 receptor antagonist (pg/ml): 2.272445019
ogtt 120 min plasma insulin (mu/l): 1.583198774
log10 ogtt fasting plasma proinsulin (pm/l): 0.73239376
ogtt 120 min plasma proinsulin (pm/l): 1.568201724
log10 ldl cholesterol (mmol/l): 0.437750563
log10 total triglycerides (mmol/l): -0.045757491
log10 urinary albumin excretion rate (ug/min): 1.166331422
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.75548099
log10 homair (insulin resistance index based on homa): -0.005243055
log10 homais (insulin secretion index based on homa): 1.549671922
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.155912689
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.061113054
log10 matsuda insulin sensitivity index: 1.061962987
lg10 serum c-reactive protein (mg/l): -0.522878745
lg10 plasma adiponectin (mg/l): 0.977723605
log10 il1 receptor antagonist (pg/ml): 2.124699809
ogtt 30 min plasma insulin (mu/l): 1.478566496
ogtt 120 min plasma insulin (mu/l): 1.064457989
log10 ogtt fasting plasma proinsulin (pm/l): 1.212187604
ogtt 120 min plasma proinsulin (pm/l): 1.617000341
log10 serum bilirubin (umol/l): 1.531478917
log10 total cholesterol (mmol/l): 0.737192643
log10 ldl cholesterol (mmol/l): 0.499687083
log10 hdl cholesterol (mmol/l): 0.330413773
log10 urinary albumin excretion rate (ug/min): 0.62291013
log2 estimated glomerular filtration rate using modification of diet in renal disease (egfr_mdrd): 6.187847951
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.299460806
log10 homair (insulin resistance index based on homa): -0.305687354
log10 homais (insulin secretion index based on homa): 1.367976785
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.352529815
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.322343361
log10 matsuda insulin sensitivity index: 1.108767833
lg10 serum c-reactive protein (mg/l): 0.045322979
lg10 plasma adiponectin (mg/l): 0.929418926
log10 il1 receptor antagonist (pg/ml): 2.402089351
log10 ogtt fasting plasma insulin (mu/l): 0.322219295
ogtt 30 min plasma insulin (mu/l): 1.421603927
ogtt 120 min plasma insulin (mu/l): 1.67669361
ogtt 30 min plasma proinsulin (pm/l): 1.316180099
ogtt 120 min plasma proinsulin (pm/l): 1.981818607
log10 total cholesterol (mmol/l): 0.86569606
log10 urinary albumin excretion rate (ug/min): 0.749187554
log10 estimated creatinine clearance rate using cockfcrot-gault formulaa (egcr): 6.329022795
plasma free fatty acids under the curve ogtt (mmol/l * min): 28.5
log10 plasma glucose area under the curve (ogtt) (mmol/l * min): 9.787086325
plasma glucose area under the curve above basal (ogtt) (mmol/l * min): 235.5
log10 insulin area under the curve (ogtt) (pmol/l * min): 4.882330969
log10 insulin area under the curve above basal (ogtt) (pmol/l * min): 4.856571815
log10 matsuda insulin sensitivity index: 0.618762803
lg10 serum c-reactive protein (mg/l): 0.049218023
log10 il1 receptor antagonist (pg/ml): 2.297235102
ogtt 30 min plasma insulin (mu/l): 2.129689892
ogtt 120 min plasma insulin (mu/l): 2.003029471
log10 ogtt fasting plasma proinsulin (pm/l): 1.224014811
ogtt 30 min plasma proinsulin (pm/l): 1.83305782
ogtt 120 min plasma proinsulin (pm/l): 1.923244019
log10 serum alanine aminotransfrase (u/l): 1.653212514
log10 total cholesterol (mmol/l): 0.784617293
log10 ldl cholesterol (mmol/l): 0.541579244
log10 total triglycerides (mmol/l): 0.255272505
tissue: human metastatic pleural effusion
cell line: MDA-MB-231; Human breast carcinoma cell line
tissue: in vivo selected lung metastasic sub-line
cell line: MDA-LM2; in vivo selected highly metastatic human breast cancer cell line
cell line: CN34; Human breast carcinoma cell line
cell line: CN34 LM1a; in vivo selected highly metastatic human breast cancer cell line
cell type: Induced endothelial cells from cultured foreskin fibroblast cells (Stegment)
cell type: Human Dermal Microvascular Endothelial Cells (Lonza)
cell type: Cultured foreskin fibroblast cells (Stegment)
tissue type: Triple Negative Breast Tumor
treatment: siRNA against SFMBT1 (#1) + LSD1 (#2) + CoREST (#1)
cell line: gastric carcinoma cell line SNU-719
treatment: MBNL1 and MBNL2 SMART-pool siRNAs
antibodies: monoclonal antibody against endogenous human Argonaute1, clone 4B8 (Beitzinger et al., 2007)
antibodies: monoclonal antibody against endogenous human Argonaute2, clone 11A9 (Ruedel et al., 2008)
antibodies: monoclonal antibody against endogenous human Argonaute3, clone 5A3 Weinmann et al., 2009)
antibodies: monoclonal antibody against endogenous human Argonaute4, clone 6C10 (Petri et al., 2011)
antibodies: monoclonal antibody against RmC, rat protein (complement system)
extraction protocol: Soft spin, Unwashed
extraction protocol: Hard spin, Unwashed
extraction protocol: Hard spin, Washed once
extraction protocol: Hard spin, Washed twice
cell type: peripheral blood mononuclear cells (PBMCs)
cell type: Human erythromyeloblastoid leukemia cells
treated with: 300ul of DMS to 15mls of cells
treated with: 400ul of DMS to 15mls of cells
cell type: induced pluripotent stem cell
diagnosis: Bilateral hippocampal sclerosis and Alzheimer changes
diagnosis: Dementia with Lewy bodies (DLB)
monozygotic twin relationship: MZ twin of T22
monozygotic twin relationship: MZ twin of T21
monozygotic twin relationship: MZ twin of T32
monozygotic twin relationship: MZ twin of T31
treatment: treated with 2uM GSK669 for 7 days
treatment: treated with 2uM GSK343 for 7 days
treatment: transduced with anti-EZH2 shRNA #2 for EZH2 for 7 days
treatment: transduced with anti-EZH2 shRNA #3 for EZH2 for 7 days
treatment: transuced with control scrambled shRNA for 7 days
treatment: transduced with control scrambled shRNA for 7 days
purification: Cells purified from normal fresh human tonsillectomy specimens by magnetic bead cell separation based on the expression the phenotypic marker IgD
cell type: Tonsillar Germinal Center B cells
purification: Cells purified from normal fresh human tonsillectomy specimens by magnetic bead cell separation based on the expression the phenotypic marker CD77
cell type: embryonal carcinoma (EC) cells
aso: specific to PWS-associated sno-lncRNAs
tissue: skin (epidermal suction blister samples)
cell type: primary human umbilical vein endothelial cells
infected with: a lentivirus containing human PR
treated with: LPS (1μM) + progesterone (100nM) for 4 hrs
treated with: LPS (1μM) + progesterone (100nM) for 8 hrs
stimulation protocol: GnRH antagonist, rFSH, hCG
cell type: EBV-negative Burkitt's lymphoma cells
ectopic barts: no (empty retroviral vector)
ip antibody: anti-human Ago2 (11A9) antibody
ectopic barts: yes (expressing EBV's BART miRNAs)
disease: patient matched uninvolved colon
disease: normal colon (patient with no polyps)
tissue: colorectal biopsy, colon ascendens
cell type: Primary human epidermal melanocytes (neonatal)
tissue: Wharton's jelly of umbilical cord
stimulated with: none (unstimluated (NS) control)
cell type: human esophageal squamous carcinoma cells
treated with: 50ng/ml of doxycyline for 4 days
cell types: HeLa cells transduced with scrambled shRNA
cell types: HeLa cells transduced with anti-ASCC3 shRNA
disease state: invasive ductal carcinoma
genotype/variation: expressing hypomorphic DNMT1 and lack DNMT3b (HCT116-DKO)
infected with: negative control shRNA-luciferase (shLuc) construct
cell type: CD4+CD25highCD127low/- Treg cells
cell sorted: In vitro expanded FOXP3+ Treg cells
cell sorted: In vitro expanded FOXP3-losing Treg cells
cell type: human mammary epithelial cell
tissue: brain (dorsal prefrontal cortex)
transfected with: siRNA against ADAR1 (ADAR knock down)
transfected with: scrambled siRNA (control)
reference rna: Agilent Universal Human Reference RNA
reference rna: FirstChoice® Human Brain Reference Total RNA
reference rna 2: FirstChoice® Human Brain Reference Total RNA
disease: chronic myelogenous leukemia (CML)
treatment: Transformed to Mesenchymal Phenotype
treatment: Mesenchymal with OVOL1 overexpression
treatment: Mesenchymal with OVOL2 overexpression
transfected with: antisense morpholino to U6atac
transfected with: antisense morpholino to control
sample note: Barcode provided after read name in fastq file
tissue: snap frozen tissue of esophageal adenocarcinoma cells
tissue: snap frozen tissue of normal esophagus
tissue: snap frozen tissue of Barrett’s esophagus
alzheimer's disease stage: early stage (control)
cell type: TICs from the H1703 cell line (PRKCI knock down)
cell type: Adherent/parental cells from the H1703 cell line
cell type: Adherent/parental cells from the H1299 cell line
cell type: TICs from the H1299 cell line
cell type: TICs from the H1299 cell line (PRKCI knock down)
cell type: Adherent/parental cells from the CHAGO cell line
cell type: TICs from the CHAGO cell line
cell type: TICs from the CHAGO cell line (PRKCI knock down)
cell type: Adherent/parental cells from the CALU cell line
cell type: TICs from the CALU cell line (PRKCI knock down)
cell type: TICs from the H1703 cell line
bromouridine labeling start: 15 minutes prior to washout
bromouridine labeling start: Immediately after washout
bromouridine labeling start: 15 minutes after washout
cell type: Cockayne syndrome group B fibroblasts
cell type: Normal prostate epithelial cells (PrEC)
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
viral infection of host cell line: Sindbis virus
viral infection conditions: 16 hpi, MOI 0.01
viral infection of host cell line: non-infected
transfection of host cell line: siRNaseL
cell type: EBV-infected human B lymphoblastoid cell line
source tissue: peripheral blood mononuclear cells
cell type: undifferentiated day 0 hiPS cells
cell type: Day 3 differentiated hiPS-derived mesoderm proginator cells
cell type: Day 12 H9-hES-derived NRP-1+CD31+ cells
cell type: Day 12 hiPS-derived NRP-1+CD31+ cells
cell type: cord blood-derived Endothelial colony forming cells
cell type: human primary dermal fibroblast
library prep protocol: SMART-Seq2 (variant 2)
library prep protocol: SMART-Seq2 (variant 1)
library prep protocol: SMART-Seq2 (variant 3)
library prep protocol: SMART-Seq2 (variant 4)
library prep protocol: standard SMART-Seq
treatment: over-express N-terminal flag-tagged YTHDF2 for 24h (0.75ug plasmid/mL)
treatment: over-express N-terminal flag-tagged YTHDF2 for 24h(0.75ug plasmid/mL)
treatment: 40nM siRNA knock-down for 48h
treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 0h
treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 3h
treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 6h
cell type: aortic valve interstitial cells
sample composition: 10 human cell lines (B lymphocyte, brain, breast, cervix, liposarcoma, liver, macrophage, skin, testis, and T lymphocyte)
cell type: human adrenal adenocarcinoma cells
genotype/variation: Overexpression of murine non-coding RNAs
biomaterial: UHRR -Universal Human Reference RNA (Agilent Technologies, #750700)
biomaterial: HuBr - human brain total RNA (Life Technologies, #AM6050)
biomaterial: Mixture of 25% UHRR and 75% HuBr Total RNA
biomaterial: Mixture of 75% UHRR and 25% HuBr Total RNA
biomaterial: Synthetic miRNA templates miR-302a-3p were spiked into human liver total RNA (Life Technologies, # AM7960) at 5 x 10^6 copies / ug RNA
biomaterial: Synthetic miRNA templates miR-302b-3p were spiked into human liver total RNA (Life Technologies, # AM7960) at 5 x 10^6 copies / ug RNA
biomaterial: Synthetic miRNA templates miR-302c-3p were spiked into human liver total RNA (Life Technologies, # AM7960) at 5 x 10^6 copies / ug RNA
biomaterial: Synthetic miRNA templates miR-302d-3p were spiked into human liver total RNA (Life Technologies, # AM7960) at 5 x 10^6 copies / ug RNA
biomaterial: Synthetic miRNA templates for miR-10a-5p, let-7a-5p, miR-302a-3p and miR-133a were spiked in serum RNA at 6000 copies per ul serum RNA
biomaterial: Synthetic miRNA templates for miR-10a-5p, let-7a-5p, miR-302a-3p and miR-133a were spiked in serum RNA at 30,000 copies, 12,000 copies, 3,000 copies, or 600 copies respectively per ul serum RNA
genotype/variation: Egfp knock out (control)
genotype/variation: Mtr4 knock out (exosome)
source: second trimester amniotic fluid supernatant
cell type: hepatocellular carcinoma cell line
rna selection method: rRNA-depletion (Ribo-zero gold)
rna selection method: polyA selection (included with TruSeq library prep kit)
cell/tissue type: Human malignant melanoma cells
transfected with: non-target shRNA control plasmid DNA
site of primary melanoma: right axillary
treatment (initiation date): TRAMETINIB (03/28/2011)
cell/tissue type: tumor biopsy (FFPE) before treatment
cell/tissue type: tumor biopsy (FFPE) after treatment
treatment (initiation date): Dabrafenib (07/29/2011)
treatment (initiation date): Vemurafenib (03-13-2012)
disease state: diffuse large B cell lymphoma (DLBCL)
tissue: normal-looking surrounding colonic epithelium
tissue: metastatic colorectal cancer to the liver
pre- or post-challenge: Unchallenged control
library construction method: Nextera (transposon)
cdna synthesis method: Sigma WTA TransPlex
library construction method: NEBNext (ligation)
transfection: lentivirus carrying control shRNA
transfection: lentivirus carrying BS69-1 shRNA
transfection: lentivirus carrying BS69-2 shRNA
tumor type: primary cutaneous diffuse large B-cell lymphoma, leg type
tumor type: primary cutaneous follicle center lymphoma
cell type: immortalized oral keratinocytes
cell type: tongue squamous cell carcinoma
antibody vendor: Bethyl Laboratories Inc.
disease course: 10 months at time of biopsy
drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO
disease course: 6 years at time of biopsy
disease course: 2.5 years at time of biopsy
disease course: 2 years at time of biopsy
genotype: C9orf72 Intron 1 Hexanucleotide Expansion
disease course: 4 years at time of biopsy
drug treatment: Transfection Control - Cells were treated with a control ASO which does not have any human genomic target.
diagnosis: Sporadic ALS (C9orf72 expansion)
disease course: 1 year at time of biopsy
drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.
disease course: 14 years at time of biopsy
cell line: stable adriamycin-resistant  cell line  variant (K562/ADM)
motor_score [higher score indicates greater disease severity]: 0
hb_percentage [a proxy for the reticulocyte content of each sample measured as the ratio of hemoglobin tags versus total aligned tags per sample (0-100%)]: 41.44
cell type: human coronary artery smooth muscle cells (HCASMCs)
treatment: Short interfering RNA against the AHR
clip antibody: anti-Ago2 polyclonal antibody
expression: p181a#1( clone 1 expressing miR-181a)
tumor histology: ovarian cancer cell line derived from an undifferentiated ovarian tumor
expression: p181a#2( clone 2 expressing miR-181a)
cell type: pluripotent human embryonic stem cells (hESCs)
infectious agent: Plasmodium falciparum (Pf)
cell type: iPSC derived motor neuron culture
tissue source: laser micro-dissected archival FFPE tissue specimens
tissue type: non-invasive adenocarcinoma in situ (ais)
tissue type: invasive lung carcinoma (inv)
tissue type: surrounding normal lung (nor)
cell type: induced pluripotent stem cells
cell type: iPSC-derived midbrain dopamine (mDA) neurons
demographic group: Admixed or American ancestry
experimental condition: Mock-Infected / W12 HeLa cells / 0 hpa
experimental condition: Mock-Infected / W12 HeLa cells / 8 hpa
experimental condition: Polio-Infected / W12 HeLa cells / 0 hpa
experimental condition: Polio-Infected / W12 HeLa cells / 4 hpa
experimental condition: Polio-Infected / W12 HeLa cells / 2 hpa
experimental condition: Polio-Infected / W12 HeLa cells / 6 hpa
experimental condition: Polio-Infected / W12 HeLa cells / 8 hpa
strain: M25 HeLa / dominant-negative mutant RNase L
experimental condition: Mock-Infected / M25 HeLa cells / 0 hpa
experimental condition: Mock-Infected / M25 HeLa cells / 8 hpa
experimental condition: Polio-Infected / M25 HeLa cells / 0 hpa
experimental condition: Polio-Infected / M25 HeLa cells / 2 hpa
experimental condition: Polio-Infected / M25 HeLa cells / 4 hpa
experimental condition: Polio-Infected / M25 HeLa cells / 6 hpa
experimental condition: Polio-Infected / M25 HeLa cells / 8 hpa
cell type: An Epstein-Barr virus (EBV)-producer line
protein expressed: Flag-Stau1-WT (65KDa Isoform)
protein expressed: Flag-Stau1-Mutant (65KDa Isoform)
protein expressed: Flag-Stau2-WT (65KDa Isoform)
protein expressed: Flag-Stau2-Mutant (65KDa Isoform)
molecule subtype: Cytoplasmic Poly(A) RNA
molecule subtype: Ribosome footprint mRNA
cell type: Human Skeletal Muscle Myoblasts (HSMM)
hits-clip antibody: Argonaute antibody 2A8 (Zissimos Mourelatos lab)
hits-clip antibody: Argonaute antibody 2A9 (Zissimos Mourelatos lab)
cell type: hESC derived anterior primitive streak (APS)
cell type: hESC derived definitive endoderm cells
cell type: hESC derived anterior foregut (AFG)
cell type: hESC derived anterior foregut (PFG)
cell type: hESC derived anterior foregut (MHG)
tissue group: overt GIST (Gastrointestinal stromal tumor)
tissue group: mini GIST (Gastrointestinal stromal tumor)
genotype/variation: expressing control shRNA; wild type
genotype/variation: expressing shRNA DAZAP1 (plKO.1); DAZAP1 knockdown
tissue: human airway smooth muscle cells
splicing factor targeted (ensembl id): ENSG00000011304
percentage knockdown (qpcr after 48h): 58
percentage knockdown (qpcr after 48h): 52
splicing factor targeted (ensembl id): ENSG00000100461
percentage knockdown (qpcr after 48h): 69
percentage knockdown (qpcr after 48h): 67
percentage knockdown (qpcr after 48h): 73
splicing factor targeted (ensembl id): ENSG00000100813
percentage knockdown (qpcr after 48h): 57
percentage knockdown (qpcr after 48h): 54
percentage knockdown (qpcr after 48h): 71
splicing factor targeted (ensembl id): ENSG00000104824
percentage knockdown (qpcr after 48h): 78
percentage knockdown (qpcr after 48h): 85
splicing factor targeted (ensembl id): ENSG00000111786
percentage knockdown (qpcr after 48h): 87
percentage knockdown (qpcr after 48h): 86
percentage knockdown (qpcr after 48h): 88
splicing factor targeted (ensembl id): ENSG00000112081
percentage knockdown (qpcr after 48h): 56
percentage knockdown (qpcr after 48h): 49
splicing factor targeted (ensembl id): ENSG00000116350
percentage knockdown (qpcr after 48h): 51
splicing factor targeted (ensembl id): ENSG00000122566
percentage knockdown (qpcr after 48h): 60
percentage knockdown (qpcr after 48h): 63
splicing factor targeted (ensembl id): ENSG00000125944
percentage knockdown (qpcr after 48h): 92
percentage knockdown (qpcr after 48h): 94
percentage knockdown (qpcr after 48h): 84
splicing factor targeted (ensembl id): ENSG00000126945
percentage knockdown (qpcr after 48h): 80
percentage knockdown (qpcr after 48h): 79
splicing factor targeted (ensembl id): ENSG00000131051
percentage knockdown (qpcr after 48h): 65
percentage knockdown (qpcr after 48h): 74
percentage knockdown (qpcr after 48h): 61
percentage knockdown (qpcr after 48h): 53
splicing factor targeted (ensembl id): ENSG00000135316
percentage knockdown (qpcr after 48h): 68
percentage knockdown (qpcr after 48h): 62
splicing factor targeted (ensembl id): ENSG00000136450
percentage knockdown (qpcr after 48h): 70
splicing factor targeted (ensembl id): ENSG00000188529
splicing factor targeted (ensembl id): ENSG00000147274
percentage knockdown (qpcr after 48h): 76
splicing factor targeted (ensembl id): ENSG00000160710
percentage knockdown (qpcr after 48h): 89
splicing factor targeted (ensembl id): ENSG00000165119
percentage knockdown (qpcr after 48h): 83
splicing factor targeted (ensembl id): ENSG00000169045
percentage knockdown (qpcr after 48h): 66
splicing factor targeted (ensembl id): ENSG00000169813
splicing factor targeted (ensembl id): ENSG00000180771
splicing factor targeted (ensembl id): ENSG00000197111
percentage knockdown (qpcr after 48h): 96
percentage knockdown (qpcr after 48h): 95
splicing factor targeted (ensembl id): ENSG00000205937
percentage knockdown (qpcr after 48h): 91
percentage knockdown (qpcr after 48h): 0
cell type: Human Parthenogenic Stem Cells
cell type: hpSC derived Neural Stem Cells
cell type: hpSC derived Dopaminergic Neuron Precursors
treatment: p37, p40, p42, p45 overexpresion
exposed to: 100 μg/ml ethyl methanesulfonate
infection: Salmonella Typhimurium, MOI 25
transfected with: control miR (final conc. of 50nM)
sample collection time: 72h post-transfection
transfected with: miR-15a (final conc. of 50nM)
transfected with: miR-16 (final conc. of 50nM)
transfected with: miR-503 (final conc. of 50nM)
infection: Salmonella Typhimurium, MOI 100
plasmodium infection: Plasmodium berghei SLTRiP-KO parasite
infection time point: 22 hrs of post sporozoite infection of HepG2 cells
plasmodium infection: Plasmodium berghei 268-KO parasite
plasmodium infection: Plasmodium berghei parasite
plasmodium infection: Normal HepG2 cells
cell type: PEL (primary effusion lymphoma) cell line
cell line: DG-75 stably expressing KSHV pri-miR-K10/12
cell line: HeLa (Human cervical carcinoma cell line)
cell line: K562 (Human erythromyeloblastoid leukemia cell line)
passage: diluted from HEK293T cell total RNA
patient description: child patient T3 (microcephaly)
patient description: child patient T4 (microcephaly)
tissue: peripheral blood mononuclear cells
cell line: Breast cancer cell line T47D-MTVL
source tissue: bone metastasis of grade IV prostate cancer
genotype/variation: WT (Luciferase knockdown control)
cell type: human pulmonary microvascular endothelial cells
antibody: anti-CTCF (Abcam, cat# ab70303, lot# GR98618-4)
antibody: anti-CTCF (Abcam, cat# ab70303, lot# GR27477-7)
antibody: anti-CTCF (Abcam, cat# ab70303, lot#s GR98618-4 and GR27477-7)
cell type: ES-derived cardiomyocyte cells
infection: Salmonella enteritidis strain SE2472
tissue: Merkel cell carcinoma cell line, MS-1
differentiation stage: early basophilic erythroblasts
differentiation stage: late basophilic erythroblasts
differentiation: Differentiation 1, 80% confluency
differentiation: Differentiation 2, full confluency
sorting#: Hoechst + LipidTOX, "low lipid" fraction (lower 20%)
sorting#: Hoechst + LipidTOX, "high lipid" fraction (upper 20%)
differentiation: Differentiation 3, full confluency
scrb-seq variant#: Proteinase K + Maxima
sorting#: Hoechst + LipidTOX, "low lipid" fraction (lower 50%)
sorting#: Hoechst + LipidTOX, "high lipid" fraction (upper 50%)
tissue: 3-dimensional neuronal aggregates that resemble a first trimester telencephalon
surface markers to isolate cells by facs-based methods: GPA low, Band3 negative and alpha 4 integrin high
surface markers to isolate cells by facs-based methods: GPA positive, Band3 medium and alpha 4 integrin high
cell type: early basophilic erythroblast
surface markers to isolate cells by facs-based methods: GPA positive, Band3 high and alpha 4 integrin high
surface markers to isolate cells by facs-based methods: GPA positive, Band3 high and alpha 4 integrin medium
surface markers to isolate cells by facs-based methods: GPA positive, Band3 high and alpha 4 integrin negative
cell type: functional hepatocytes generated by lineage reprogramming
cell type: functional hepatocytes generated by ES differentiation
cell type: Neural progenitor cells (NPCs) developed from iPSCs
transduced with: Scrambled vector (control)
sample type: undifferentiated Epstein-Barr virus (EBV)-positive NPC xenograft
sample type: undifferentiated Epstein-Barr virus (EBV)-positive NPC cell line
sample type: well-differentiated NPC cell line
sample type: immortalized nasopharyngeal epithelial cell line
cell type: human embryonic stem cells differentiated to "stage 6" containing insulin-expressing cells
cell type: diffuse large B-cell lymphoma (DLBCL)
tumor subtype: germinal center B-cell like
tissue type: Rituximad resistant DOHH2 xenograft
cell type: normal primary dermal fibroblasts
human cell type: embryonic lung-derived diploid fibroblast cell line
cell type: HUVEC (human umbilical vein endothelial cells)
cell type: lymphatic endothelial colony forming cells
cell type: blood endothelial colony forming cells
treatment: transfection with scrambled siRNA
treatment: transfection with RUNX1-ETO siRNA
cell type: breast cancer cancer cell line
cell type: in vitro differentiated erythroid cells
cell composition: majority in proerythroblast stage
cell composition: immature erythroid cells
cell composition: including basophilic and polychromatic erythroblast cells
cell composition: orthochromatic erythrolast and 30% reticulocyte
cell type: human primary lung fibroblasts
genotype/variation: expressing shRNA directed against luciferase as a control
genotype/variation: expressing shRNA directed against macroH2A1
origin: hES-derived pancreatic endocrine assosiated cells
origin: hES-derived pancreatic non-endocrine assosiated cells
cell type: Primary Human Aortic Endothelial Cells (HAECs)
treated with: suberoylanilide hydroxamic acid (SAHA)
sample group: Luciferase tetra-loop construct
differentiation stage: embryonic stem cells
differentiation stage: mesoderm committed cells
differentiation stage: early vascular progenitor cells
differentiation stage: late vascular progenitor cells
differentiation time: Fully differentiated Endothelial cells
differentiation stage: Human umbilical vein endothelial cells
antibody/details: Ribozero processed and fragmented RNA
cell line: bronchial epithelial BEAS2B cells
cell type: epithelial (virus transformed)
cell type: Anterior hemogenic endothelial-derived cardiac myocytes
cell type: Cardiac progenitor cell-derived cardiac myocytes
cell type: Glioblastoma (Astrocytoma) cells
clip antibody vendor: Santa Cruz Biotechnologies
transfected with: ADAR1 RNA binding mutant (EAA)
transfected with: ADAR1 overexpression vector
transfected with: control vector (pcDNA4)
source: Cells obtained from trachea of adult lung transplant donor
tissue: Induced pluripotent stem cells (iPSCs)
bromouridine labeling start: 10 minutes prior to washout
bromouridine labeling start: 10 minutes after washout
cell type: PBMC derived macrophage (HMDM)
cell type: iPSC derived macrophage (IPSDM)
cell type: Induced pluripotent stem cell (iPSC)
cell line: human neural progenitor cells
condition: 5 days post induction with Dox
condition: 5 days after not inducing with Dox
diagnosis: Hepatosplenic T-cell lymphoma (HSTL)
diagnosis: Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
treatment: 0.2 ug/ml Doxorubicin 12 hours
disease status: hepatocellular carcinoma (HCC)
cell type: iPSC derived from female with normal fertility
cell type: differentiated Control_c7 cells
cell type: iPSC derived from Turner syndrome patient
cell type: iPSC derived from triple X female
growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC
growth protocol: grown in EMEM (Wisent) supplemented with 1 mM sodium pyruvate and MEM nonessential amino acid (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC
cell type: immortalized normal skin fibroblast
growth protocol: grown in alpha-MEM (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC
cell type: immortalized normal ovarian fibroblast
growth protocol: grown in OSE medium (Wisent) , supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC
treatment: Treated with siRNA targeting NOP58 (CUUCUACCGUUCAGAUUCU). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.
treatment: Treated with siRNA targeting NOP58 (GACAAGUCCCAAACACAAA). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.
treatment: Treated with siRNA targeting RBFOX2 (GAUGGUCACACCAUAUGCA). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.
treatment: Treated with siRNA targeting RBFOX2 (CACCUCCGCAGAAUGGAAU). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.
par-clip antibody: hnRNPC (sc-32308, Santa Cruz)
plasmid: pLKO-puro-scramble shRNA (Addgene 1864)
cell type: prostate cancer cell line DU-145 xenograft
cell type: Dermal lymphatic endothelial cells
treatment: 48 hours with p38-MAPK inhibitor SB203580 (Millipore)
treatment: control (normal; BDE209 in DMSO-free medium)
tissue: Eutopic endometrium of endometriosis patient
tissue: Adjacent healthy peritoneal tissue
cell type: induced pluripotent stem cells 7 days after TRA-1-60(+) cell sorting on day 28
cell type: induced pluripotent stem cells 7 days after 2nd passage
cell type: induced pluripotent stem cells 7 days after 3rd passage
cell type: induced pluripotent stem cell TIG108-4f3 subclone 6
cell type: induced pluripotent stem cell TIG118-4f1subclone 7
cell type: induced pluripotent stem cells TKCBV5-6 subclone 1
cell type: induced pluripotent stem cells 451F3 subclone 5
cell type: Metastatic castration resistant prostate cancer
infected with: retroviruses expressing short haiprin against JMJD3
infected with: retroviruses expressing short haiprin against UTX
infected with: retroviruses expressing short haiprin against RENILLA
cell type: ES-derived neural progenitor cells
cell type: Adenocarcinomic human alveolar basal epithelial cells
cell type: Embryonic kidney derived cells
rna purification: Ribosome protected RNA fragments
cell type: EBV transformed peripheral blood B lymphocytes
cell line: WIBR3 with AAVS1-lox-stop-loxRFP
organoid stage: human embryonic stem cells
condition: induction with estradiol (10-8 M) and medroxyprogesterone acetate (10-6 M)
condition: control (without any induction)
cell type: foreskin fibroblast cell line
cell type: cultured human lung fibroblasts
cell type: cultured human foreskin fibroblasts
culture progenitor w5c5 status: W5C5 positive
culture progenitor w5c5 status: W5C5 negative
cell type: NUT-variant NUT Midline Carcinoma
diagnosis: NLRC4-Macrophage Activation Syndrome (MAS)
treatment status: Prior to anakinra treatment
treatment status: Post anakinra treatment
diagnosis: Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
cell type: Tongue squamous cell carcinoma
cell type: colon carcinoma epithelial cells
cell type: human Neural Stem Cells (hNSCs)
transfected with: shCHD8 #C (CloneID: V2LHS_201084)
transfected with: shCHD8 #G (CloneID: V3LHS_311510)
reporter gene: b-globin PTC39 reporter expressed from Flp-In locus
reporter gene: no gene inserted in Flp-In locus
barcode: a mix of 3 barcodes (AGACAGCAG, CTTCAGCAG, GATCAGCAG ) and 30 % phiX as spike in.
genotype: tet-regulated IRES-GFP expression (control)
cell type: Primary CD14+/CD16+ monocytes
treatment: stimulated with interferon gamma and LPS
cdna amplification kit: Ovation RNA-Seq FFPE System (NuGEN)
rna-seq library preparation kit: Encore NGS Multiplex System I (NuGEN)
cdna amplification kit: Ovation RNA-Seq System V2 (NuGEN)
cdna amplification kit: SeqPlex RNA Amplification Kit (Sigma-Aldrich)
rna-seq library preparation kit: Ovation Ultralow Library Systems (NuGEN)
cdna amplification kit: SMARTer Ultra Low RNA Kit (Clontech)
cell type: dedifferentiated liposarcoma (DDLPS)
cell type: mobilized peripheral blood cells
cell type: adult human dermal microvascular ECs (hDMECs)
cell type: human umbilical vein ECs (HUVECs)
treatment: TNF + co-culture with fibroblast
cell line: modified Burkitt's lymphoma cell line (Akata)
genotype/variation: harboring control tet inducible gene
genotype/variation: harboring BZLF1 tet inducible gene
cell type: Induced pluripotent stem cells from human fibroblasts from patients with FA disease
genotype correction status: not corrected
cell type: Differentiated Glioma Cell Line
time point: 15 days post LV-sh transduction
cell line: MDA-MB-231 breast cancer cell line
molecule subtype: Ribosomal RNA-depleted total RNA
cell type: neonatal dermal blood vascular endothelial cells (BECs)
culture condition: laminar flow at 2 Dyne/cm2
tissue: Peripheral blood mononuclear cells (PBMCs)
disease/genotype: Li-Fraumeni Syndrome (LFS) patient
cell subtype: mesenchymal stem cells (MSCs)
time point: day 0 of osteoblast differentiation treatment
cell subtype: mesenchymal stem cells (MSCs) intermediate
time point: day 14 of osteoblast differentiation treatment
time point: day 17 of osteoblast differentiation treatment
time point: day 7 of osteoblast differentiation treatment
cell type: tumor tissue isolated from Nude mice
tissue: Triple Negative Breast Cancer Primary Tumor
tissue: Uninvolved Breast Tissue Adjacent to ER+ Primary Tumor
tissue: Reduction Mammoplasty - No known cancer
tissue: Uninvolved Breast Tissue Adjacent to TNBC Primary Tumor
sample group: coronary artery calcification case
cell type: Colorectal carcinoma derived cell line
treated with: 100 µg/ml cycloheximide for 30 min at 37°C
molecule subtype: Ribosome protected fragments
treated with: 50 µM lactimidomycin for 30 min at 37°C
cell type: Primary Monocytes(rest cell population after CD14+ selection)(BC14)
genotype: siBCL6;etopic expression of WT BCL6
genotype: siBCL6;etopic expression of BCL6 RD2 mutant
response to smoothened (smo) inhibitors: Normal
response to smoothened (smo) inhibitors: Resistance
response to smoothened (smo) inhibitors: Sensitive
rna prep: chromatin-associated RNA fraction
cell line: K562 erythroleukemia cell line
treated with: 200 µM hydrogen peroxide for 2hr
rna extraction time point: 6 days after the initiation of treatment
cell type: Hippocampal dentate gyrus (DG) granule neurons
degree of dysplasia: High Grade Dsyplasia
biopsy site: Barrett's Oesophagus segment
degree of dysplasia: Low Grade Dsyplasia
degree of dysplasia: Simple intestinal metaplasia
cell type: CD34+ HSPC-derived proerythroblasts
days in culture: day 30 of differentiation
protocol: differentiated with calcium chloride for 2 days
protocol: differentiated with calcium chloride for 2 days and incubated with recombinant human IL-4 for 3 hours
protocol: differentiated with calcium chloride for 2 days and incubated with recombinant human IL-4 for 24 hours
protocol: differentiated with calcium chloride for 5 days
protocol: differentiated with calcium chloride for 5 days with recombinant human IL-4
protocol: transfected with control siRNA, differentiated with calcium chloride for 2 days and then stimulated with recombinant human IL-4 for 24 hours
protocol: transfected with STAT6 siRNA, differentiated with calcium chloride for 2 days and then stimulated with recombinant human IL-4 for 24 hours
cell type: Monocyte-derived denditric cells
cell type: Neutrophil isolated from peripheral blood
cell type: ER Positive Breast Cancer Cells
treated with: 100 nM 17β-estradiol (E2) for 40min
treated with: 100 nM 17β-estradiol + 25 ng/mL TNFα for 40min
treated with: vehicle (0.1% EtOH) as control for 72hrs
treated with: 4-OHT (10-6mol/L) for 72 hrs
treated with: E2 (10-9mol/L) plus 4-OHT (10-6mol/L) for 72 hrs
treated with: PP2 (5x10-6mol/L) for 72 hrs
treated with: E2 (10-9mol/L) plus PP2 (5x10-6mol/L) for 72 hrs
treated with: vehicle (0.1% EtOH) as control for 24hrs
treated with: 4-OHT (10-6mol/L) for 24 hrs
tissue type: glioma - non-enhancing FLAIR+ sample
tissue type: glioma - contrast-enhancing sample
cell line vendor/cat. #: Invitrogen #R750-07
shRNA info: negative control shRNA (Addgene #10879)
shRNA info: control shRNA for engagement of the RNAi pathway; ASNA1 encoded on Chr19
shRNA info: shRNAs targeting Chr5q35 loci; N4BP3 at Chr5:177,540,556
shRNA info: shRNAs targeting Chr5q35 loci; TMED9 at  Chr5:177,019,213
shRNA info: shRNAs targeting Chr5q35 loci; TSPAN17 at Chr5:176,074,388
cell type: human cervical cancer cell line
cell type: human adipose-derived stem cells
lentiviral transfection: Mature hMADS adipocytes (day 10) were incubated with lentivirus expressing shRNA against Scramble  for 24 hours.
lentiviral transfection: Mature hMADS adipocytes (day 10) were incubated with lentivirus expressing shRNA against KLF11  for 24 hours.
infection: RB binding mutant and P300 binding mutant-infected
infection reagent: Herpes simplex virus 1, strain 17
time post infection: 60 min 500 µM 4sU prior to infection
time post infection: 60 min 500 µM 4sU at 0-1 h p.i.
time post infection: 60 min 500 µM 4sU at 1-2 h p.i.
time post infection: 60 min 500 µM 4sU at 2-3 h p.i.
time post infection: 60 min 500 µM 4sU at 3-4 h p.i.
time post infection: 60 min 500 µM 4sU at 4-5 h p.i.
time post infection: 60 min 500 µM 4sU at 5-6 h p.i.
time post infection: 60 min 500 µM 4sU at 6-7 h p.i.
time post infection: 60 min 500 µM 4sU at 7-8 h p.i.
treatment: infection with adenovirus with GFP
cell type: Non-tumorigenic immortalized breast epithelia line
treatment: infection with adenovirus with MEK
treatment: infection with adenovirus with MEK and EGFR
treatment: infection with adenovirus with EGFR
cell type: SV-40 transformed primary human fetal epididymis cells
cell type: T-ALL cell line containing a t(7;9) rearrangement and aberrant NOTCH1 activation
cell type: Triple negative breast cancer cell line containing an activating Notch1 mutation, grown in suspension
cell type: Mantle cell lymphoma cell line containing an activating Notch1 mutation
tissue type: Gastrointestinal Stromal Tumor
activation: anti-CD3/CD28 beads, 48 hours
treatment: Hypoxia (Oxygen deprivation was carried out in an incubator with 1% O2, 5% CO2 and 94% N2 for 19 h.)
infection with: Herpes simplex virus 1, strain 17
cell type: human colorectal cancer cell line
genotype/variation: mutations in DNA methyltransferases (double knockout)
cell type: hPGC isolated from developmental week 7 genital ridge
cell type: Gonadal somatic cells isolated from developmental week 7 genital ridge
cell type: Human embryonic stem cell cultured in 4i condition
cell type: Day 2 pre-induced cells derived from hESC
cell type: Day4 hPGCLCs derived from day2 pre-induced cells
cell type: Human embryonic stem cell cultured in conventional condition
cell line origin: female caucasian with ductal carcinoma
transfected with: negative control siRNAs
subject status: poikiloderma with neutropenia (PN) patient
cell type: foreskin fibroblasts from PN patient (PNFF)
genotype/variation: PNFF-hMPN1; compensated with hMPN1
time: 3 days after adipogenic stimulation (Day 3)
differentiation state: Non-proliferating, differentiated for 3 days
time: 2 days before adipogenic stimulation (Day -2)
time: The day of adipogenic stimulation (Day 0)
differentiation state: Non-proliferating (confluent), undifferentiated
time: 9 days after adipogenic stimulation (Day 9)
differentiation state: Non-proliferating, differentiated for 9 days
cell description: beast cancer cell line
treatment: siCTL, 1hr treatment with 100nM E2
treatment: siCTL, 1hr treatment with vehicle control
treatment: siGATA3, 1hr treatment with 100nM E2
treatment: siGATA3, 1hr treatment with vehicle control
treatment: shCTL, 1hr treatment with vehicle control
treatment: shCTL, 1hr treatment with 1μM RA
treatment: shCTL, 1hr treatment with 100nM E2
treatment: shRARs, 1hr treatment with vehicle control
treatment: shRARs, 1hr treatment with 100nM E2
treatment: shRARs, 1hr treatment with 1μM RA
treatment: shAP2g, 1hr treatment with vehicle control
treatment: shAP2g, 1hr treatment with 100nM E2
treated with: None (spontaneously immortal)
sample group: spontaneously immortal cells
treated with: None (grown until growth arrest)
cell type: in vitro activated Th0 condition for 3 days
culture condition: Naïve CD4+CD45RA+CD45RO- T cell population was sorted using FACS Aria II
genotype/variation: Normal human muscle autopsy
molecule subtype: oligodT selected total RNA
genotype/variation: DM human muscle autopsy
reporter: canonical Wnt signaling reporter
cell type: U87-MG glioblastoma human cells
xenografts host mice: 7-wks old male Balb/C nude mice
transfected with: vectors coding for Myc-KPC1
transfected with: vectors coding for Flag-p50
cell line source: Personal Genome Project iPS cell line PGP1 (hu43860C)
genotype/variation: harboring doxycycline inducible Neurogenin vectors
cell subtype: Fibroblast derived iPS cells, differentiated neurons
cell type: human telomerase-immortalised retinal pigmented epithelial cells
infection: Influenza A (A/PR/8/34) ΔNS1-Infected
treated with: si RNAs against Integrator 11
treated with: si RNAs against control (scrambled)
molecule subtype: ribosomal RNA depleted whole cell RNA
treatment: 1% DMSO + 20 μM PhenDC3, 48hr
cell type: low passage primary melanoma cultures
growth protocol: cells were treated with 10nM of scamble siRNA. Cells were harvested 72h after transfection.
growth protocol: cells were treated with 10nM pool of siRNAs against all 4 TEADs. Cells were harvested 72h after transfection.
cell type: human gastric cancer cell line with natural EBV infection
ebv infection status: EBV(+); naturally infected with EBV
cell type: human gastric cancer cell line
cell type: NUGC3 in vitro infected with EBV
ebv infection status: EBV(+); experimentally infected with EBV
cell type: SNU-484 in vitro infected with EBV
cell type: SNU-638 in vitro infected with EBV
treatment: subjected to quiescence using 150 days contact inhibition
tissue: primary bone marrow derived mesenchymal progenitor cells
cell line: induced pluripotent stem cell line
cell type (precursor used to generate ipscs): dermal fibroblast
cell type (precursor used to generate ipscs): LCL
cell type: Isolated from human trachea-bronchial tissues
cell type: bone marrow mononuclear cells (BM MNC)
type of chronic myelomonocytic leukemia: CMML-1
type of chronic myelomonocytic leukemia: CMML-2
cell type: senescent cells expressing ZFP36L1mut
cell type: senescent cells expressing ZFP36L1wt
cell type: ESCs (H9 NIH code WA09, ISL1 Ds-Red); ESC-derived neural precursors
transient transfection: siGL2 and siXRN1
transient transfection: siSMG6 and siXRN1
transient transfection: siUPF1 and siXRN1
cell type: Bone Marrow Mononuclear Cells
library type: whole RNA fragment sequencing
donor's disease state: autism spectrum disorder with macrocephaly
cell type: iPSC-derived neural progenitors
number of days in vitro in terminal differentiation conditions: 11
number of days in vitro in terminal differentiation conditions: 31
number of days in vitro in terminal differentiation conditions: 0
shRNA target gene and trc accession: CHD8 (TRCN0000016512)
shRNA target gene and trc accession: CHD8 (TRCN0000016511)
shRNA target gene and trc accession: CHD8 (TRCN0000016510)
shRNA target gene and trc accession: CHD8 (TRCN0000360109)
shRNA target gene and trc accession: CHD8 (TRCN0000367896)
shRNA target gene and trc accession: CHD8 (TRCN0000360108)
shRNA target gene and trc accession: GFP (TRCN0000072181)
shRNA target gene and trc accession: LacZ (TRCN0000072236)
cell type: burst-forming unit-erythroid cells (BFU-E)
cell type: colony-forming unit-erythroid cells (CFU-E)
cell type: human bronchiolar epithelial cells
cell type: Undifferentiated nuclear-transfer embryonic stem cells
cell type: Undifferentiated induced pluripotent stem cells
cell type: Undifferentiated embryonic stem cells
enrichment type: ribosome protected fragments
culture condition: monolayer (m) cultured cell
culture condition: sphere (s) forming cell
age: 54-57 days post conception (gestation)
cell type: hESC-derived liver progenitors
cell line: Ewing sarcoma cell line SKMNC
cell type: pancreatic ductal adenocarcinoma
treatment: ClonTracer-barcoded HCC827 cell population was treated with 0.1% DMSO for 4 days.
resistant to: Vehicle control - Treated with 0.1% DMSO
treatment: ClonTracer-barcoded HCC827 cell population was treated with 2 µM erlotinib for 47 days to generate the erlotinib-resistant cell population.
treatment: The erlotinib-resistant HCC827 cell population was treated with 2 µM erlotinib+0.2 µM crizotinib combination for 10 days to enrich for erlotinib/crizotinib dual-resistant subpopulations.
resistant to: 2 µM erlotinib+0.2 µM crizotinib combination
treatment: ClonTracer-barcoded KCL-22 cell population was treated with 0.1% DMSO for 7 days.
treatment: ClonTracer-barcoded KCL-22 cell population was treated with 2.5 µM imatinib for 27 days to acquire imatinib-resistant cell population.
treatment: ClonTracer-barcoded KCL-22 cell population was treated with 0.3 µM nilotinib for 27 days to acquire nilotinib-resistant cell population.
treatment: ClonTracer-barcoded KCL-22 cell population was treated with 2.5 µM GNF-2 for 21 days to acquire GNF-2-resistant cell population.
treatment: Single clone was isolated from 2.5 µM GNF-2-resistant ClonTracer-barcoded KCL-22 subpopulation and expanded. This clone is never exposed to catalytic BCR-ABL inhibitors.
resistant to: 2.5 µM imatinib/0.3 µM nilotinib/2.5 µM GNF-2
treatment: Single clone was isolated from 2.5 µM imatinib-resistant ClonTracer-barcoded KCL-22 subpopulation and expanded. This clone is never exposed to allosteric BCR-ABL inhibitors.
resistant to: 2.5 µM imatinib/0.3 µM nilotinib
cell type: human acute monocytic leukemia (AML) cell line
treatment: cells were transfected with siCTL, after 1hr treatment with ethanol
treatment: cells were transfected with siCTL, after 1hr treatment with 100nM E2
treatment: cells were transfected with siNCAPG, after 1hr treatment with ethanol
treatment: cells were transfected with siNCAPG, after 1hr treatment with 100nM E2
treatment: cells were transfected with siNCAPD3, after 1hr treatment with ethanol
treatment: cells were transfected with siNCAPD3, after 1hr treatment with 100nM E2
tissue: Activated (IL4, anti-CD40, IgM, and IgD) peripheral blood
treatment: lentiviral infection with sh control
treatment: lentiviral infection with sh KBTBD8
treatment: lentiviral infection with sh TCOF1
extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction
cell type: a RasV12-transformed human ovarian epithelial cell line
cell type: an immortalized but non-transformed ovarian epithelial cell line
marker: CD4+ CD8- CD45RO+ and CD4- CD8+ CD45RO+
cell line: Dermal Fibroblast from Coriell Institute (GM03348)
cell type: normal intestinal subepithelial myofibroblasts
treated with: 0.5% dimethyl sulfoxide (DMSO) for 24hrs
cell type: iPS cell-derived neuronal samples
treatment: DOX days 0-5; LSD1 inhibition
treatment: DOX days 0-13; LSD1 inhibition
cell type: Human mammary epithelial cells (HMEC)
phenotype: Wild type (Non targeting siRNA)
cell line: Barrett's esophagus cell line, CPA
age: Differentiated day 12 neuron progenitors
treatment: transfect siRNA with single N
treatment: transfect siRNA with double N
culture: Colonies in feeder-free condition
transfected with: non-silencing siRNA control
transfected with: siRNA oligonucleotides targeting JunB
treatment: T3- and T4-bound agarose, 24hrs
cell type: Breast adenocarcinoma epithelial cells
culture media: DMEM/F12 supplemented with transferrin (0.01 mg/ml), insulin (20nM), cortisol (100nM), and triiodothyronine (T3, 0.2 nM). For the initial four days, the differentiation medium was additionally supplemented with dexamethasone (25nM), IBMX (250 μM) and rosiglitazone (2 μM).
culture media: SGBS pre-adipocytes were grown in DMEM/F12 medium supplemented with 10% fetal calf serum (FCS), 1.7 mM panthotenat, 3.3 mM biotin and 1% penicillin/streptomycin
culture media: PAZ6 pre-adipocytes were cultured in DMEM/F12 medium enriched with 8% FCS, 15mM Hepes and 1% penicillin/streptomycin
culture media: SW872 cells were cultured in DMEM/F12 medium enriched with 8% FCS, 15mM Hepes and 1% penicillin/streptomycin
culture media: Oleic acid was added at a final concentration of 100 μM to initiate differentiation
culture media: At full confluency differentiation was propagated by addition of 5% FCS, 15mM Hepes, 33 μM biotin, 17 μM panthotenat, 1nM T3, 100nM dexamethasone, 1 μM rosiglitazone and 1% pen-strep to DMEM/F12 medium. Additionally, for the initial four days 0.25 mM IBMX was added to the differentiation medium
treatment: Sterile PBS b.i.d. IP for 10 days
growth protocol: PDX was established in NSG mice for 4 passages
treatment: 80mg/kg/b.i.d ribavarin IP for 10 days
cell type: HEK and 3T3 mix at final droplet concentration of 50 cells per microliter.
cell type: HEK and 3T3 mix at 50 cells per microliter final concentration in droplets.
cell collection details: Sample from 1 individual
cell differentiation status: Non-proliferating, differentiated for 3 days
cell differentiation status: Non-proliferating, differentiated for 9 days
treatment- reagent: Silencer select negative control siRNA #2 (Ambion)
treatment- knockdown v. overexpression: knockdown
treatment- reagent: Silencer select EHF siRNA (s25399, Ambion)
treatment- reagent: pcDNA3.1- empty vector
treatment- knockdown v. overexpression: overexpression
cell type: surrounding non-tumoral tissue
molecule subtype: rRNA-depleted total RNA
transfected with: DIS3, DIS3L and hRRP6 siRNA (triple knock-down)
disease status: myelodysplastic syndromes (MDS)
molecule subtype: total RNA (rRNA depleted)
treatment: doxycycline induced, a-amanitin (2.5 mg/ml) 42 hr
tissue: T cell acute lymphoblastic leukemia
genotype/variation: overexpression of mutant REST
genotype/variation: overexpression of wild type REST
antibodies: anti-CHKA (Sigma) cat no. HPA024153
cell type: Cultured erythroid progenitors
cell type: Peripheral Blood Mononuclear Cell (PBMC)
cell type: myometrial cells grown in culture
cell type: myofibrobalsts (ATCC: CRL-2854) grown in culture
cell type: chondrocytes (ATCC: CRL-2847) grown in culture
cell type: follicular dendritic cells isolated and grown in culture
cell type: endometrial stromal fibroblast (ATCC: CRL-4003) grown in culture
cell type: in vitro decidualized endometrial stromal fibroblast (ATCC: CRL-4003) grown in culture
cell line: pancreatic ductal carcinoma cell line
cell type: sorted Pdx1-EGFP+ pancreatic progenitors derived from Pdx1-EGFP HUES8
sources: AKT-activated human umbilical vein endothelial cells to be cultured in serum-free condition (a gift from Dr. Shahin Rafii)
screening chemicals: (trans) Retinoic acid
transfection: esiRNA targeting PRMT9 (1ug esiRNA/10cm dish)
cell type: immortalized mesothelial cells
treatment: 5 μg/cm2 of crocidolite asbestos exposure for 8 hrs
cell line: Human lung cancer cell lines NCI-H1975 and HCC827
cell type: Immortalized prostate cancer cell line
library preparation protocol: whole-exome capture
library preparation protocol: poly(A)+ selection
treatment: infected Hi176 at MOI of 100:1
cell type: Non-small-cell lung cancer (NSCLC) cells
treatment: infected with empty vector & treated with DMSO
treatment: infected with empty vector & treated with PLX4720
treatment: infected with empty vector & treated with Trametinib
treatment: infected with shRNA against YAP1 & treated with DMSO
treatment: infected with shRNA against YAP1 & treated with PLX4720
treatment: infected with shRNA against YAP1 & treated with Trametinib
cell type: original Pancreatic Ductal Adenocarcinoma (PDAC) cell line
cell type: CFPAC1 genome-edited clonal cell line
cell type: CFPAC1 cells transfected with empty vector
cell type: CFPAC1 cells transfected with ZEB1 expressing vector
cell type: human mesenchymal stem cell (hMSCs)
cell type: umbilical cord blood hematopoietic stem cells
cell type: ES-derived CD271+CD73+ neural crest-like progeny
treatment: Nodal/Activin/TGFb inhibitor and FGF2
treatment: Nodal/Activin/TGFb inhibitor and FGF2 then FGF2 alone
cell type: Human liver (hepato cellular carcinoma) cells
cell type: alveolar macrophages from BAL fluid
sampling time: post-allergen challenge 48 hr
treatment: Cytosolic Hsp60 depletion and TNF-alpha negative
cell type: aortic vascular smooth muscle cells
treatment: Cytosolic Hsp60 depletion and TNF-alpha positive
treatment: Cytosolic Hsp60 normal and TNF-alpha positive
treatment: Cytosolic Hsp60 normal and TNF-alpha negative
treatment: treated with erlotinib + PBS-1086
treatment: infected with empty vector & treated with erlotinib
treatment: infected with vector expressing IkB-alpha super-repressor & treated with DMSO
treatment: infected with vector expressing IkB-alpha super-repressor & treated with erlotinib
treatment: infected with constitutively-active RelAS536E & treated with DMSO
treatment: infected with constitutively-active RelAS536E & treated with erlotinib
subject status: DCM-diagnosed patients who had undergone heart transplant (hDCM)
cell type: neonatal human foreskin fibroblasts (primary culture cells)
treatment: transduced with MycER and BPTF-targeting shRNA, treated with 4-hydroxytamoxifen (4-OHT)
treatment: transduced with MycER and BPTF-targeting shRNA, not treated with 4-hydroxytamoxifen (4-OHT)
treatment: transduced with MycER and control shRNA, treated with 4-hydroxytamoxifen (4-OHT)
treatment: transduced with MycER and control shRNA, not treated with 4-hydroxytamoxifen (4-OHT)
type of surgical procedure: adjustable gastric banding
type of surgical procedure: Roux-en-Y gastric bypass
culture condition: 3 day in vitro culture for Th0, treatment (IL6)
culture condition: 3 day in vitro culture for Th0, treatment (IL27)
culture condition: 3 day in vitro culture for Th0
genotype: complex I deficient (patient ND5)
genotype: complex I deficient (patient NDUFS2)
phenotype group (birth outcome): Group II-ii
phenotype group (birth outcome): Group III-ii
phenotype group (birth outcome): Group III-i
phenotype group (birth outcome): Group II-iii
phenotype group (birth outcome): Group II-i
phenotype group (birth outcome): Group I
mi type: non-myocardial infarction control
differentiation stage: Day 30 post-differentiation
treatment: 1μg/ml of tunicamycin and ISRIB (200 nM) for 1 hour
treatment: 1μg/ml of tunicamycin for 1 hour
differentiation stage: day 8 after retinoic acid treatment
differentiation stage: day 4 after retinoic acid treatment
differentiation stage: day 2 after retinoic acid treatment
cell sorting date: 15-May-2013 (BD FACS Aria)
cell population: IL3Ra-low progenitor cells
cell population: IL3Ra-high progenitor cells
cell line origin: derived from parental OVCAR-3 ovarian carcinoma cells
type of shrna: COX-1 pRS shRNA HuSH-29 plasmid (OriGene)
type of shrna: scrambled pRS shRNA HuSH-29 plasmid (OriGene)
cell line: MYC-ER HMECs with dox-inducible shBUD31 (pINDUCER-shBUD31-3'UTR)
cell type: Immortalized mammary epithelial cell
condition: Hyperactivated MYC and depleted BUD31
disease: Normal, SI Neuroendocrine tumor
disease: Normal, colonic inertia, TI submucosal hemorrhage (but looked inflamed on macro)
disease: Normal, Hartmann reversal after colon cancer
facs population: LeX+ Glast+ Prominin-low
facs population: LeX+ Glast+ Prominin-high
time point: T0; before bariatric surgery
time point: T3; 3 months after bariatric surgery
cell type: MCF10a human breast cancer cells
cell type: mixture of U87 human glioma cells and MCF10a human breast cancer cells
cell type: mixture of U87 human glioma cells and WI-38 human lung fibroblast cells
cell type: WI-38 human lung fibroblast cells
group: C: aCD3/aCD28-coated bead expanded nTreg
group: B: Allogeneic mature moDC-expanded nTreg
treatment: no AlkB-derived enzyme mixture
disease state: relapsing-remitting multiple sclerosis (RRMS)
cell type: mixture of multiple cell lines
cell type: HEK and 3T3 mix at a final concentration of 12.5 cells / ul in droplets.
tissue: MDA-MB-231 human breast adenocarcinoma cell line (ATCC, HTB-26)
mouse strain: Fox Chase SCID Congenic-CB17/Icr-Prkdcscid/IcrIcoCrl
tissue: MDA-MB-231 tumor and mouse mammary tissue
tissue: MCF7-EGFP tumor and mouse mammary tissue
tissue: MCF7 human breast adenocarcinoma cell line (ATCC, HTB-22)
tissue: MDA-MB-231 human breast adenocarcinoma cell line (ATCC, HTB-26) and 3T3-L1 mouse embryonic fibroblast cell line (ATCC, CL-173)
cell population: CCR6+, CD4+ T cells from HLA-DR4+ MS patient, myelin tetramer positive
cell population: CCR6+, CD4+ T cells from HLA-DR4+ MS patient, myelin tetramer negative
cell population: CCR6+, CD4+ T cells from HLA-DR4+ healthy control, myelin tetramer positive
cell population: CCR6+, CD4+ T cells from HLA-DR4+ healthy control, myelin tetramer negative
cell type: human embryonic stem cells (hESCs)
cell type: Day 8 differentiated cells with TSA treatment during days 4-8
cell type: Day 4 differentiated cells  with TSA treatment during days 0-4
treatment: Treatment with BxPC-3 exosomes
treatment: Treatment with PAN02 exosomes
treatment: Treatment with normal pancreas exosomes
cell type: acute myeloid leukemia (AML) cells
passages: Untreated cells grown in DMEM/F-12  medium +10% FBS
cell type: cervical cancer cell line with integrated HPV16
subject group: LOAD (late onset of Alzheimer’s disease)
cell type: primary human neonatal keratinocytes
developmental stage: fetal (12-18 gestational weeks)
sirs outcomes: Acute Kidney Injury stage 0
sirs outcomes: Acute Kidney Injury stage 1
sirs outcomes: Acute Kidney Injury stage 2/3
compound: siRNAs targeting no expressed gene in the human genome
compound: siRNAs targeting the hnRNP A1 and A2 mRNA
cell type: GFP negative neural retina cells
cell type: GFP positive neural retina cells
organism: mixed sample (human cell line HeLa-S3 + Salmonella typhimurium SL1344)
strain: Salmonella Typhimurium SL1344 delta-pinT
treatment: pladienolide B treated for 4 h
treatment: Control siRNA transfection for 48 h
treatment: BuGZ siRNA transfection for 48 h
treatment: Bub3 siRNA transfection for 48 h
organism: mixed sample: human cell line THP-1 (-PMA)and Salmonella Typhimurium SL1344
organism: mixed sample: human cell line LoVo and Salmonella Typhimurium SL1344
organism: mixed sample: human cell line HT29 and Salmonella Typhimurium SL1344
organism: mixed sample: human cell line HEK 293 and Salmonella Typhimurium SL1344
organism: mixed sample: human cell line CaCo-2 and Salmonella Typhimurium SL1344
organism: mixed sample: human cell line AGS and Salmonella Typhimurium SL1344
organism: mixed sample: human cell line HeLa-S3 and Salmonella Typhimurium SL1344
cell type: RPE-1 cells immortalized with hTERT
cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were harvested 45 min later through mitotic shake-off
drug pre-treatment: cells were pretreated with cycloheximide
cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr and harvested
cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were collected 45 min later through mitotic shake-off and replated to allow normal mitotic exit. 3hr later G1 cells were harvested.
cell type: Colorectal carcinoma cell line
treated with: enantiomer (control) for 6h
cell type: non tumorigenic (Melanocytes)
transfected with: TALE-activator targeting HBG1
transfected with: TALE-activator targeting IL1RN
treatment: 150 uM H2O2 added and then cultured at 21% O2 tension in vitro for 3 days
treatment: 150 uM H2O2 added and then cultured at 10 % O2 tension in vitro for 3 days
treatment: 10 % O2 tension in vitro for 3 weeks
treatment: 21% O2 tension in vitro for 3 days
treatment: 10 % O2 tension in vitro for 3 days
cell type: HeLa Tet-inducible INTS11 shRNA cell clone
bacterial community type: Prevotella dominant
collection site and cell type: Cervical APC
bacterial community type: Gardnerella dominant
bacterial community type: Lactobacillus dominant
transfection dosage: 400 ng plasmids per well in 6-well cell culture plate
treatment: Co-RNAi against RC3H1 and RC3H2, addition of 50 ug/ml ActD 2h before harvesting
treatment: Co-RNAi against RC3H1 and RC3H2, addition of 50 ug/ml ActD 1h before harvesting
treatment: Co-RNAi against RC3H1 and RC3H2, no addition of ActD
treatment: Mock treatment, addition of 50 ug/ml ActD 2h before harvesting
treatment: Mock treatment, addition of 50 ug/ml ActD 1h before harvesting
treatment: Mock treatment, no addition of ActD
cell type: immature monocytic myeloid cells (IMMCs)
cell line: Kupffer cells (Primary culture (Life technologies))
cell type: Epithelial fetal human kidney cells
cell modifications: Contains SV40 T-antigen
cell type: Female human lung fibroblasts
cell type: dermal fibroblast cells (hDF)
tissue subtype: renal cell carcinoma (RCC)
cell markers: CD34+CD7neg CD1aneg CD4negCD8neg
protocol: DNA control, no reverse transcriptase, dUTP stranded protocol
treatment: Gata6 overexpressing hESC line2 in mTeSR media
treatment: Gata6 overexpressing hESC line1 in mTeSR media
treatment: Gata6 overexpressing hESC line2 in KSR media
treatment: Gata6 overexpressing hESC line1 in KSR media
cell stimulation: Phorbal myristate acetate (PMA) stimulation
cohort: Control; healthy control subject
history of brucellosis: Chronic brucellosis (<10 years)
response to treatment of brucellosis: Complete remission
history of brucellosis: Acute brucellosis
response to treatment of brucellosis: Reinfection
history of brucellosis: NA; healthy control
response to treatment of brucellosis: NA; healthy control
response to treatment of brucellosis: Leishmaniasis
history of brucellosis: Chronic brucellosis (>10 years)
response to treatment of brucellosis: Relapse
cell type: day 10 ES cells differentiating along the cardiac lineage
cell type: day 6 ES cells differentiating along the cardiac lineage
cell type: day 2 ES cells differentiating along the cardiac lineage
cell type: mesoderm differentiated cells
cell origin: made from CD34+ PBMC-derived induced pluripotent stem cells
cell origin: made from fibroblast-derived induced pluripotent stem cells
cell origin: made from CD34+ cord blood-derived induced pluripotent stem cells
cell type: FACS sorted CD (45+/34+/33+/123+)
cell origin: prepared from human bone marrow
description: GMP promyelocytes sorted from BM
description: promyelocytes sorted from BM
description: myeloid progenitors-differentiated from iPSC
genotype: inducible 3xFLAG exon-excluded PTBP1 at Flp-In locus
genotype: inducible 3xFLAG full-length PTBP1 at Flp-In locus
reprogramming vector: Sendai virus (SeVdp(KOSM)302L)
time: 72 days of neuronal differentiation
condition: EGF Stimulation + A66 (20min preincubation)
condition: no EGF + A66 (20min preincubation)
isolation method: Negative selection (beads)
cell type: LHSAR overexpressed with HOXB13
cell type: LHSAR overexpressed with FOXA1
cell type: LHSAR overexpressed with HOXB13 and FOXA1
cell type: LHSAR overexpressed with LacZ
cell storage: cryopreserved primary cells
cell storage: freshly isolatedprimary cells
cell storage: freshly isolated primary cells
tumor subpopulation: tumor cell line passage 4
cell subtype: CD1c+ myleoid dendirtic cells (mDC)
cell subtype: plasmacytoid dendritic cells (pDC)
cell type: Human Umbilical Vein Endothelial Cells (HUVECs)
culture condition: hypoxia (0.1-0.2% O2)
tumor stage: castrate-resistant prostate cancer
mice generation: 2nd generation Xenograft
mice generation: 1st generation Xenograft
cell type: EBV-positive gastric carcinoma
cell type: proximal tubular epithelial cells
transfection: dCas9-VPR and a gRNA of length 14nt targeting ACTC1
transfection: dCas9-VPR and a gRNA of length 16nt targeting ACTC1
transfection: dCas9-VPR and a gRNA of length 14nt targeting HBG1/2
transfection: dCas9-VPR and a gRNA of length 16nt targeting HBG1/2
transfection: dCas9-VPR and a gRNA of length 20nt targeting HBG1/2
transfection: dCas9-VPR and a gRNA of length 14nt targeting MIAT
transfection: dCas9-VPR and a gRNA of length 16nt targeting MIAT
transfection: dCas9-VPR and a gRNA of length 20nt targeting MIAT
transfection: dCas9-VPR and a gRNA of length 20nt targeting ACTC1
cell type: Cranial neural crest cells (CNCCs)
cell line: MCF7+BORIS (Clone2, single-cell clone of MCF7 cell, stably expressing BORIS)
cell line: MCF7+BORIS (Clone1, single-cell clone of MCF7 cell, stably expressing BORIS)
cell type: Clear Cell Renal Carcinoma cells
genotype/variation: loss of ARNT protein using a lenti-crispr mediated sgRNA
genotype/variation: loss of ARNT protein by virtue of RNAi-mediated knockdown using a shRNA targeting ARNT
treatment: 4h - incubation time period  with JQ1  ( final concentration of 2 uM)
treatment: JQ1 was not added to the medium
cell type: 293Trex (cells originating from embryonic kidney)
treatment: 7h -incubation time period  with Tetracycline (final concentration of 1ug/ml).
treatment: 2h -incubation time period  with Tetracycline (final concentration of 1ug/ml).
treatment: 3h -incubation time period  with Tetracycline (final concentration of 1ug/ml).
treatment: No Tetracycline was added to the media
cell line: TC-797 (Toretsky et al. 2003)
treatment: 4h - incubation time period  with JQ1  ( final concentration of 500 nM)
treatment: 2h30min-incubation time period  with JQ1  ( final concentration of 500 nM)
treatment: 1h-incubation time period  with JQ1  ( final concentration of 500 nM)
treatment: 1h -incubation time period  with JQ1  ( final concentration of 500 nM)
cell line: PC-3 prostate carcinoma cells
culture condition: fluid shear stress 20 dyne/cm^2
treatment: Doxycycline was added day 11-14
cell type: Human umbilical vein vascular endothelial cells
cell type: Chronic myelogenous leukemia cell line
ar expression status: Transduction with lentiviral particles for expression of the AR-V7
ar expression status: Transduction with lentiviral particles for expression of the AR-WT
differentiation time: Embryoid body, day 50
cell type: Human iPSC-derived neural progenitor cells
differentiation time: Embryoid body, day 17
cell type: NPC derived from primary fibroblasts
experimental_condition: A103 addback - siCaf1z
cell type: cultured embryonic stem cells
sample group: Fixed cells_Triton X Lysis
cell type: Induced pluripotent stem cells (iPSC)
cell type: triple negative breast cancer cell line
treatment: krab2: a guide RNA (e3 #2) recognizing the e3 enhancer region
treatment: krab1: a guide RNA (e3 #1) recognizing the e3 enhancer region
treatment: Control: a guide RNA with no target
treatment: 20nM RRP6/ 20nM DIS3 siRNA - Dharmacon
treatment: Isoginkgetin - EMD Millipore Chemicals # CAS548-19-6
genotype/variation: Control cells (GFP expressed)
growth protocol: Normal, non-neoplastic cells were derived from patient tissue specimens of neurosurgical resection in accordance with a Cleveland Clinic Institutional Review Board-approved protocol. Informed consent was obtained by the tissue bank, which provided de-identified excess tissue to the laboratory immediately following surgical resection. Specimens used for cell culture were dissociated with a Papain dissociation kit (Worthington). Cells were cultured adherently in media containing 50% Neurobasal medium (Gibco) and 50% Dulbecco's modified Eagle medium (DMEM) with B27 (without vitamin A, Invitrogen, basic fibroblast growth factor (10 ng/ml), epidermal growth factor (10 ng/ml), sodium pyruvate and L-glutamine, and 5% FBS. All cultured cells were used within five passages of dissociation.
cell characterization: Single cells were sorted using anti-A2B5 MicroBeads (130-093-388, Miltenyi Biotec) according to manufacturer’s protocol. In brief, live cells were incubated first with FcR Blocking Reagent (Miltenyi) for 10 mins then A2B5 antibody for 15 min at 4oC (2.5 μg A2B5 antibody per million cells). Cells positive for A2B5 were double enriched by passing through magnetic field (MACS Separator) twice. Both A2B5 positive and negative fractions were collected, lysed with TRIzol (Invitrogen) for RNA isolation. A population of A2B5+ cells were plated and allowed to attach overnight before fixing and staining with standard immunofluorescence techniques. A2B5+ cells stained positive for GFAP (DAKO, 1:5000) and Nestin (DSHB, 1:200).
growth protocol: Human OPCs were differentiated from the human embryonic stem cell line H7 over a 154 day protocol (NIH Human Embryonic Stem Cell Registry WA07; NIH Approval Number: NIHhESC-10-0061) as previously demonstrated (Hu et al., 2009; Wang et al., 2013).
cell characterization: hESC-derived OPCs were characterized by co-staining of Sox10 (R&D Systems,AF2864; 1:100) and Olig2 (Millipore,AB9610 1:500).
growth protocol: IN528 cells from a primary patient derived GBM tumor model were injected subcutaneously into the flank of a immunocomprimised athymic nude mouse and allowed to grow into a tumor.
cell characterization: Cells were dissociated from the tumor and sorted on CD133 to collect the cancer stem cell population.
cell type: ENCODE EBV-immortalized B cell line
disease status: systemic lupus erythematosus (SLE)
bacterial infection: M. abscessus Smooth (MAB-S)-infected
bacterial infection: M. abscessus Rough (MAB-R)-infected
cell type: human colorectal metastatic adenocarcinoma
cell type: colorectal metastatic adenocarcinoma
cell type: colorectal primary adenocarcinoma
patient status: undergoing inguinal radical orchiectomy for a clinical diagnosis of testicular cancer
sample type: Human epididymis epithelial (HEE) cell cultures
cell type: Fibrolamellar hepatocellular carcinoma
tissue: nomral lung tissue adjacent to benign pulmonary tumors
tissue: idiopathic nonspecific interstitial pneumonia
cell type: metastatic renal cell carcinoma
shRNA: doxycycline-inducible shRNA against PNN
cell type: Polycystic biliary stem cells
disease state: control (clean resection edge liver metastasis)
lentivirus-introduced modification: Stably transduced with  shRNA to SREBF2
cell culture condition: 80nM PMA for 72h
lentivirus-introduced modification: Stably transduced with  shRNA to SREBF1
lentivirus-introduced modification: Stably transduced with Non-targeting shRNA
infection: Infected with Toxoplasma gondii
cell type: Primary lymphatic-specific endothelial cells
cell type: Primary blood-specific endothelial cells
molecule type: Ribosome protected fragments
cell line: H9 hESCs expressing pJAZ NLS-GFP-OsJAZ33
cancer type: Non-small cell lung cancer (NSCLC)
tumor type: high-grade serous ovarian cancer
cell line: HPV31-positive, CIN612-9E cells
treatment: dox to induce IFN-kappa expression
cell line: H3 hESC NKX2-10eGFP/alpha-MHC-mCherry
cell line: H3 hESC NKX2-11eGFP/alpha-MHC-mCherry
cell line: H3 hESC NKX2-9eGFP/alpha-MHC-mCherry
cell line: H3 hESC NKX2-8eGFP/alpha-MHC-mCherry
cell type: hESC derived cardiac progenitor
cell line: H3 hESC NKX2-7eGFP/alpha-MHC-mCherry
cell type: hESC derived endoderm progenitr
cell line: H3 hESC NKX2-6eGFP/alpha-MHC-mCherry
cell type: hESC derived mesoderm progenitor
cell line: H3 hESC NKX2-5eGFP/alpha-MHC-mCherry
tissue type: lesional skin from psoriasis patient
time point: after 1 month of adalimumab treatment
differentiation stage: Late basophilic erythroblasts
culture condition: EDM-II doxycycline+ (Day5)
differentiation stage: Early basophilic erythroblasts
culture condition: SFEM doxycycline+ (Day0)
cell type: CD14+ cells from peripheral blood
cell line: H1975 erlotinib-resistant H1975 cells (strain M1)
cell line: H1975 erlotinib-resistant H1975 cells (strain M2)
tissue: Muscle biopsy 2hr after surgery and tourniquet
tissue: Muscle biopsy immediately before surgery
tissue: Dissociated whole cerebral organoid
tissue: Microdissected cortical-like ventricle from cerebral organoid
genetic manipulation: CRISPR sgRNA p21enhancer_Tiling_Hit147
genetic manipulation: CRISPR sgRNA p21enhancer_Tiling_Hit38
genetic manipulation: CRISPR sgRNA p21enhancer_Tiling_Hit4
genetic manipulation: CRISPR sgRNA for Enhancer3507_Hit3
genetic manipulation: CRISPR sgRNA for Enhancer3507_Hit2
genetic manipulation: CRISPR sgRNA for Enhancer3507_Hit1
genetic manipulation: p53 silencing using shRNA
genetic manipulation: p53 targeting using CRISPR-Cas9
cell type: immortalized human bronchial epithelial cell
genotype/variation: expressing wild type LDB1
sample description: RNase L-KO HAP1 cells, Ribo-Zero sequencing
sample description: HAP1 cells, Ribo-Zero sequencing
sample description: RNase L-KO HAP1 cells, poly-A sequencing
sample description: HAP1 cells, poly-A sequencing
sample description: T47D cells semi-permeabilized with digitonin +2-5A for 9 minutes
sample description: T47D cells semi-permeabilized with digitonin +2-5A for 3 minutes
sample description: T47D cells semi-permeabilized with digitonin +2-5A for 1 minute
sample description: T47D cells semi-permeabilized with digitonin for 9 minutes
sample description: T47D cells semi-permeabilized with digitonin for 3 minutes
sample description: T47D cells semi-permeabilized with digitonin for 1 minute
genotype/variation: 36h scrambled RNA control
sample description: 36h scrambled RNA control followed by poly-IC treatment for 6h
sample description: 36h scrambled RNA control
genotype/variation: 36h RNAi for RNase L
sample description: 36h RNAi for RNase L followed by poly-IC treatment for 6h
sample description: 36h RNAi for RNase L
genotype/variation: 24h Overexpression of WT human RNase L
sample description: 24h Overexpression of WT human RNase L
sample description: 24h Overexpression of H672N RNase-inactive human RNase L
sample description: HeLa S10 extract treated with recombinant human RNase L + 2-5A for 5 seconds
sample description: Control HeLa RNA from S10 extracts
sample description: Control HeLa RNA from S10 extracts exposed to room temperature for 1 hr
sample description: HeLa S10 extract treated with 2-5A for 1 hr
time of analysis: 2h after infusion of trypsinised MSC
time of analysis: directly after trypsinisation
cell line: Parkin-expressing MRC5 fibroblasts
cell state: Mitochondrial deficient senescent
cell type: Laser Capture microdissected MNs from post-mortem spinal cord
cell type: human foreskin fibroblasts (HFFs)
incubated with: CAPERα-shRNA encoding retrovirus for 48hrs
incubated with: TBX3-shRNA encoding retrovirus for 48hrs
incubated with: control vector containing shRNA oligonucleotides targeting luciferase
growth conditions: OP9 co-culture in IMDM with 20%  FBS, IL3, IL6 and SCF
cell type: iPSC-derived neural progenitor cells
tissue: prefrontal cortex (Brodman Area 9)
tissue: Hepatocellular carcinoma primary tumor
tissue: HCC Non-recurrent Tumor's Adjacent Normal
definitions: RFA=Radiofrequency ablation; VATS=Video-assisted thorascopic surgery; OLT=Orthotopic liver transplantation; AFP=Alpha-fetoprotein
tissue: HCC Recurrent Tumor's Adjacent Normal
tissue: HCC Recurrent Tumor's  Adjacent Normal
treatment: control siRNA without IFNg treatment
tissue: frozen postmortem brain from NICHD
cell type: Adrenocortical carcinoma cells
cell type: Pancreatic adenocarcinoma cells
collection site: Atlanta VA Medical Center
no of uniquely mapped reads: 100,294,010
genetic background: HES5::eGFP BAC transgenic human ES cells (H9; WA-09; Wicell) expressing GFP under the HES5 promoter 
cell type: neural precursor cell derived neuronal like cells
collection site: U. Toronto Sunnybrook Research Centre
cell type: neural precursor cell derived astrocyte like cells
tissue: normal breast epithelial organoid
no of uniquely mapped reads: 101,038,395
tissue: Calcified tricuspid aortic valve
no of uniquely mapped reads: 123,211,885
no of uniquely mapped reads: 102,465,236
no of uniquely mapped reads: 251,516,583
no of uniquely mapped reads: 100,596,892
no of uniquely mapped reads: 111,754,397
cell type: Primary Monocytes(rest cell population after CD14+ selection)(BC13)
genetic manipulation: control CRISPR-Cas9 sgRNA